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Protein Folding Coupled to Disulphide Bond Formation
Thomas E. Creighton
European Molecular Biology Laboratory, Suite 312,
78 Marylebone High Street, London W1M 4AR UK
Protein folding that is coupled to disulphide bond for-
mation has many experimental advantages. In par-
ticular, the kinetic roles and importance of all the disul-
phide intermediates can be determined, usually un-
ambiguously. This contrasts with other types of pro-
tein folding, where the roles of any intermediates de-
tected are usually not established. Nevertheless, there
is considerable confusion in the literature about even
the best-characterized disulphide folding pathways.
This article attempts to set the record straight.
Key words: α-lactalbumin / BPTI / Folding pathways /
Kinetic intermediates / Ribonuclease A.
Introduction
Understanding in detail the mechanism of protein folding
in vitro requires knowing all the conformational states that
the protein encounters while it is folding, plus the limiting
transition state (Creighton, 1994). The unusual aspect of
protein folding is the very large number of conformations
accessible to a polypeptide chain of even modest size.
Folding generally occurs much more rapidly than expec-
ted for encountering the unique native conformation by
a random process amongst so many possibilities, even
as fast as within milliseconds for small proteins. Never-
theless, unfolded conformations will change on the 10~10 s
time scale, so a single molecule could sample a very large
number of conformations even during folding that is very
rapid. Moreover, an experimental sample of unfolded pro-
tein contains a large number of molecules, typically 1015to
1017, and each probably has a unique conformation upon
initiating folding. Therefore, a very large number of confor-
mations might need to be characterized with a typical ex-
perimental sample. Fortunately, the kinetics of refolding
are usually observed to be relatively simple and indicate
that all the unfolded molecules rapidly equilibrate confor-
mationally (unless they differ in some intrinsically slow iso-
merization, such as cis or frans peptide bonds, disulfide
bond topologies, etc.) and converge on what can be con-
sidered a single, common transition state.
Upon initiating refolding by changing the conditions,
proteins are observed to adopt a wide variety of confor-
mations very rapidly, before acquiring the fully folded
state. Some remain unfolded, others adopt partly-folded
conformations, while many adopt a compact but disor-
dered state that has come to be known as the 'molten glob-
ule' (MG) (Kuwajima, 1989; Ptitsyn, 1995). These relatively
stable partly-folded and MG conformations are frequently
assumed to be crucial for initiating the folding process, so
much effort has gone into characterizing them. This is
usually difficult experimentally, as kinetic intermediates
are present only transiently. Furthermore, they are at best
only partly folded, and their consequent conformational
heterogeneity makes them inherently difficult to charac-
terize; generally only an average conformation can be de-
termined, and there is even uncertainty about the exact
nature of unfolded polypeptide chains under unfolding
conditions, which are stable and can be studied at leisure.
Determining the kinetic roles of intermediate species,
as to whether they are kinetic intermediates, kinetic traps,
or simply the preferred conformational state of the un-
folded protein under refolding conditions, is especially dif-
ficult with a complex process like protein folding. There is
little direct evidence about the kinetic importance of most
stable folding intermediates that have been detected
(Creighton, 1990,1994,1995).
Many of the intrinsic complications and uncertainties
about experimental studies of protein folding can be over-
come by studying folding that is coupled to formation of
disulphide bonds between cysteine residues (Creighton,
1978,1992,1994). Using the appropriate methods, the ra-
tes of formation and breakage, and the stabilities, of pro-
tein disulphide bonds can reflect the role of the protein
conformation in bringing each pair of cysteine residues
into the appropriate proximity and keeping them there.
The most important attributes of this approach are the abi-
lity to trap and to characterize all disulphide intermediates
and to define their kinetic roles, usually unambiguously.
The trapped intermediates are stable, and their conforma-
tions can be determined in detail (van Mierlo ef a/., 1991,
1993,1994).
It is, of course, necessary that the process of disulphide
formation and breakage reflect the conformational folding
of the polypeptide chain, and not result from any peculiar
chemical properties of the cysteine sulphur atoms or the
chemistry involved in making disulphide bonds. The thiol-
disulphide exchange reaction (Figure 1) is well-under-
stood (Szajewski and Whitesides, 1980), readily control-
led, and easily interpreted. A crucial factor in this reaction
is that it is the ionized, thiolate form of the thiol group that
is the reactive species. Normal thiol groups of cysteine re-
sidues in aqueous environments tend to have pKa values
close to 8.7, but a nonpolar environment or nearby nega-
tive charges will increase this, while nearby positive char-
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Fig. 1 Formation of an Accessible Protein Disulphide Bond by
Thiol-Disulphide Exchange with a Reagent in the Thiol and
Disulphide Forms, RSH and RSSR, Respectively.
For a reagent like glutathione, with a thiol group or a disulphide
bond chemically like those of proteins, the intrinsic rate constant
for the thiol-disulphide exchange reaction between them is kex.
The rate constant most pertinent to protein folding is /c/nifa, which
includes the protein conformational transition involved in disul-
phide formation. If the protein disulphide bond is buried, the
reverse rate constant, for its reduction, will be lowered from the
indicated value of kex.
ges decrease the pKa. The value of the pKa determines
both the ionization of the thiol group and the intrinsic reac-
tivity of the thiolate anion (Szajewski and Whitesides,
1980). Fortunately, there are many techniques for meas-
uring the chemical reactivities of thiol and disulphide
groups, and the most appropriate methods used for disul-
phide formation and breakage yield such information di-
rectly in many instances. The pKa values of thiol groups
can be determined relatively easily by monitoring the ab-
sorbance at 240 nm of the thiolate anion (Polgär, 1974).
Discussions of the relevance of rates of disulphide forma-
tion to protein folding should emphasize the rate of the in-
tramolecular step, in which a second cysteine residue of
the protein displaces the mixed-disulphide on the first
(Figure 1); it is only this step in which protein conformatio-
nal folding is involved.
Disulphide folding studies are most informative about
protein folding if carried out at relatively high pH values
where the thiolate anion is present significantly. This mini-
mizes any difference in reactivity arising from differences
in pKa values of the thiol groups. The reactivities with
GSSG (Figure 1) of protein thiol groups having different
pKa values are nearly the same at pH 8.7, whereas they will
differ accordingly at lower and higher pH values (Darby
and Creighton, 1993). For example, a thiol group with a
pKa value that is 1.0 pH unit lower than normal will react
5-fold more rapidly at pH 7.4, but at the normal rate at pH
8.7. A further advantage of high pH is that the thiolate an-
ion is not readily buried, inhibiting the formation of quasi-
native conformations that are fully folded, but lacking one
or more disulphide bonds and with the unpaired cysteine
residues buried (see below). Such quasi-native species
can accumulate to high levels with very stable proteins at
low pH, and further disulphide formation is not governed
by protein folding but by thiol group accessibility and re-
activity. Minimizing the occurrence of quasi-native spe-
cies at high pH tends to keep disulphide formation cou-
pled to protein folding.
Although disulphide folding pathways can be eluci-
dated in detail, and relatively unambiguously, there is a
remarkable amount of confusion and controversy about
even the best-characterized disulphide folding pathways,
those of bovine pancreatic trypsin inhibitor (BPTI), bovine
ribonuclease A(RNaseA), and human and bovine a-lactal-
bumin (aLA). A number of misconceptions are very popu-
lar. This article attempts to set the record straight.
Unfolded Proteins Produced Simply by
Reducing Disulphide Bonds
The native conformations of small model proteins like
BPTI, RNaseA, and aLA unfold upon simply reducing all
their disulphide bonds, even under physiological condi-
tions and in the absence of denaturants. Reduced proteins
are stable indefinitely in the absence of oxidants, and the
unfolded state of the protein can be studied under the
same physical conditions as when folding occurs. Folding
and disulphide formation are initiated simply by adding
small amounts of an oxidant, usually a reagent like the di-
sulphide forms of glutathione or dithiothreitol (Figure 1).
Therefore, the same noncovalent interactions will be pres-
ent in both the unfolded and folded conformations, except
for the disulphide bonds. In contrast, the unfolded states
of other proteins are stable only under unfolding condi-
tions and are only transient under refolding condition. The
reduced proteins are useful stable models of such pro-
teins. Many theories of protein folding would predict that
they would generally undergo hydrophobic collapse,
adopt substantial secondary structure, or adopt the MG
conformation.
The starting point for considering the conformational
properties of unfolded proteins must be the idealized ran-
dom coil. The most realistic definition of a random coil is
one where the conformational properties of each residue
are independent of those of other residues distant in the
primary structure, and where there are no net interactions,
other than steric exclusion, between such distant resi-
dues. The average conformational properties of this en-
semble will depend primarily on the intrinsic conformatio-
nal preferences of the individual residues, which differ
amongst the various amino acids, and on their immediate
neighbors in the primary structure. The NMR properties
expected of such a random coil have been described
(Fiebig etal., 1996); they can correspond closely to the ob-
served properties of small unfolded proteins (Smith etal.,
1996).
One of the most thoroughly studied reduced proteins,
using a wide variety of techniques, is that of BPTI. Most,
but not all, of the evidence indicates that it is very unfol- t
ded, approximating a random coil, but with weak interac- \
tions between groups close in the sequence. NMR spec-
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tra of reduced BPTI, with the thiol groups free, blocked co-
valently, or replaced by other side chains (Kemmink and
Creighton, 1993; Lumband Kim, 1994; Ferrer ef a/., 1995;
Pan ef a/., 1995), are similar to each other and to a set of
overlapping peptides representing the entire primary
structure (Kemmink and Creighton, 1993). Therefore, only
local interactions between groups close in the primary
structure can be present. The simplicity of the peptides
made it possible to characterize those local interactions
that are present (Kemmink and Creighton, 1995). Those
most apparent by NMR involved aromatic side-chains in-
teracting with nearby nonpolar groups or a glycine back-
bone NH group. Each of these interactions was between
residues no more than two apart in the sequence, and the
same interactions were present in short peptides, some of
only four residues. Therefore, the interactions are strictly
local in nature, and they could be studied easily. Two in
particular could be characterized in detail and quantified
(Kemmink and Creighton, 1995); both are weak, being
present only about 26% and 64% of the time at 10 °C and
having favourable enthalpies of interaction of about -3
kcal/mol. Such weak interactions can be either readily
disrupted to adopt alternative conformations or used and
strengthened by further folding of the polypeptide chain;
examples of both types were observed (Kemmink and
Creighton, 1993).
Other studies of reduced BPTI confirmed the presence
of these interactions (Lumb and Kim, 1994; Pan ef a/.,
1995). A very detailed study of the intact protein (Pan ef a/.,
1995) claimed also to detect many further examples of
such local interactions, but the possibility that this was
due to NMR spin diffusion was not ruled out. The local in-
teractions present in reduced BPTI have been described
as 'extensive' (Pan ef a/., 1995) and to indicate the pres-
ence of a 'hydrophobic cluster' (Lumb and Kim, 1994) or a
'molten coir state (Barber ef a/., 1995). In reality, they are
isolated, independent and weak interactions between
only pairs of residues close in the covalent structure. Other
than for a slight tendency to adopt an α-helix near the C-
terminus, no evidence for any cooperative interactions or
folded structure in reduced BPTI has been presented.
One of the most contentious issues is the overall com-
pactness of the reduced BPTI molecule, with claims that it
is not expanded like a random coil but very compact like a
MG (Ittah and Haas, 1995) or a 'molten coil' state (Barbar
ef a/., 1995). There is considerable evidence that reduced
BPTI is not compact, including the absence of NMR inter-
actions between groups distant in the primary structure,
the similarity of the chemical shifts of protons in intact
reduced BPTI and in short peptides (Kemmink and
Creighton, 1993; Pan ef a/., 1995), and its electrophoretic
mobility in non-denaturing polyacrylamide gels. The elec-
trophoretic mobility, relative to the same protein in the na-
tive conformation, is a sensitive measure of overall molec-
ular dimensions. The decreased mobility of reduced BPTI
is very close to that of a very unfolded polypeptide. In con-
trast, true MG states have compactness and electropho-
retic mobilities very close to that of the native conforma-
tion (Ewbank and Creighton, 1993a). Moreover, the elec-
trophoretic mobility of reduced BPTI is not affected by
urea or by various amino acid replacements (Goldenberg
and Zhang, 1993). Only one very slight change was detec-
ted (in mutant G12V), and it can be explained by abolishing
one of the local interactions noted in reduced BPTI and
peptides, of the TyrlO side-chain with the NH of residue
12, which occurs only when the latter is Gly (Kemmink and
Creighton, 1993).
Compact but unfolded protein molecules, especially
MGs, tend to bind the dye ANS (1 -anilinonaphthalene-8-
sulfonate) and to enhance its fluorescence. Weak enhan-
cement of ANS fluorescence by reduced BPTI has been
taken to indicate that the protein is a 'molten coil1 and not
fully unfolded (Ferrer ef a/., 1995). This presumed binding
of ANS to reduced BPTI was claimed to have been missed
in an earlier study (Darby and Creighton, 1993), but the ex-
perimental observations were actually very similar in the
two studies. The enhanced fluorescence appeared insig-
nificant in Darby and Creighton (1993) because it was
being compared to that by a true MG. Reduced BPTI does
apparently bind somewhat more ANS than does native
BPTI, but this is only a small fraction of that exhibited by a
true MG (Darby and Creighton, 1993). Any unfolded pro-
tein will have more exposed nonpolar surface area acces-
sible to ANS than the folded, native conformation, so
slightly greater binding under the same conditions does
not necessarily mean the presence of a collapsed state.
The experimental evidence that most dramatically sug-
gests a compact conformation for reduced BPTI comes
from energy transfer between fluorescent groups intro-
duced into the protein, which indicated distances too
short for an unfolded polypeptide chain (Ittah and Haas,
1995). This may, however, result from physical attractions
between the two bulky aromatic fluorescent groups that
were introduced into the protein for the fluorescence
measurements. An attraction between the two groups
was indicated by the observation of intermolecular energy
transfer between them when they were present at only
micromolar concentrations on different reduced BPTI
molecules (Ittah and Haas, 1995), concentrations much
lower than those where unmodified reduced BPTI aggre-
gates. They are also lower than the millimolar 'effective
concentrations' of two groups within the same molecule of
reduced BPTI (Darby and Creighton, 1993). Therefore, the
attractive interactions between the separate molecules
observed at micromolar concentrations will be much
greater when they are attached to the same BPTI mole-
cule. I n this case, the two fluorescent groups would tend to
associate with each other and consequently would report
distances shorter than those that would be present in their
absence.
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Disulfide Formation in Unfolded Polypeptide
Chains
In addition to their direct physical properties, the confor-
mational properties of reduced proteins can be further
inferred from what disulphide bonds they form initially
(Figure 2). A random coil will introduce disulphide bonds
between the various cysteine residues not close in the co-
valent structure in proportion to n'3/2 to n~5/2, where n is the
number of residues between the cysteine residues. Even
only small amounts of unstable nonrandom conformation
that brings two cysteine residues into proximity to form a
disulphide bond will be apparent by a preponderance of
disulphide bonds being formed between these two cys-
teine residues (Figure 2B). For example, a nonrandom
conformation that is present in only 1 % of the reduced
protein molecules, but stabilizes a particular disulphide
bond by a modest factor of 102, will double the preponder-
ance of that particular disulphide bond over the expected
statistical level.
Whatever effect a folded conformation has on the sta-
bility of a disulphide bond, the disulphide bond must have
the same quantitative effect on the stability of the folded
conformation (Figure 2A). Therefore, any nonrandom con-
formation that stabilizes a particular disulphide bond must
be stabilized to the same extent by the presence of that
disulfide bond. The stabilizing conformation might be too
Kronf —
Fig. 2 The Predicted Effects of an Element of Nonrandom Con-
formation that Stabilizes a Particular Disulphide Bond in a Protein.
(A) The stability of the folded conformation in the species with that
disulphide bond for various stabilities of the nonrandom confor-
mation in the reduced protein, K5onf,and for various linkage fac-
tors, C, by which the conformation and the disulphide bond stabi-
lize each other. Consider a reduced protein with two or more
cysteine residues that is largely unfolded, Ρυ, but has a tendency
to adopt a folded conformation, RF, that brings two cysteine resi-
dues into correct proximity for forming a disulphide bond. The
equilibrium constant for this conformational equilibrium is
PF]
[Ru] (1)
The disulphide bond formed will be more stable in RF\han in RUt
by a factor taken to be C. It is a thermodynamic necessity that the
presence of the disulphide bond, in the species I, stabilizes the
folded conformation by the same factor C:
KS- CK5* (2)
Disulphide formation and folding are therefore linked functions,
and the two phenomena must have the same quantitative effect
on each other. For example, if the folded conformation stabilizes
a disulphide bond by a factor of 102 (C = 102) and the folded con-
formation is present in the reduced protein only 1 % of the time
(Kcont = 10"2). it will be present 50% of the time in the one-disul-
phide species I (K^nf = 1)·
(B) The effect on the equilibrium concentration of the species I
with the stabilized disulphide bond. The particular one-disulphide
species I will normally be in equilibrium, by intramolecular disul-
phide interchange, with all the other one-disulphide species, de-
signated here as 1SSu- In the ideal unfolded, random-coil unfol-
ded state, this equilibrium will be statistical in nature and depend
simply upon the distances in the primary structure between all the
various pairs of cysteine residues:
111
Kstat 1SSu (3)
On average, the equilibrium constant Ksfaf will have the approxi-
mate value of n -1, where π is the number of 1 -disulphide species
possible. The presence of the folded form of I, IF, as in Equation 2,
will increase the total amount of species I:
I Kcon> ι * s^tat 1QQ IA\
The fraction of one-disulphide molecules present as I will be given
by
C Kconf + 1
Kstat
(5)
This is depicted here for an average case where the protein has six
cysteine residues, Kstat = 14.
unstable to be populated substantially in the reduced pro-
tein, but it will be populated substantially more in the pre-
sence of the disulphide bond. The greater the stability of
the nonrandom conformation in the absence of the disul-
phide bond, the greater its stability in the presence of the
disulphide bond. Nonrandom conformations in a reduced
protein populated sufficiently to make disulphide for-
mation nonrandom must be present in substantial, de-
tectable amounts when the favoured disulphide bond is
present. Therefore, it must be possible to detect and to
characterize such a conformation.
Reduced BPTI
As expected for a random coil, reduced BPTI forms its first
disulphide bonds nearly randomly, and most of the one-
disulphide species formed are unfolded (Darby and
Creighton, 1993). The first disulphide bonds formed direct-
ly are rearranged intramolecularly, however, and the re-
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suiting equilibrium mixture is not statistical. The partly-
folded (30-51) intermediate (van Mierlo ef a/., 1993) pre-
dominates, because it has a partly-folded conformation
and a decreased free energy, but it folds only after the di-
sulphide bond is formed (Darby and Creighton, 1993). Its
partly-folded conformation is not expected to be suffi-
ciently stable in the reduced protein to be apparent
(Creighton, 1988).
An exception to statistical disulfide formation in redu-
ced BPTI has been reported (Dadlez and Kim, 1995), in
that, under some conditions, a disulphide bond is formed
most rapidly between Cys 14 and 38; this disulphide bond
is also present in native BPTI. This has been claimed to in-
dicate the presence of native-like conformation in the re-
duced protein (Dadlez and Kim, 1995). If so, the (14-38)
intermediate should have been stabilized relative to the
other one-disulphide intermediates (Figure 2B), and that
nonrandom conformation should have been present in the
(14-38) intermediate (Figure 2A). The large magnitude of
the kinetic effect in the reduced protein in this case should
result in the nonrandom conformation being exceptionally
stable in the presence of the disulphide bond. Neither con-
sequence was observed (Dadlez and Kim, 1995), how-
ever. The (14-38) intermediate is not more stable than the
others; it rearranges very rapidly to the others, and they
predominate at equilibrium. Also, an analogue of the inter-
mediate (14-38) was reported to be unfolded under the
same conditions (Dadlez and Kim, 1995). [Replacing the
other free cysteine residue with α-amino-n-butyric acid
residues produced a partly-folded structure, but only at
very low temperatures (Ferrer ef a/., 1995; Barbar et a/.,
1995)].
Rather than nonrandom conformation, the observa-
tions indicated that the greater rate of formation of the 14 -
38 disulphide bond in reduced BPTI is due to an exceptio-
nal reactivity of the Cys14 and Cys38 sulphur atoms. This
is probably for electrostatic reasons, for the phenomenon
occurs primarily at pH 7.3, much less under the more alka-
line conditions that are more appropriate for characteri-
zing disulphide folding pathways. Some enhanced reac-
tivity of the Cys14 and 38 thiol groups was detected by
chemical modification even at alkaline pH (Creighton,
1992), and it should be enhanced at lower pH values
(Darby and Creighton, 1993). It is probably due to the pres-
ence of basic residues adjacent to both Cys14 and Cys38
in the primary structure, respectively Lys15 and Arg39. It is
known that adjacent basic or acidic residues can alter the
ionization and reactivities of cysteine thiol groups and their
tendency to make disulphide bonds (Snyder ef a/., 1983).
A subsequent study of the reactivities of the individual cy-
steine residues in analogues of reduced BPTI and in short
peptides confirmed the greater reactivity of the Cys14 and
38 thiol groups and indicated that it was due solely to local
interactions that were not affected by urea (Dadlez and
Kim, 1996). Likewise, the reactivities of the cysteine thiol
groups were quantitatively the same in the peptides and in
reduced BPTI, indicating the absence of any stable folded
conformation in reduced BPTI affecting them.
Such anomalous thiol reactivity effects should be mini-
mized if disulphide bond formation is to provide informa-
tion about protein conformation and folding. Their sub-
stantial magnitude in Cys14 and Cys38 in the study of
Dadlez and Kim (1995,1996) is undoubtedly due to the use
of the relatively low pH of 7.3, where differences due to
thiol pKa are much greater than at higher pH. It was con-
cluded from that study that reduced BPTI is compact, but
the only experimental evidence indicating that was a smal-
ler than expected variation in the rate of the intramolecular
step in disulphide formation with distance between the
cysteine residues in the primary structure. A much greater
dependence was observed in the earlier study with five of
the fifteen possible pairs of cysteine residues at the more
appropriate pH 8.7 (Darby and Creighton, 1993). In any
case, studies of disulphide formation in proteins where ei-
ther or both Cys14 and 38 are blocked or removed indicate
that they have no special role in forming the first disulphide
bonds, although they do at the two-disulphide stage
(Creighton, 1977a; Marks ef a/., 1987; Goldenberg, 1988;
Darby ef a/., 1995).
Reduced Ribonuclease A
Reduced RNaseA also appears from most of its properties
to be very close to a random coil. Nevertheless, it was pro-
posed, on the basis of enzyme activity and immunological
measurements, that the native conformation is present in
1.5 to 6% of reduced RNaseA molecules (Garel, 1978;
Chavez and Scheraga, 1980). If so, the first disulphide
bonds formed in this reduced protein should have been
predominantly between native pairs of cysteine residues,
and the native conformation should have been greatly sta-
bilized when the native disulphide bonds formed (Figure 2)
(Creighton, 1988). Therefore, essentially all the one-disul-
phide species generated should have had native disul-
phide pairings and the fully folded native conformation. In
reality, all the studies indicate that many different disul-
phide bonds are formed initially in reduced RNase A and
that these intermediates are all unfolded (Creighton, 1979;
Xu ef a/., 1996), as expected if reduced RNase A is a ran-
dom coil.
The greatest reported exception to random disulphide
formation in reduced RNaseA is that between two cys-
teine residues very close in the primary structure, Cys65
and Cys72, which is present in the equilibrium mixture of
one-disulphide species 2.4-fold more than expected (Xu
ef a/., 1996). This comparison was based, however, on
simple statistical calculations using solely the number of
residues between the cysteines that did not take into ac-
count the intrinsic conformational tendencies of the poly-
peptide chain. The same relative stability of the 65-72
disulphide bond was found in a short peptide of only
residues 58 to 72 (Altmann and Scheraga, 1990), indi-
cating that the cause of this stability is strictly local in the
polypeptide chain. It was attributed to a favourable back-
bone geometry and does not result from a nonrandom
conformation due to the presence of stabilizing noncova-
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lent interactions between groups distant in the covalent
structure. The other one-disulphide intermediates appear
to be much closer to their expected simple statistical dis-
tributions (Creighton, 1979; Xu et a/., 1996), indicating that
there are probably no noncovalent interactions between
groups distant in the covalent structure of reduced
RNaseA that affect significantly the relative proximities of
any other pairs of the eight cysteine residues. Therefore,
all these observations are consistent with reduced RNase
A closely approximating a random coil.
The observations with reduced BPTI and RNaseA dem-
onstrate that unfolded proteins under physiological, fol-
ding conditions can remain very unfolded and approxi-
mate random coils. The nonrandom structure that is
apparent in some instances is due to weak, local interac-
tions between groups close in the primary structure. The
weakness of these interactions makes them readily bro-
ken by productive folding; alternatively, they can be
strengthened if they favour further interactions and then
ultimately incorporated into the final folded structure
(Kemmink and Creighton, 1993). Such local interactions
presumably can also influence the average overall confor-
mational properties of the unfolded polypeptide chain, but
it otherwise remains unfolded. There is no general hydro-
phobic collapse or other substantial interactions between
residues distant in the primary structure.
The MG Conformation of a-Lactalbumin
Reduced aLA exists as an equilibrium mixture of unfolded
and MG conformations (Kuwajima, 1989). The unfolded
state of reduced aLA is not as well-characterized as that of
reduced BPTI and RNaseA, but its general properties sug-
gest that it is similar (Ewbank and Creighton, 1993b). A
detailed study of the homologous hen lysozyme found a
situation similar to that in reduced BPTI, approximating a
random coil with some of the same types of solely local in-
teractions (Fiebig et a/., 1996). The presence of the MG
conformation in reduced aLA is apparent from its
(1) relative compactness (Kuwajima, 1989; Ewbank and
Creighton, 1993b),
(2) substantial content of secondary structure (Kuwajima,
1989),
(3) significant binding of ANS (Ewbank and Creighton,
1993b),and
(4) the distribution of disulphide bonds it forms (Ewbank
and Creighton, 1993a).
The equilibrium between the MG and unfolded conforma-
tions is gradually shifted by denaturants to the unfolded
state.
Reduced aLA forms very many different first disulphide
bonds, mostly non-native. The main effect of its MG con-
formation is to bring cysteine residues distant in the pri-
mary structure into closer proximity than they would be in
a fully unfolded conformation (Ewbank and Creighton,
1993a; Creighton and Ewbank, 1994). None of the disul-
phide bonds, native or non-native, have much effect on
the stability of the MG conformation. With three disulphide
bonds, non-native disulphide pairings are much more
stable in the MG conformation than the native pairings
(Ewbank and Creighton, 1991,1993a). Moreover, the non-
native pairings maintain the MG conformation, which can-
not have a native-like topology in these instances.
All of the experimental observations indicate quite un-
ambiguously that the MG conformation of aLA is very dis-
ordered and without a fixed backbone topology in the ab-
sence of native-like constraints, such as the four native
disulphide bonds. Nevertheless, the contrary conclusion
has been reached in another study because one particular
native disulphide bond was found to be more stable than
two non-native alternatives (Peng and Kim, 1994; Wu ef
a/., 1995; Peng ef a/., 1995). Some observations of that
study suggest that the conformation stabilizing this par-
ticular disulphide bond might be the native conformation
rather than the MG (Creighton, 1997). In any case, the
slight preference for this one disulphide bond, which is be-
tween cysteine residues near the ends of the polypeptide
chain, is insignificant when compared to all the other to-
pologies and disulphide bonds that this MG conformation
can adopt.
Pathways of Disulphide-Coupled Folding
The pathways of disulphide formation and folding have
been elucidated in vitro to varying extents for reduced
BPTI, RNase A, and aLA (Figure 3). They demonstrate
similar general properties, but with variations (Creighton,
1992; Creighton ef a/., 1995).
Disulphide formation in an unfolded reduced protein is
essentially random (when corrected for any differences in
reactivities of the cysteine thiol groups), depending prima-
rily upon the distance in the primary structure between the
pairs of cysteine residues. The resulting disulphide inter-
mediates will tend to have random disulphide bonds,
which can rapidly interchange intramolecularly, and to re-
main unfolded. Each disulphide bond introduced sequen-
tially into an unfolded protein is increasingly unstable, un-
less stabilized by the adoption of a folded conformation.
An example is RNaseA, which readily forms up to two di-
sulphide bonds randomly, but third disulphide bonds are
formed only slowly and are very unstable (Creighton,
1979). The presence of the compact MG conformation pri-
marily increases the probability of forming a disulphide
bond between cysteine residues distant in the primary
structure, as in reduced aLA (Ewbank and Creighton,
1993a). If the polypeptide chain has sufficient tendency to
adopt a fixed conformation that brings two particular cys-
teine residues into proximity, the disulphide bond between
them will be more stable than the other possibilities and
the folded conformation will be stabilized (Figure 2); an ex-
ample is the partly-folded (30-51) intermediate of BPTI
(Figure 4) (van Mierlo ef a/., 1993). Such partly-folded con-
formations will increase the rate of forming disulphide
bonds between cysteine residues brought into proximity
(unless that disulphide bond will become buried, see be-
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(5-55, 14-38)N
(30-51,5-38)PF
+
(30-51, 5-14)PF
(30-51,5-55)N
(30-51,14-38)N
B R„ 2SSu- 3SSu
4SSu
C RU/MO - ^SSu/MG « 2SSU/MG
(61-77,73-91)MC/ir
3SSU/MG
(28-lll,61-77,73-91)MG/u •NN/MG
2-f(61-77,73-91) Ca;F • (28-111,61-77,73-91) Ca^"· NCa,
Fig. 3 The Disulphide Folding Pathways of (A) BPTI; (B) RNase A; (C) a-LA
In each case, R is the fully reduced protein. Intermediates with specific disulphide bonds are indicated by the residue numbers of the cys-
teine residues paired. A mixture of many isomers with different disulphide bonds (which are usually interconverting by intramolecular di-
sulphide rearrangements when thiol groups are also present) is depicted by the number of disulphide bonds present, e.g. 1 SS, 2SS, 3SS
and 4SS. Arrows to and from such species can represent the collective formation, breakage or rearrangement of many different disulphide
bonds. The designation 3NSS indicates that all three disulphide bonds are native-like. N is the protein with all the native disulphide bonds:
(30-51,14-38,5-55) in BPTI; (26-84,40-95,58-110,65-72) in RNase A; and (6-120,28-111,61 -77,73-91) in «LA. The arrows indi-
cate the most important steps, in kinetic terms, and can involve either disulphide formation, breakage, or rearrangement. The predomi-
nant conformations of the various species are indicated by the subscripts U (unfolded), MG (molten globule), PF (partly-folded), and N
(native). Where two or more conformations are present substantially in equilibrium, there are separated by/. The brackets in (A) indicate
that the one-disulphide intermediates included are in equilibrium; the V between two more species indicates that they have the same
kinetic roles.
low), while inhibiting it when the cysteine residues are kept
apart.
Disulphide formation continues in this way, depending
upon any change in conformation, until blocked by
(1) the instability of further disulphide bonds,
(2) the acquisition of a quasi-native folded conformation
(see below), or
(3) encountering a kinetic block (see below).
In very many cases, the kinetic block is overcome by intra-
molecular disulphide rearrangements, to reach the fully
native conformation with all the disulphide bonds.
The variations on the disulphide-coupled folding path-
ways (Figure 3) are similar to variations observed in protein
folding not involving disulphide formation (Creighton,
1994). Some proteins remain unfolded until undergoing an
all-or-nothing folding transition, comparable to RNaseA,
which forms initially only random disulphide bonds. In
other proteins, the MG conformation is populated during
folding, as in the case of α-LA. In others, partly-folded in-
termediates are detected, as in BPTI (Figure 4).
Quasi-Native Species
In general, a protein disulphide bond generally simply sta-
bilizes a pre-existing protein conformation. The degree of
stabilization is determined by
(1) the distance between the cysteine residues in the pri-
mary structure (which determines the loss of confor-
mational entropy in forming the disulphide bond and
the consequent destabilization of the unfolded state),
(2) the free energy of the disulphide bond itself and the
extent to which the folded conformation stabilizes it
(Goldenberg and Creighton, 1985), and
(3) any interactions of the thiol groups with the reduced
form of the protein (Creighton ef a/., 1995).
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Others
HS.
(30-51, 5-55) (30-51,5-55, 14-38)
Native
(30-51) (30-51,5-14)
(30-51, 14-38)
Fig. 4 The Conformational Basis of the Productive Disulphide Folding Pathway of BPTI.
The major disulphide intermediates at pH 8.7 are depicted with their approximate conformations indicated schematically; solid portions
of polypeptide backbone are unfolded or very flexible. The non-productive quasi-native species (5-55) and (5-55,14-38) are omitted.
The relative rates of the most prominent steps, refering to the value of kintra (Figure 1), are indicated semi-quantitatively by the thickness of
the appropriate arrowhead; the wider the arrowhead, the greaterthe rate in that direction.
If the last factor is especially favourable, even intrinsically
stable disulphide bonds can destabilize a folded con-
formation (Creighton eta/., 1995).
In many cases, the native conformation of a protein is
sufficiently stable to withstand the loss of one or more sta-
bilizing disulphide bonds. For example, the very same
folded conformation is observed, but with varying stabili-
ties, with BPTI lacking any one of its three disulphide
bonds, and even in one instance when it is lacking two (van
Mierlo etal., 1991,1993). Less stable homologues of BPTI
do not adopt the native-like conformation in the less stable
of these species (Kortemmeef a/., 1996). RNaseTI with
just the 6-103 disulphide bond adopts a native con-
formation (Pace and Creighton, 1986; Mayr ef a/., 1994).
Two such native-like species have been detected with
RNaseA, one lacking the 40-95 disulphide bond (Creigh-
ton, 1980; Lief a/., 1995), the other the 65-72 (Tallurief a/.,
1994). aLA lacking the 6-120 disulphide bond maintains
a native-like conformation if Ca2+ is bound (Kuwajima et
a/., 1990; Ewbankand Creighton, 1993b)
Such species with incomplete disulphide bonds are
fully folded, so they are designated as 'quasi-native'. In
these species, forming the missing disulphide bonds is
not coupled to protein folding. Instead, the rate of disul-
phide bond formation depends primarily upon the acces-
sibility and reactivity of the protein thiol groups (Figure 1).
If the cysteine thiol groups are readily accessible, disul-
phide bonds can be formed very rapidly because the cy-
steine residues are in appropriate proximity, as occurs in
the (30-51,5-55) intermediate, also designated N|H, of
BPTI, and such disulphide bonds are generally formed last
during disulphide folding (Figure 4). In contrast, cysteine
thiol groups that are buried in the interior of the folded con-
formation and are inaccessible to disulphide reagents
(Figure 1) cannot be formed readily. A most extreme ex-
ample is species (5-55,14-38) of BPTI, where the two re-
maining thiol groups of Cys30 and Cys51 are buried, inac-
cessible and unreactive (States et a/., 1984; Creighton and
Goldenberg, 1984; Eigenbrot ei a/., 1992). In addition,
there is a kinetic block in forming any protein disulphide
bond that will be buried after it is formed by the protein
conformation (see below), irrespective of whether or not
the cysteine thiol groups are reactive.
The kinetic roles of such quasi-native species, in which
final disulphide formation is blocked and not linked to
folding, is not of immediate relevance to protein folding.
For example, there are many unresolved questions about
why the quasi-native species of RNaseA lacking the 65-
72 disulf ide bond can be observed only with very high con-
centrations of reducing agent and trapped by some un-
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usual methods (Talluri et a/., 1994; Li et a/., 1995), and not
by others (Creighton, 1979; Wearne and Creighton, 1988).
The discrepancy is usually attributed to the difficulties of
trapping by reacting buried residues (Li et a/., 1995), but
the study of Wearne and Creighton (1988) also used un-
folding in urea that should not have been limited by thiol
group unreactivity. A more likely explanation is that in the
latter study, where the intermediate could not be detected,
the rate of generation of this intermediate by reduction
with moderate concentrations of thiol reagent was slower
than its disappearance, probably by intramolecular disul-
phide rearrangements; therefore, the intermediate was
not populated substantially in this case but was with the
very high thiol reagent concentrations. The important con-
clusion that the rate-limiting step in disulphide breakage
and unfolding of RNase A is normally reduction of the first
disulphide bond was confirmed by the other study (Li et
a/., 1995). In any case, the uncoupling between protein
folding and disulphide formation in quasi-native species
implies that the details of the pathway followed are unlikely
to provide information about protein folding. The accumu-
lation of such quasi-native species should be minimized
by carrying out studies at alkaline pH, where the cysteine
thiol groups tend to be ionized and, therefore, less likely to
be buried in a folded conformation.
A more positive aspect of quasi-native conformations
is that they demonstrate that disulphide bonds do not de-
termine the folded conformation, as is often mistakenly
stated, but only stabilize it. The very same folded confor-
mation is observed in BPTI species lacking any one of the
three native disulphide bonds (States ef a/., 1984; van
Mierloefa/., 1991; Eigenbrot ef a/., 1992).
A reexamination of the BPTI folding pathway found the
quasi-native species (5-55), (5-55,14-38) and (30-
51,14-38) to predominate and assigned them the most
important roles in the folding process (Weissman and Kim,
1991). The especially large quantities of these intermedi-
ates that accumulated in that study were due, however,
primarily to the use of a low pH, 7.4, where they are more
stable. Furthermore, these intermediates accumulate to
high concentrations because there is a kinetic block in
completing disulphide formation (Creighton, 1977a). The
great accumulation of these quasi-native species dis-
tracted from the important kinetic intermediates, which
occurin lower quantities and more transiently (Darby ei a/.,
1995).
Kinetic Blocks in Disulphide Formation
In virtually all the known disulphide folding pathways
(Figure 3), there occurs a kinetic block to the formation of
particular disulphide bonds, in that these bonds are for-
med very much more slowly, if at all, than those preceding;
in some cases alternative disulphide bonds are formed
more rapidly. In each case, forming the disulphide bond
that is blocked would produce a stable folded conforma-
tion in which that disulphide bond would be buried and in-
accessible. Usually, these are native disulphide bonds.
The best-characterized example is the kinetic blockage in
forming the 30-51 disulphide bond in the intermediates
(5-55) and (5-55,14-38) of BPTI (Figure 4). In both in-
stances, very stable, fully folded native conformations
would result.
The reason for these kinetic blockages is apparent from
the kinetics of the reverse step, reduction of the buried di-
sulphide bond (Creighton, 1978; Creighton ei a/., 1995).
The kinetics of disulphide formation and breakage in BPTI
have been shown to follow microscopic reversibility, in
that the ratio of the rate constants for both directions of
forming any disulphide bond is the same as the measured
equilibrium constant forthat step; consequently, the same
transition state is encountered in both directions. Reduc-
ing a disulphide bond buried in a stable folded conforma-
tion by reaction with a thiol reagent (Figure 1) is slow and
has a high free energy barrier, because the folded confor-
mation must be perturbed or unfolded for the reagent to
gain access to the disulphide bond. Buried disulphide
bonds also tend to be the most stable in a folded confor-
mation (Creighton and Goldenberg, 1984). Generally, it is
the first step in reducing the disulphide bond that is rate-
limiting. Due to microscopic reversibility, the same high-
energy transition state is encountered in forming the disul-
phide bond, and the same step is slow in this reverse di-
rection. Consequently, forming a disulphide bond that will
become buried in a stable folded conformation is expec-
ted to be slow. This should be a general phenomenon, but
it is presently uncertain whether it occurs only when the
species lacking the disulphide bond is already at least
partly folded (Mendozaef a/., 1994; Creighton ef a/., 1995).
In the disulphide unfolding process, accessible disul-
phide bonds on the protein surface tend to be the least
stable and the most reactive and accessible to the thiol
reagent. Consequently, they are the first to be reduced in
the native conformation. Likewise, such accessible disul-
phide bonds also tend to be formed last in disulphide fold-
ing. In this case, both forming and breaking disulphide
bonds tend to occur most readily by intramolecular disul-
phide rearrangements, using the thiol groups of the ac-
cessible cysteine residues.
These principles are well-illustrated by the BPTI folding
pathway (Figure 4) (Creighton, 1977a). The first kinetic
block encountered occurs with the very slow formation of
the 5-55 disulphide bond in the partly-folded interme-
diate (30-51). The reason is that the stable folded confor-
mation of (30-51,5-55) would result, in which the 5-55
disulphide bond would be stable and buried and, there-
fore, reduced only slowly. The very slow rate measured for
forming this disulphide bond is that expected from the rate
constant for reducing this disulphide bond and the infer-
red equilibrium constant for the process. The second ki-
netic block occurs in forming the 5-55 disulphide bond in
the quasi-native species (30-51,14-38), which would
produce the fully folded native conformation of BPTI with
all three disulphide bonds. Again, reducing the 5-55 di-
sulphide bond in native BPTI is very slow, and the very
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slow reverse rate of its formation is that expected simply
on this basis. The same kinetic block would be expected in
forming the 30-51 disulphide bond in (5-55,14-38), but
this is obscured by the inaccessibility and unreactivity of
the CysSO and 51 thiol groups in this quasi-native two-di-
sulphide species (States ef a/., 1984; Creighton and
Goldenberg, 1984).
Although these principles have been established only in
BPTI, the kinetics of disulphide formation observed with
other comparable proteins indicate that they also apply
there (Creighton et a/., 1995); they would be expected to
be universal.
It might be thought that these principles would be spe-
cific for disulphide bonds, but it has been pointed out that
qualitatively similar, although smaller quantitatively, ener-
getic considerations would be expected with hydrogen
bond formation [Figure 9 of Creighton (1978)]. Other fac-
tors being equal, forming hydrogen bonds that will be bu-
ried in the protein interior should be more rapid when it oc-
curs by hydrogen bond exchange (involving either other
hydrogen bonding groups of the protein or solvent water)
than by forming hydrogen bonds in isolation. In that re-
gard, it may be pertinent that formation of buried polar in-
teractions has been shown to be a slow step in acquisition
of the fully folded state of a protein not involving disulphide
bonds (Waldburger eta/., 1996).
Kinetic Blockages and Thiol Group Reactivity
In some BPTI intermediates in which there is a kinetic
block, such as (5-55,14-38), the cysteine thiol groups
are buried and inaccessible (States ef a/., 1984; Creighton
and Goldenberg, 1984). That factor alone would appear
sufficient to explain why a disulphide bond cannot be form-
ed readily between them. Probably for that reason, it has
become a popular idea that kinetic blocks generally occur
because of the folded conformation and because of the
thiol groups being inaccessible and nonreactive (Goto
and Hamaguchi, 1981; Weissman and Kim, 1991,1995).
Nevertheless, this is not correct, as the experimental data
in other instances demonstrate directly and unam-
biguously (Creighton, 1981).
It is straightforward to determine whether a kinetic
block in disulphide formation occurs because the slow
step is reaction of the protein thiol groups with the disul-
phide reagent or the second step of displacement of the
resultant mixed-disulfide (Figure 1). If the latter step is
slow, the mixed-disulphide intermediate will be generated
at a normal rate, but it will not disappear rapidly; conse-
quently, it will accumulate to a substantial extent. If, on the
other hand, the initial reaction of the Cys thiol group with
the reagent is the slow, rate-determining step, the mixed
disulphide will be generated only slowly and will then be
rapidly displaced by the second reaction; consequently,
the mixed-disulphide will not accumulate substantially,
even less than in forming a disulphide bond with no kinetic
block. Therefore, the accumulation of substantial levels of
the mixed-disulphide species is direct and positive evi-
dence that the reactivity of thecysteine thiol group was not
the rate-limiting step (Creighton, 1981).
The experimental observations with the BPTI (30-51)
and (30-51,14-38) intermediates are unambiguous and
unequivocal. During folding of reduced BPTI with GSSG
as disulphide reagent at pH 8.7, where the quasi-native
(5-55) is not populated substantially, only two interme-
diate species are observed to accumulate as -SG mixed-
disulphide species: (30-51) with Cys55-SG, and (30-
51,14-38) with Cys5-SG and Cys55-SG (Creighton,
1977a). The accumulation of these mixed-disulphide spe-
cies, and none others, is direct and positive proof that the
kinetic blockage of forming the 5-55 disulphide bond in
both instances is not due to inaccessibility of the cysteine
thiol groups. Instead, it is because the second step of
Figure 1 is slow.
It has been argued that the folded conformations of
(30-51) and (30-51,14-38) restrict the accessibility of
the Cys55 thiol group and that this is the reason for the ki-
netic block in forming the 5-55 disulphide bond in both in-
stances (Weissman and Kim, 1991,1995). The folded con-
formation may cause there to be some decrease in the rate
of reaction of Cys55 with disulphide reagents (Figure 1),
but this is not the basis of the kinetic block in disulphide
formation. The Cys55 thiol group is observed directly to
react, by formation of the mixed-disulphide (Creighton,
1977a; Weissman and Kim, 1995). The accumulation of
this intermediate demonstrates directly that the second
step in forming the disulphide bond is even slowerthan the
first in this case, even though it is solely intramolecular.
Finally, that the second step is rate-limiting in disulphide
formation is consistent with the general explanation given
above, based on the slow reduction of buried disulphide
bonds occurring via the same transition state. The reverse
of the second step is normally the slow step in disulphide
reduction and would be expected also to be rate-limiting
in disulphide formation.
Disulphide Rearrangement Pathways
The BPTI pathway is infamous for normally occurring
through intramolecular disulphide rearrangements involv-
ing intermediates with non-native disulfide bonds. Weiss-
man and Kim (1991) concluded that the occurrence of
specific non-native disulphide bonds was an indication
of non-native stabilizing interactions, an unpopular idea
amongst protein folders, and attempted to disprove their
significance. They found the species with non-native di-
sulphide bonds in somewhat lower quantities than previ-
ously, but this was of no significance for their kinetic roles
in the pathway. Ironically, those studies confirmed the ex-
pected kinetic behaviour of these intermediates and their
roles in disulphide rearrangement (Weissman and Kim,
1992). There was, in fact, nothing heretical about the di-
sulphide rearrangement pathway, for
Brought to you by | Universitaetsbibliothek Basel
Authenticated
Download Date | 11/21/17 12:26 PM
Disulphide-Coupled Protein Folding 741
(1) the stabilities of the non-native disulphide bonds were
known to indicate that they were not stabilized by any
conformation (Creighton, 1977b),
(2) only native-like conformation had been detected in the
trapped intermediates (States et a/., 1987), and
(3) a pathway involving only native-like nonrandom con-
formations had been proposed earlier (Creighton,
1990).
In confirmation, the occurrence of the two specific non-
native disulphide bonds, 5-14 and 5-38, in the nonnative
species (30-51,5-14) and (30-51,5-38), respectively, is
now known to occur because of the presence of native-
like conformation in the remainder of the partly-folded
conformation (van Mierlo etal., 1994).
The disulphide folding pathways of other proteins gener-
ally also involve disulphide rearrangements (Creighton,
1992). It is a general phenomenon, because it is the most
rapid way of inserting a disulphide bond into a protein
when the result will be a folded conformation in which that
disulphide bond will become buried.
The disulphide rearrangement pathway of BPTI occurs
because of the kinetic block in inserting either the 30-51
or 5 - 55 disulphide bonds (which are both buried in the na-
tive conformation) into species with one other native disul-
phide bond. The appearance of two native disulphide
bonds would cause the fully folded native conformation to
become stable, and the 30-51 or 5-55 disulphide bond
introduced would become buried. Forming such buried
disulphide bonds by the disulphide rearrangement pro-
cess is more rapid than direct disulphide formation be-
cause it is an intramolecular process, whereas forming a
disulphide bond by intermolecular reaction with a disul-
phide reagent is intermolecular (Figure 1). It has long been
recognized that the intramolecular transition states for the
two processes have very similar free energies, as would
be expected if the same conformational transition took
place in both (Creighton, 1978); this was subsequently re-
discovered by Weissman and Kim (1992).
In some instances of blocks in disulphide formation, al-
ternative disulphide bonds are formed much more rapidly,
such as 14-38 in intermediate (5-55) of BPTI (Creighton
and Goldenberg, 1984). On the other hand, if no alterna-
tives can be formed rapidly, disulphide formation is slowed
dramatically. In some cases, the alternatives are non-
native disulphide bonds; these have the potential to rear-
range intramolecularly to the native disulphide bond
whose formation was blocked, thereby by-passing the ki-
netic block. This also occurs in the folding pathway of
BPTI, in which there are kinetic blocks to forming the 5-55
disulphide bond (Figure 3). The first such block occurs in
the partly-folded (30-51) intermediate, which cannot
readily form the 5-55 disulphide bond, as it would pro-
duce the stable, fully folded intermediate (30-51,5-55).
Instead, it can form readily any of the three disulphide
bonds possible between Cys5, 14 and 38 (Creighton,
1977a). This is readily explicable on the basis of the partly-
folded conformation of this intermediate (van Mierlo etal.,
1993,1994). These three cysteine residues are in flexible
or unfolded parts of the polypeptide chain, so there are no
restrictions on their forming disulphide bonds. They are
not formed because of favourable conformation, but be-
cause of the lack of conformation, although the partly-fold-
ed conformation does keep them in moderate proximity.
The main role of the partly-folded conformation is to re-
strict disulphide formation with Cys55, even formation of
the native 5-55 disulphide bond.
If the 14-38 disulphide bond is formed in (30-51), the
quasi-native conformation results, due to the high stability
of the native conformation of BPTI (van Mierlo etal., 1991).
If the native conformation is less stable, as in some homo-
logues of BPTI, only a somewhat more ordered, but still
partly-folded, conformation results (Kortemme et a/.,
1996). The other two disulphide bonds that can be formed
in (30-51), 5-14 and 5-38, are non-native and do not
alter substantially the partly-folded conformation (van
Mierlo etal., 1994). These two disulphide bonds are still in
flexible portions of the chain and can react slowly with the
thiol group of Cys55 to rearrange intramolecularly to the
native 5-55 disulphide; the stable native-like (30-51,
5-55) results (Figure 4). Direct formation of the 5-55 di-
sulphide bond was blocked kinetically, so the intramo-
lecular disulphide rearrangements appear to have by-
passed the kinetic blockage.
Recently, it has been proposed that the disulphide rear-
rangement pathway of BPTI arises because of the folded
conformation of (30-51,14-38) (Weissman and Kim,
1995). This proposal is incorrect, because the rearrange-
ment pathway of BPTI still predominates in the absence
of this species. This has been shown using a mutated form
of BPTI where (30-51,14-38) is greatly destabilized
(Zhang and Goldenberg, 1993) and by covalently blocking
(Creighton, 1977a) or replacing (Darby ef a/., 1995) either
Cys14 or Cys38, when the 14-38 disulphide bond and in-
termediate (30-51,14-38) are not possible. The mistaken
proposal arose because intermediate (30 - 51,14 - 38) was
assigned, solely on the basis of its high accumulation,
an incorrect kinetic role as an important intermediate
(Weissman and Kim, 1991). Instead, it accumulates to high
levels because of the stability of its quasi-native confor-
mation (van Mierlo etal., 1991)and because it is kinetically
trapped due to its inability to form readily the missing na-
tive disulphide bond (Creighton, 1977a).
Assigning Roles and Importance to Kinetic
Intermediates
There is a remarkable degree of confusion about how to in-
terpret the kinetics of protein folding and decide the kine-
tic importance of any partly-folded species other than
unfolded (U) and native (N). Any such structurally interme-
diate species is generally, in the absence of any experi-
mental evidence to the contrary, assigned a role as a cru-
cial intermediate (I), as in
U I N (D
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This kinetic scheme states that all the molecules refold
through I and that N would not be formed in the absence of
I. It is generally not possible to distinguish experimentally
between this kinetic scheme and one where I is an off-
pathway species, because U and I are generally in rapid
equilibrium. Consequently, the kinetic roles of most inter-
mediate species in protein folding are generally not
known.
The disulphide approach to folding has the great ad-
vantage that the kinetic roles of all the disulphide species
can usually be determined unambiguously. It is straight-
forward to determine whether a step involves disulphide
formation, breakage, or rearrangement, simply by wheth-
er the rate is, respectively, proportional to the concentra-
tion of the disulphide or thiol reagent, or independent of
both (Figure 1). A specific intermediate can be trapped re-
versibly, purified, and then studied in isolation. Specific
cysteine residues can be replaced or blocked, disallowing
all species having that residue in a disulphide bond.
Finally, each step must involve the formation, breakage, or
rearrangement of only a single disulphide bond. The kine-
tic role of a disulphide intermediate generally remains am-
biguous only when that intermediate is in rapid equilibrium
with others by intramolecular disulphide exchange.
The BPTI pathway of Figure 4 has been determined un-
ambiguously by such kinetic analysis. Furthermore, it has
been shown that this pathway and a single set of rate con-
stants can account for the rates of appearance and disap-
pearance of all the species under the same conditions, but
a variety of redox conditions for forming and breaking di-
sulphide bonds (Creighton and Goldenberg, 1984; Darby
et a/., 1995).
Usually, those partly-folded species in protein folding
that are detected in the greatest amounts are considered
the most important. However, such species often accu-
mulate to high levels simply because they are kinetically
blocked and stable. In general, the least-populated inter-
mediates are those most important kinetically. Rather than
its level of accumulation, the kinetic importance of an in-
termediate should be judged by
(1) what fraction of molecules pass through it during the
reaction and
(2) the degree to which the reaction is slowed if that inter-
mediate is not possible.
The non-native two-disulphide intermediates (30-51,
5-38) and (30-51,5-14) of BPTI (Figure 4) fulfill both of
these requirements (Darby et a/., 1995). Folding through
these two specific intermediates accounts quantitatively
for the rate of appearance of fully native protein, and com-
plete disulphide formation is blocked in their absence.
Consequently, these are the most important kinetic inter-
mediates, even though they are not populated as much as
the kinetically-trapped quasi-native species; their kinetic
roles had been questioned simply on that basis (Weiss-
man and Kim, 1991). The quasi-native species may predo-
minate, but they fail the second test, in that the rate of BPTI
folding is not slowed by their absence.
Although the intermediates (30-51,5-38) and (30-
51,5-14) of BPTI are the most important kinetically, their
partly-folded conformations serve merely to direct some-
what the disulphide pathway. They probably become un-
folded to a substantial degree in the over-all rate-limiting
step, just before attaining the fully native conformation.
The intramolecular steps in folding are slowed only about
14-fold over-all in the presence of 8 M urea, where all the
intermediates are unfolded (Creighton, 1977c, 1978,
1992). The most productive intermediates in folding are
too unstable to be detected, which is probably a common
feature of protein folding reactions.
The lessons from disulphide-coupled folding are likely
to be applicable to protein folding in general.
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Type I allergy represents a hypersensitivity occurring
in almost 20% of the population that is based on the
recognition of innocuous airborn antigens (pollen,
mite, mould and pet allergens) by specific immunoglo-
bulin E. Allergic symptoms (e.g. allergic rhinitis, con-
junctivitis, asthma) are caused by the release of bio-
logical mediators from effector-cells after allergen-
induced crosslink of receptor-bound IgE. Here we dis-
cuss strategies to obtain recombinant allergen-spe-
cific antibody fragments (Fabs) from mouse and hu-
man cell lines as well as directly from allergic patients
lymphocytes via the combinatorial library technology.
It is suggested to use recombinant allergen-specific
Fabs for the standardization of allergen extracts cur-
rently used for diagnosis and treatment, to determine
allergen contents in allergen sources and the environ-
ment to allow preventive measures and to use aller-
gen-specific Fabs as therapeutic tools to interfere
with the allergen-lgE interaction. The latter appears
possible because IgE represents the least abundant
class of immunoglobulins and there is increasing evi-
dence for a limited diversity among allergens and their
B-cell epitopes. Moreover, allergic effector reactions
are mostly confined to accessible target organs so
that a local application of competing Fabs prior to al-
lergen exposure might represent a feasible therapeu-
tic approach.
Key words: Allergen /Allergen-specific antibody
fragments-Fab / Combinatorial libraries / Diagnosis /
Prevention/Therapy/Type I allergy/lgE.
Introduction
Type I allergy represents an immunoglobulin-E (IgE)-me-
diated hypersensitivity reaction towards otherwise harm-
less antigens (e.g. pollen-, insect-, animal-, and mould
proteins). With a prevalence of almost 20%, IgE-mediated
diseases represent a health threat of increasing impor-
tance in industrialized countries (Miyamoto, 1993). In sen-
sitized patients, innocuous environmental allergens can
immediately induce a cascade of allergic reactions by
crosslinking of effector-cell bound IgE-antibodies (Segal
et a/., 1977). Allergic symptoms comprise allergic rhinitis,
conjunctivitis, dermatitis, asthma and even anaphylactic
shock. Diagnosis of Type I allergy is currently performed
by serological measurement of specific IgE-antibody lev-
els and in vivo testing (skin prick reactivity) using allergen
preparations obtained from various allergen sources.
These crude extracts are difficult to standardize regarding
their allergen contents. Recent progress in the field of mo-
lecular allergen characterization by recombinant DMA
technology has brought about two major achievements.
First of all, sequence, structural and immunological simi-
larities among the relevant allergens indicate a limited di-
versity of allergens and their B-cell epitopes. Second, a con-
stantly increasing panel of recombinant allergens has
become available for diagnosis and specific therapy of
Type I allergy (reviewed in: Scheiner and Kraft, 1995;
Valenta and Kraft, 1995). While diagnosis with allergen ex-
tracts at best permitted to identify the allergen source
against which a patient is sensitized, recombinant aller-
gens allow the precise determination of the patients indi-
vidual IgE-reactivity profile (allergogram) (Valenta ef a/.,
1991; Valenta et a/., 1992; Menz ef a/., 1996, Pauli et a/.,
1996). The knowledge about a limited diversity of aller-
gens together with the possibility to determine sensitivity
to defined components with the aid of recombinant aller-
gens led us to consider the interaction of allergens and pa-
tients IgE antibodies as a possible target for the treatment
of Type I allergy. Allergen-specific IgG antibodies present
in sera of patients who had received successful immuno-
therapy are long known as natural competitors of IgE anti-
bodies and therefore represent suitable candidates for
specific passive blocking therapy of Type I allergy. In the
present contribution we describe strategies to obtain al-
lergen-specific antibodies and recombinant antibody
fragments and their use for diagnosis, prevention and
therapy of Type I allergy.
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Obtaining Allergen-Specific Antibodies and
Antibody Fragments (Fabs)
For the production of allergen-specific antibodies and an-
tibody fragments at least three approaches may be pur-
sued. Animals (e.g. mice) can be immunized with allergens
to establish hybridomas that secrete monoclonal anti-
bodies. Alternatively it is possible to isolate directly peri-
pheral lymphocytes from allergic patients to establish hu-
man allergen-specific cell lines or as a source to construct
combinatorial libraries that can be screened for clones
with specificity to a given allergen (Figure 1). Allergen-spe-
cific antibodies or recombinant antibody fragments (Fabs)
may be used for different purposes. They can be applied
for the detection and quantifiaction of certain allergens in
allergen-sources and extracts that are currently used for
diagnosis and therapy, but also for the detection of aller-
gens in the environment and food.
Antibodies represent also valuable research tools to in-
vestigate the interaction of allergens and patients IgE anti-
bodies. Those antibodies which compete with the binding
of IgE antibodies either bind to/or close to IgE-epitopes or
induce conformational changes in the allergen that pre-
vent IgE-recognition. Unexpectedly mouse and human
monoclonal antibodies were discovered which increased
IgE-binding to allergens, most likely by causing a confor-
mational change that makes additional IgE-epitopes avai-
lable (Viscoef a/., 1996; Lafferefa/., 1996; Lebecqueefa/.,
1997). While at present there is no evidence that such an-
tibodies may cause disease exacerbation, the beneficial
role of antibodies that compete with the allergen-lgE inter-
action is well established. In order to obtain blocking anti-
bodies, mouse monoclonal antibodies may be tested in
vitro for their ability to block IgE-binding (Lebecque et a/.,
1997). If mouse monoclonal antibodies are considered for
therapy it will be necessary to modify them by humaniza-
tion or to produce them as Fabs to reduce their immuno-
genicity. Human monoclonal antibodies may represent
even better candidates for antibody based therapy, how-
ever similar as for the mouse antibodies, production via
tissue culture methods is rather labor intensive and sets li-
mits as to the number of different antibodies that can be
obtained and screened. We therefore suggest to employ
combinatorial library technology for the production of re-
combinant allergen-specific antibody fragments. Using
peripheral blood mononuclear cells from allergic individu-
als it is possible to generate cDNAs coding for heavy chain
fragments and light chains by reverse transcription and
PCR. Heavy chain and light chain cDNAs can then be
combined and co-expressed in bacterial expression sys-
tems to represent the complete humoral diversity of the
donor (Huseef a/., 1989). Clones producing allergen-spe-
cific Fabs can then be selected using defined allergens by
direct immunoscreening (Huse et a/., 1989) or panning
(McCafferty et a/., 1990; Barbas ef a/., 1991). In the last
decade considerable advances were achieved regarding
the expression of functional antibody fragments in
Eschenchia coll. Basically two systems allow the presen-
tation of heavy and light chain variable regions on the
surface of filamentous phage. The pCANTAB system
(Pharmacia, Uppsala, Sweden) is designed to express
single-chain variable fragments (Fvs) of heavy and light
chain which are artificially joined with a neutral linker
(Winter and Milstein, 1991). In contrast, the pCOMB sys-
tem co-expresses heavy chain fragments including a por-
tion of their constant region together with the light chain
(Barbas ef a/., 1991). Both systems allow the efficient iso-
lation of antigen-specific scFvs or Fabs by panning of the
phage to a given antigen. The advantage of both systems
over conventional cell culture technique lies in the fact
that both Fabs and scFvs can be produced in E. coli
(Hoogenboomef a/., 1992; Pl ckthun 1992; Soderlindef
a/., 1992; Winter ef a/., 1994; Harrison et a/., 1996). The re-
PBMC
CELL LINE HYBRIDOMA
Ό- cDNA: heavy chain fragmentlight chain fragment
recombinant allergen specific Fabs
Fig. 1 Obtaining Allergen-Specific Recombinant Fabs.
PBMC, peripheral blood mononuclear cells; he, heavy chain; Ic,
light chain.
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Fig. 2 A Phi p 2-Specific Human IgE Fab Crossreacts with
Group 2 Allergens in Pollen from Different Grass Species.
Comparable amounts of pollen extracts from ten monocots (Ant
o: Anthoxantum odoratum, Ave s: Avena saf/Va, Cyn d: Cynodon
dactylon, Lol p:Loliumperenne, Phra: Phragmitesaustralis, Poa
p: Poa pratensis, Sec c: Seca/e cerea/e, Tri s: Triticum sativum,
Zea m: Zea mays, Phi p: Phleum pratense) were separated by
SDS-PAGE, blotted onto nitrocellulose and probed with a human
IgE-Fab with specificity for the major timothy grass pollen aller-
gen Phi p 2 (Dolecek ef a/., 1993).
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combinant antibody fragments are small and hence less
immunogenic and can be subjected to in vitro manipula-
tion (/n vitro affinity maturation by mutagenesis, shuffling
of heavy and light chains or the corresponding variable re-
gions or other manipulations) (Gram ef a/., 1992; Pack ef
a/., 1995; Lowefa/., 1996; Hoogenboom, 1997). Since re-
combinant antibody fragments lack the major part or the
complete constant region they will not elicit effector reac-
tions which are mediated via Fc receptors. Using appro-
priate oligonucleotide primers, recombinant antibody
fragments can be produced starting from spleen, cell
lines, hybridomas of human or animal origin or by con-
structing combinatorial libraries directly from patients B-
lymphocytes.
Recombinant Allergen-Specific Fabs as
Tools to Explore the Allergen-lgE Interaction:
Cloning Allergen-Specific IgE
The understanding of the interaction of allergens and pa-
tients IgE-antibodies requires structural analysis of the al-
lergen and its IgE-epitopes as well as the characterization
of allergen-specific IgE-antibodies (Fedorov ef a/., 1997).
The latter has been a major obstacle because of the extre-
mely low levels of serum IgE, and the low frequency of IgE-
secreting B-cells. In order to characterize allergen-spe-
cific human IgE antibodies on a molecular level, we have
chosen the combinatorial library approach. A combina-
torial IgE library was constructed from peripheral blood
lymphocytes obtained from a grass pollen allergic patient
during the grass pollen season (Steinbergeref a/., 1996).
Using recombinant major timothy grass pollen allergens
Phi p1 (Lafferefa/., 1994), Phlp2(Dolecekefa/., 1993) and
Phi p 5 (Vrtalaef a/., 1993) for panning, phage expressing
specific IgE-Fabs could be isolated. cDNAs coding forthe
IgE heavy chain fragments and their corresponding light
chains were sequenced and recombinant soluble IgE
IgE-Fab otPhi p 5
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Fig.3 A Phl p 5-Specific Human IgE Fab (Steinberger ei a/.,
1996) Crossreacts with Group 5 Allergens in Pollen from Different
Grass Species.
Comparable amounts of pollen extracts from ten monocots were
separated by SDS-PAGE, blotted onto nitrocellulose and probed
with a human IgE-Fab with specificity for the major timothy grass
pollen allergen Phi p 5 (Vrtalaef a/., 1993). Abbreviations are as in
Figure 2.
Fabs with specificity for the major grass pollen allergens
could be expressed and purified up to milligram amounts.
As is shown in Figures 2 and 3, human IgE-Fabs with spe-
cificity for the major timothy grass pollen allergens Phi p 2
and Phi p 5 crossreact with homologous allergens present
in several other grass species, thus explaining allergic
symptoms of grass pollen allergic patients after contact
with different grass species as being based on immuno-
logical crossreactivity. Further molecular and structural
analysis of the interaction of IgE-Fabs and their corre-
sponding allergens will provide knowledge regarding their
mode of interaction, and help to device specific forms of
therapy that are based on the interruption of this contact.
Recombinant allergen-specific IgE Fabs lack most parts
of their constant region and in particular their Fee receptor
I binding site and therefore are unable to activate allergic
effector cells (e.g. mast cells, basophils) to release media-
tors. As IgE-Fabs contain the variable region needed for
allergen-binding they will compete with complete IgE-an-
tibodies for binding to allergens and represent possible
therapeutic tools.
Recombinant Allergen-Specific Fabs for
the Standardization of Natural Allergen Extracts
Used for Diagnosis and Therapy
Diagnosis and specific therapy (specific immunotherapy)
of Type I allergy are currently performed with natural aller-
gen extracts. Natural allergen extracts are used for biolog-
ical (i.e. elicitation of immediate type skin reactions) as
well as for serological diagnosis (i.e. detection of IgE-anti-
bodies with specificity for a certain allergen extract) of
Type I allergy. The application of increasing doses of aller-
gen extracts by injection (i.e. specific immunotherapy) is
known since 1911 as an effective treatment of Type I al-
lergy (Noon, 1911). For both, diagnosis and treatment of
Type I allergy, natural extracts are still prepared from the al-
lergen sources and, in addition to allergens, contain a se-
ries of other ill defined components. Moreover, extracts
prepared from complicated tissues lack certain allergens
due to inefficient extraction and degradation. The estima-
tion of the contents of individual allergens in allergen ex-
tracts represents therefore a difficult problem that needs
to be addressed by standardization procedures. Allergen
extracts are currently standardized by biological methods
(i.e. by testing their capacity to elicit immediate type skin
reactions) and their allergen content is evaluated with an-
tibodies (e.g. serum IgE from allergic patients, polyclonal
antisera and monoclonal antibodies raised against de-
fined allergens). Recombinant allergen-specific Fabs will
represent extremely useful tools for the standardization of
natural allergen extracts. Among the recombinant Fabs,
human IgE-Fabs are of particular interest for standardiza-
tion procedures because they mimick the reactivity of pa-
tients serum IgE most closely.
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Use of Recombinant Allergen-Specific Fabs
for the Measurement of Allergens in
Allergen Sources and the Environment;
Tools to Prevent Allergen Exposure
Sensitization is believed to occur early in childhood in ge-
netically prone individuals after increased exposure to al-
lergens. The exact measurement of the presence of aller-
gens in our environment (i.e. air, buildings, and food) might
therefore represent a relevant first line for allergy preven-
tion. The generation of allergen-specific antibodies and
recombinant antibody fragments will allow the precise de-
tection of allergens and their amount in the environment
and in various food products. Preventive measures may
comprise the elimination of certain allergen sources (e.g.
mites), the selection of 'hypoallergenic' plants and crops
and the identification of food products with low allergen
contents. The latter application may be also of interest re-
garding the analysis of food which has been modified by
genetical engineering.
Allergen-Specific Antibodies and Antibody
Fragments for Passive Therapy
There is good reason to expect that allergen-specific Fabs
which interfere with the allergen-lgE interaction might be
used for therapeutic purposes. Experimental data which
indicate a limited diversity of allergens and their B-cell epi-
topes (reviewed in: Valenta and Kraft, 1995; Valenta et a/.,
1996) as well as the observation that the IgE-reactivity pro-
file in allergic patients is subjected to little variations en-
courage to consider passive therapy with blocking antibo-
dies. IgE antibodies represent the least abundant class of
immunoglobulins and it should therefore be possible to
apply excess doses of competitors. It is further notable
that allergic symptoms (allergic rhinits, conjunctivitis,
asthma, dermatitis, food intolerance) are mostly confined
to certain target organs that are easily accessible and
hence allow local therapy instead of systemic application.
Our contention that therapy with blocking allergen-spe-
cific Fabs might be a realistic approach is further support-
ed by a body of experimental data on the effectiveness of
blocking antibodies. The occurrence of allergen-specific
antibodies which did not belong to the 'reaginic' class was
reported early (Cooke et a/., 1935). It was demonstrated
that certain allergen-specific IgG antibodies were able to
inhibit anaphylactic reactions (Loveless, 1940; Lichten-
stein et al., 1968). Moreover it was speculated that
blocking antibodies, in particular those belonging to the
lgG4 subclass might be induced by specific immuno-
therapy (Aalberse et a/., 1983). It was recently shown in a
defined experimental system that human monoclonal an-
tibodies with specificity for the major birch pollen allergen,
Bet v 1 (Breiteneder et a/., 1989), blocked IgE-binding to
Bet v 1 and inhibited the Bet v 1 -induced histamine release
(Viscoefa/., 1996).
We suggest to use recombinant allergen-specific Fabs,
either human IgG or IgE Fabs, for passive (blocking)
therapy of Type I allergy. Bacterially expressed Fabs can
be modified by standard molecular biological techniques
and engineered according to the desired application. To
reduce the immunogenicity of the Fabs it is possible to fur-
ther reduce their size as well as to remove immunogenic
parts. Alternatively, mouse monoclonal antibodies can be
humanized to reduce their immunogenicity. By in vitro ma-
turation, using mutagenesis or CDR rearrangements it is
possible to improve the affinity of a recombinant Fab to its
antigen. Such a manipulation might even increase the
blocking activity of allergen-specific Fabs. Molecular and
structural analysis of blocking Fabs might finally provide
templates to build synthetic competitors of the allergen-
lgE interaction.
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MHC Class II Compartments: Specialized Organelles of the
Endocytic Pathway in Antigen Presenting Cells
Jean Pieters
Basel Institute for Immunology, Grenzacherstr. 487,
CH-4005 Basel, Switzerland
Mounting an immune response against foreign, extra-
cellular material requires that this material be interna-
lized by antigen presenting cells, processed to peptide
fragments and then displayed on the cell surface for
recognition by the T cell receptor on T helper cells.
Such peptides, derived from internalized antigens are
generally presented to T cells in association with
Major Histocompatibility Complex (MHC) class II mole-
cules. Recent work has identified subcompartments
of the endosomal/lysosomal system that appear to be
important sites for the generation of peptide-MHC
class II complexes. These so-called MHC class II com-
partments receive antigenic fragments from endoso-
mes and lysosomes and load them onto class II mole-
cules. From these compartments, peptide-loaded
class II molecules are transported to the plasma mem-
brane, where they can trigger T cells bearing appro-
priate receptors.
This review summarizes recent work characterizing
MHC class II compartments as specialized organelles
of the endosomal/lysosomal pathway. Interestingly,
MHC class II compartments share many features com-
mon to organelles present in a wide variety of speci-
alized cells with quite different functions. Modifying
the endocytic pathway to serve the needs of special-
ized cells may be a common mechanism which allows
very different cell types to carry out their disparate
functions.
Key words: Antigen presentation / Endocytic pathway /
MHC class II molecules/Subcellular organelles.
Introduction
Microorganisms such as viruses, bacteria, and certain
fungi are part of our natural environment, but many of
these can also lead to infectious diseases. Despite a con-
tinuous exposure to these potential pathogens most ver-
tebrates can control an infection because they possess
an immune system. In addition to the first-line defense,
called 'innate' (inborn) immunity, which is the non-specific
engulfment and destruction of microorganisms by phago-
cytes, the immune system has evolved several more spe-
cific ways to eliminate foreign material (Germain, 1994).
These mechanisms rely on the ability of an infected cell to
signal to the immune system that it harbors an infection.
One efficient way infected cells can do this is by displaying
on its surface small peptides derived from those infectious
agents. These peptides can then be recognized by the T
lymphocytes of the immune system, which, upon activa-
tion, can mount an immune response resulting in the con-
trol and possibly elimination of the infection (Germain,
1994; Townsend and Bodmer, 1989; Townsend ef a/.,
1985). Two subsets of T cells are able to recognize antige-
nic peptides. Cytotoxic T cells release the content of their
cytotoxic granules upon recognition of an antigenic pep-
tide, resulting in rapid destruction of the presenting cell
(Kagi et a/., 1996). Alternatively, T helper cells, when trig-
gered by a surface displayed peptide, leave the presenting
cell intact and assist in the generation of an antibody
mediated response (Noelle and Snow, 1992).
How peptides are presented to these two T cell subsets
has been worked out in great detail over the past decades.
A set of molecules encoded in the major histocompatibility
complex or MHC, a genomic region that contains a num-
ber of genes involved in immune recognition of an infec-
tion (Hansen ei a/., 1993) were found to play an essential
role in this process by the pioneering work of Doherty and
Zinkernagel (Zinkernagel and Doherty, 1974 a,b). These
molecules come into two forms, the MHC class I and class
II molecules; both are transmembrane molecules synthe-
sized on endoplasmic reticulum associated ribosomes
and are cotranslationally inserted into the endoplasmic
reticulum membrane (Dobberstein and Robinson, 1979;
Kvistefa/., 1982; Ploeghefa/., 1979) (see Figure 1).
The type of immune response and the class of MHC
molecules involved appears to be largely dependent on
the site of residence of the infectious agent: MHC class I
molecules present peptides derived from pathogens that
have access to the cytosol (e.g. viruses), whereas MHC
class II molecules function in the presentation of peptides
derived from antigens that are present exogenously (as is
the case for many bacteria) (Jackson and Peterson, 1993;
Wolf and Ploegh, 1995).
MHC class I molecules are expressed by all nucleated
cells. They associate in the endoplasmic reticulum with
another molecule, ß-2-microglobulin. Viruses and bacte-
ria that reside in the cytosol are degraded by the cytosolic
proteolytic machinery, the proteasome, and the resulting
peptides are transported into the endoplasmic reticulum
by transporter molecules, the TAP molecules (for trans-
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Fig. 1 Model of the MHC Class I and MHC Class ll-lnvariant Chain I Complexes.
The left panel shows the MHC class I molecule, that in association with -2 microglobulin can bind antigenic peptides that are imported
into the endoplasmic reticulum. The middle panel depicts the MHC class II complex, consisting of an α chain, a chain and the invariant
chain. The right panel shows a model of the nonameric class ll/li complex that is exported from the endoplasmic reticulum. The MHC class I
heavy chain and class II α and β chains have a type I transmembrane topology, i.e. they contain a lumenal N-terminal region and a cyto-
plasmic C terminal domain. The class II associated invariant chain adopts a type II orientation: it contains a cytoplasmically located Ν ter-
minus, and a lumenal C-terminal domain. Adapted from Pieters, 1997.
porter associated with antigen processing) (Deverson et
a/., 1990; Koopmannefa/., 1997; Spies et al., 1990). MHC
class I molecules become loaded with antigenic peptides
in the endoplasmic reticulum, and are then transported via
the secretory pathway through the Golgi complex to the
cell surface where they can be recognized by a subset of T
lymphocytes, the cytotoxic T cells (Townsend ef a/., 1989).
As mentioned, triggering of T cell receptors on cytotoxic T
cells usually results in the killing of the antigen presenting
cell. Not only viral peptides, but also peptides derived from
tumor associated antigens can be presented by MHC
class I molecules and are able to trigger cytotoxic T cells
(Boon and van der Bruggen, 1996). Therefore, class I re-
stricted presentation is an efficient way to eliminate cells
that are detrimental to the organism.
In contrast to MHC class I molecules, class II molecules
are expressed by only a subset of cells specialized in the
presentation of antigens that are present extracellularly;
these include B cells, macrophages and dendritic cells.
Expres-sion of MHC class II molecules, however, is indu-
cible in a variety of other cells by interferon gamma, and
has recently been shown to be controlled by the MHC
class II transactivator protein [Cll TA (Pober ef a/., 1983;
Steimleef a/., 1993)]. Deposition of peptide-loaded MHC
class II mole-cules on the cell surface of antigen presen-
ting cells does not only involve organelles of the secretory
pathway, but also of the endocytic pathway.
The endocytic network comprises a heterogeneous set
of organelles that function in the uptake of material from
the extracellular environment (Mellman, 1996). Therefore,
it is also the primary site where extracellular infectious
material gains access to the antigen presenting cell.
Understanding the mechanisms involved in loading pep-
tides onto class II molecules not only adds to our under-
standing of the immune system but may also increase our
knowledge regarding compartmentalization of eukaryotic
cells in general. Recent work has highlighted the involve-
ment of specialized organelles in the process of class II
restricted antigen presentation, which is the scope of this
review. These organelles, called MHC class II compart-
ments, seem to share several features with other speciali-
zed organelles carrying out quite distinct functions.
MHC Class II Molecules in the
Biosynthetic Pathway
MHC class II molecules consist of an alpha chain of 35 kDa
and a beta chain of 27 kDa molecular weight. These trans-
membrane molecules display their C termini cytosolically,
leaving a large N-terminal region in the lumen of the ER.
This N terminal lumenal region is highly polymorphic, and
forms the peptide binding site that, after maturation, is dis-
played at the plasma membrane (Cresswell ef a/., 1987).
During translation, MHC class II molecules associate
with a third transmembrane molecule, the invariant chain
[li; (Jonesefa/., 1978; Kvistef a/., 1982)]. The expression of
li is also under the regulation of CIITA, ensuring that all
class II molecules form complexes with li upon biosynthe-
sis (Chang and Flavell, 1995; Kern ef a/., 1995). li has the
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opposite topology as compared to class II molecules,
containing a small, N terminal cytoplasmic segment and a
relatively large C-terminal region located in the lumen (see
Figure 1). Despite the name 'invariant1, given because it is
not polymorphic, several isoforms of li can be coexpres-
sed in most cells (Pieters, 1997; Sant and Miller, 1994;
Strubinefa/., 1986).
The class ll/li complex consist of one li trimer, associa-
ted with three MHC class II dimers, a model of which is
shown in Figure 1 (Cresswell, 1996; Roche et a/., 1991).
While non-assembled class II and/or li molecules are retai-
ned and partially degraded in the ER, this nonameric com-
plex is readily transported out of the ER to the Golgi com-
plex (Kvistef a/., 1982; Pietersef a/., 1991). Most probably,
retention in the ER provides a quality control function to
ensure that only properly synthesized and assembled
complexes are exported to later stages of the pathway
(Arunachalam and Cresswell, 1995; Hurtley and Helenius,
1989; Marks ef a/., 1995; Schaiff ef a/., 1992).
Targeting of MHC Class ll/li Complexes
to the Endocytic Pathway
Peptides presented by MHC class I I molecules are usually
derived from material or infectious organisms that enter
the endocytic pathway of the antigen presenting cells.
How MHC class II molecules, being synthesized in the bio-
synthetic pathway, gain access to this material has been a
major question over the past decade. Early work indicated
that MHC class II molecules do intersect the endocytic
pathway (Blum and Cresswell, 1988; Cresswell, 1985).
This was followed by the demonstration that this intersec-
tion involves newly synthesized MHC class II molecules,
which are sorted at the level of the trans Golgi network
from proteins destined for the cell surface (Davidson ef a/.,
1991;Neefjesefa/.,1990).
The MHC class II associated invariant chain appears to
play a crucial role at different stages of the biogenesis of
the appropriate MHC class ll-peptide complexes. First,
the C-terminal, lumenal domain of li prevents antigenic
peptide binding to class II molecules in the endoplasmic
reticulum, as the class II molecules should sample the
endocytic pathway for peptides (Roche and Cresswell,
1990; Teyton ef a/., 1990). Second, the invariant chain func-
tions in the transport of the class ll/li complex to endoso-
mes. Site directed mutagenesis showed that the N-ter-
minal, cytoplasmic tail of li contains targeting/retention
signals for endocytic compartments (Bakke and Dob-
berstein, 1990; Lotteau ef a/., 1990; Pieters ef a/., 1993).
Targeting to the endocytic pathway is mediated by leucine
containing stretches of amino acid residues (Pieters ef a/.,
1993); deletion or mutation of these leucine containing
motifs in the N-terminal cytoplasmic tail abolished endo-
somal targeting and resulted in the appearance of these li
mutants at the cell surface.
To analyze the precise pathway followed by the MHC
class ll/li complex, we have been using as a model system
the human melanoma cell line Mel JuSo (Johnson ef a/.,
1981). This cell line has been a valuable tool for the analy-
sis of class II biology in several aspects. First, these cells
express high amounts of MHC class II and invariant chain
molecules, as well as other accessory molecules such as
HLA-DM that are involved in the actual peptide loading
event (cf. below). Second, they can efficiently process and
present antigens and third, these cells are well suited for
morphological and biochemical analysis (Pieters ef a/.,
1991;Tulpefa/.,1994).
In Mel JuSo cells, as in B lymphoblastoid cells, MHC
class II molecules are transported to endosomal organel-
les following export from the endoplasmic reticulum and
transport through the Golgi complex. Upon arrival in the
endocytic pathway, degradation of li takes place in dis-
tinct steps. This degradation, most probably mediated by
the endosomal proteases cathepsin S and/or L (Bevec ef
a/., 1996; Riese ef a/., 1996), occurs selectively from the
lumenal, carboxyterminal region leaving the N-terminal
cytoplasmic tail attached to the class II complex (see
Figure 2). Interestingly, in B lymphoblastoid cells, li proteo-
lysis is much more rapid, and N-terminal proteolytic frag-
ments are detected only when endosomal proteolysis is
inhibited (Blum and Cresswell, 1988) while the amount of
class II molecules located intracellularly is much smaller in
these cells. Given the function of the li N-terminal domain
as a targeting and retention domain for the MHC class II
complex, it is conceivable that the rate of Ii proteolysis and
its dissociation from class II molecules dictate transport
to, retention in and export from endocytic compartments
(Pieters ef a/., 1991).
Specialized Peptide Loading Compartments
The location of MHC class ll/li complexes in the endocytic
pathway has been confirmed by immunocytochemistry in
a variety of cell lines (Peters ef a/., 1991; Pieters ef a/.,
1991). One puzzling observation in these earlier studies
was that the bulk of MHC class II molecules could not be
localized to a conventional early endosome, late endo-
some, or lysosome. Class II containing structures were
therefore named 'MIIC's' (Peters ef a/., 1991) or'multivesi-
cular bodies' (Pieters ef a/., 1991), based on the high con-
centration of class II molecules or morphological appear-
ance, respectively. The subsequent biochemical isolation
and characterization of organelles, part of the endocytic
pathway but clearly distinct from conventional endoso-
mes and lysosomes established the class II compart-
ments as separate entities in the endosomal/lysosomal
pathway (Amigorenaef a/., 1994;Tulpefa/., 1994; West ef
a/., 1994). Newly synthesized MHC class II molecules are
transported to these compartments in association with
the invariant chain. Upon arrival in these organelles, the
class II associated invariant chain is proteolytically de-
graded and antigenic peptides, derived from endocyto-
sed proteins, are loaded onto class II molecules. From the
MHC class II compartment, peptide loaded class II mole-
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Fig. 2 Intracellular Pathways Followed by MHC Class ll/lnvariant Chain (li) Complexes.
After assembly in the endoplasmic reticulum, the class ll/li complex is targeted at the trans-Golgi network to MHC class II compartments
by virtue of targeting signals that reside in the li cytoplasmic tail. Upon arrival in MHC class II compartments, li is progressively de-
graded from its lumenal, C-terminal region through the action of cathepsins. Removal of the li C-terminal domains allow MHC class II
molecules to acquire antigenic peptides, a process catalyzed by HLA-DM. Antigenic peptides are somehow imported into the MHC class
II compartment from the endocytic pathway. Class II molecules loaded with peptides are then exported to the plasma membrane by as yet
undefined mechanisms. Modified from (Pieters, 1997).
cules are exported to the plasma membrane for presenta-
tion to Τ helper cells.
A recently discovered molecule, the human leukocyte
antigen (HLA)-DM that is involved in the generation of
MHC class II peptide complexes, is also located in MHC
class II compartments (Nijman et a/., 1995; Pierre eta/.,
1996; Sanderson et a/., 1994). HLA-DM was discovered as
a 'peptide-loader' when it was observed that mutant anti-
gen presenting cell lines lacking this molecule would per-
fectly stimulate T cells when supplied with peptides, but
could not present peptides when intact antigen was admi-
nistered (Mellins et a/., 1990). This suggested that these
mutant cells either had lost the ability to process antigens,
or were unable to load intracellularly generated peptides
onto MHC class II molecules. Several subsequent studies
showed that, both in vitro and in vivo, HLA-DM is required
for loading peptides onto MHC class II molecules (Denzin
and Cresswell, 1995; Fung-Leung ef a/., 1996; Martin ef
a/., 1996; Miyazakief a/., 1996; Sherman eta/., 1995; Sloan
efa/.,1995).
Although HLA-DM molecules have been localized in
MHC class II containing compartments, HLA-DM is targe-
ted intracellulary via a tyrosine motif present in its cyto-
plasmic tail (Lindstedtef a/., 1995; Marksei a/., 1995). This
signal is different from the leucine motif present in the in-
variant chain cytoplasmic tail responsible for targeting the
MHC class ll/li complex intracellularly, and recent evi-
dence suggests that a distinct machinery may be involved
in di-leucine based and tyrosine based targeting (Marks ef
a/., 1996). In accordance with this, we have recently found
that in Mel JuSo cells, li and DM reside in two physically
and functionally distinct MHC class II containing compart-
ments. Furthermore, these two compartments appear to
have a different accessibility to endocytosed material;
while the class II associated li was found to be degraded in
an endocytic organelle, HLA-DM dependent peptide
loading occurred in a distinct organelle that was not ac-
cessible for internalized antigens directly (Ferrari and
Pieters, in preparation). The precise mechanisms that re-
gulate the transport of li and HLA-DM between these com-
partments, however, remain to be established.
A general picture describing biogenesis of MHC class
ll-peptide complexes is depicted in Figure 2. It summari-
zes work from many different laboratories using a variety
of cell lines, including B lymphoblastoid cell lines and
melanoma cells.
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How does this trafficking scheme look in more physio-
logical situations? Recently, procedures have been devel-
oped to obtain large numbers of dendritic cells isolated
from peripheral blood (Sallusto and Lanzavecchia, 1994).
This opened the possibility to analyze the trafficking path-
ways of class II molecules in these highly specialized, pro-
fessional antigen processing and presenting cells (Stein-
man, 1991). Dendritic cells play an important role in the
immune response: in an immature state, they are believed
to acquire antigens in peripheral tissues. After migration to
the lymphoid organs they can, in a mature state, present
these peptides associated with MHC class II to T cells
(Cella ef a/., 1997·; Steinman, 1991). Immature dendritic
cells can internalize antigens while most class II molecules
reside intracellularly. During maturation, dendritic cells
downregulate their endocytic capacity and relocate the
MHC class II molecules to the plasma membrane (Cella et
al., 1997a, b; Sallusto et a/., 1995; Steinman and Swanson,
1995). Thus, the dendritic cell system provides an excel-
lent model to analyze the cell biology of class II restricted
antigen presentation.
Morphological studies confirmed the existence of MHC
class II compartments in immature dendritic cells, with
characteristics very similar to the ones described in B lym-
phoblastoid cells and melanoma cells (Nijman ef a/., 1995;
Sallusto and Lanzavecchia, 1994, Engering ei a/., 1997).
Surprisingly, after in vitro maturation of dendritic cells,
MHC class II compartments disappear, concomitant with
a shift of the class II molecules from an intracellular site to
the plasma membrane (Sallusto and Lanzavecchia, 1994).
This suggests that transport of MHC class II molecules to
the precise subcellular location in these cells is highly reg-
ulated at different stages of maturation. Indeed, several
mechanisms seem to operate during DC maturation that
redistribute class II molecules among various subcellular
compartments (Engering ef a/., 1997, Cella eta/., 1997a).
The Endocytic Pathway as a Host to
Specialized Organelles
The MHC class II compartment in antigen presenting cells
may be regarded as a specialized endocytic organelle:
First, its distribution is restricted to specialized cells that
function in the presentation of exogenous antigens.
Second, in these cells, it performs a defined function,
namely the loading of peptides onto MHC class II mole-
cules. Third, the physical properties as well as the mole-
cular composition of the MHC class II compartment
clearly distinguishes it from early and late endosomes.
A number of questions however still remain. How is the
MHC class II compartment positioned in the endocytic
pathway? What mechanisms control the flow of material
to and from these organelles? Is the transport of peptide-
loaded class II molecules from the MHC class II compart-
ment to the cell surface regulated? Recent work carried
out with dendritic cells suggests that several regulatory
mechanisms may be involved in MHC class II restricted
presentation. Unfortunately, the further characterization
of MHC class II compartments has so far been hampered
by the lack of marker molecules other then the class II
molecules themselves. However, the MHC class II com-
partment is, in several aspects, similar to organelles pres-
ent in at least three other types of specialized cells and
may therefore share characteristics with these specialized
organelles. These include the glucose transporter-4
(Glut-4) containing vesicles ('Glut-4 compartment') in adi-
pocytes (James and Piper, 1994; Thorens, 1993), cytoto-
xic granules in T lymphocytes (Griffiths, 1995) and synap-
tic vesicles in neuronal cells (De Camilli, 1995; Sudhof,
1995).
First, in adipocytes, Glut-4 facilitates the uptake of glu-
cose in an insulin dependent manner. Glut-4 resides in an
intracellular, post Golgi compartment and is rapidly trans-
ported to the cell surface following stimulation of the cells
with insulin (Satohefa/., 1993; Slotef a/., 1991). TheGlut-
4 compartment has characteristics of endosomes but can
be isolated as a vesicle population containing only low
amounts of endosomal markers such as transferrin recep-
tor and mannose-6-phosphate receptor (Herman ef a/.,
1994; Hudson et al., 1993). Second, cytotoxic granules
present in T lymphocytes are secretory granules that are
the storage site of a number of lytic proteins (Griffiths and
Argon, 1995). Upon activation of T cells, these proteins are
released from these organelles, and cause the destruction
of the target cell (Griffiths, 1995). Release of the granule
content is triggered by engagement of the T cell receptor
present at the cell surface (Isaaz ei a/., 1995). These cyto-
toxic granules can be considered part of the endoso-
mal/lysosomal pathway, as a number of the resident lytic
proteins are targeted there via the mannose-6-phosphate
receptor, that is used in most cells to sort lysosomal en-
zymes from the secretory pathway (Griffiths and Isaaz,
1993). In addition, the pH is mildly acidic in these vesicles,
as is also the case for endosomal/lysosomal organelles
(Griffiths, 1995). Third, synaptic vesicles, present e.g. in
neuronal and neuro-endocrine cells, are vesicular carriers
that mediate the secretion of non-peptide neurotransmit-
ters. These organelles originate from endosomes, are aci-
dic and contain membrane proteins that arrive there from
the biosynthetic pathway as well as cargo that is imported
from the cytoplasm (Clift ei a/., 1990; Kelly, 1993; Maycox
ef a/., 1992, Schmidt ef a/., 1997).
The MHC class II compartment may represent a specia-
lization of the endocytic pathway in antigen presenting
cells, just as the Glut-4 compartment, cytotoxic gran-
ules and synaptic vesicles do in the above described cell
types. Interestingly, one determinant involved in intracel-
lular targeting/retention of Glut-4 molecules is a di-leucine
motif similarto the intracellular targeting/retention motif of
the MHC class II associated invariant chain. The determi-
nants involved in targeting and retaining molecules in
cytotoxic granules and synaptic vesicles are not well
characterized; at least a subset of these molecules reach
these compartments after internalization from the plasma
membrane (Griffiths, 1996; Thomas-Reetz and De Camilli,
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1994), a pathway that may be utilized by MHC class ll/li
complexes in a number of cases (Pinet ef a/., 1995;
Warmerdamefa/., 1996).
How is material from these intracellular storage sites
transported to the cell surface? For Glut-4 vesicles, cyto-
toxic granules and synaptic vesicles a trigger at the cell
surface is required for transmitting a signal that results in
exocytosis of their content. For Glut-4 vesicles the signal
is insulin stimulation; in the case of cytotoxic granules, T
cell receptor triggering; and for synaptic vesicles, electri-
cal stimulation causes exocytosis (Isaaz et a/., 1995;
Satoh ef a/., 1993; Sudhof, 1995). Whether similar mecha-
nisms are involved in the transfer of class I I molecules from
the class II compartment to the cell surface is not known.
Conclusion
The pathways followed by MHC class II molecules from
their site of synthesis, the endoplasmic reticulum, to the
plasma membrane have now well been characterized. In
various antigen presenting cells, specialized organelles,
the MHC class II compartments, have been described that
function in the loading of antigenic peptides onto class II
molecules. From these compartments, peptide loaded
class II complexes are transported to the cell surface
where they can trigger T cell receptors on T helper cells.
These specialized MHC class II compartments are part
of the endosomal/lysosomal network and resemble in var-
ious aspects other types of specialized organelles that
are also part of the endosomal system. Apparently, there is
an enormous plasticity within the endosomal network to
accommodate specialized functions. As suggested be-
fore (Kelly, 1993), all cells may contain a 'housekeeping'
endosomal network that performs the basic functions
necessary for normal cell growth, such as recycling of
LDL/transferrin receptors and trafficking of endocytosed
material to lysosomes for degradation. In addition to this
basic endocytic system, in specialized cell types endo-
somal-derived organelles may be present containing
proteins involved in carrying out the specific function to
which these specialized cells are dedicated. Analysis of
the molecular composition of various specialized organel-
les in disparate cell types might allow identification of
common mechanisms that govern traffic of constituents
and cargo to and from these different compartments.
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Calcium-Sensing Receptor: Roles in and beyond
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The cloning of a Ca§*-sensing receptor (CaR) from pa-
rathyroid and kidney, coupled with the identification
of inherited disorders in Ca^-sensing resulting from
inactivating or activating mutations of this CaR, has
provided substantial insights into how Cao* is regula-
ted at a systemic level. The CaR plays a central role
in mediating, on one hand, the inhibitory effect of Cao*
on parathyroid hormone (PTH) secretion and, on the
other, the stimulatory action of Ca§* on calcitonin
secretion, which provide for a sophisticated, bi-direc-
tional regulation of the secretion of calciotropic hor-
mones mediated by the same receptor. Indeed Cao* it-
self can be viewed as a calciotropic 'hormone' acting,
along with PTH and calcinotin (CT), on its target tis-
sues involved in mineral ion homeostasis, particularly
the kidney. In the kidney, Ca2,*, acting via the CaR, con-
trols renal handling of divalent mineral ions in the cor-
tical thick ascending limb (CTAL) and perhaps also in
the distal convoluted tubule (DCT). In CTAL the CaR
not only affects renal calcium handling indirectly by
modulating the secretion of PTH but also directly at the
level of the tubule, where it is localized on the same
basolateral surface of the cells where the PTH recep-
tor is located. Moreover, renal CaRs likely subserve
important functions involved in integrating mineral
ion metabolism with the homeostasis of water and,
perhaps, monovalent cations (e.g., elevating Ca§* pro-
duces a CaR-mediated inhibition of NaCI reabsorption
in the CTAL).
More recent data, however, accumulated since the
cloning of the CaR, have suggested additional roles of
the receptor in cells uninvolved in mineral ion metabo-
lism. Examples include the brain, intestine and skin,
where the receptor may regulate, respectively, the ac-
tivities of ion channels and probably other neuronal
functions, proliferation of the cells of the colonic
crypts and differentiation of keratinocytes, presuma-
bly in response to local changes in Ca2/. It is also pos-
sible that the CaR responds to other endogenous ago-
nists, either polyvalent agonists, such as Mg<j* or orga-
nic polycations, including spermine or even prota-
mine. Finally additional studies are needed to deter-
mine whether there are additional members of a
putative family of structurally-related ion-sensing
GPCRs, such asthat apparently present in osteoblasts
that sense Ca§* and, perhaps, in other cell types that
recognize additional ions [e.g., Cd2/ in dermal fibrob-
lasts (Smith eta/., 1989)].
Key words: Brain / Keratinocytes / Kidney / Lens
epithelium / Parathyroid gland.
Introduction
Calcium ions are known to play a variety of roles in myriad
cellular and biochemical processes in essentially all organ-
isms. The involvement of calcium is well recognized in
the mechanisms of cellular signaling, secretion, cell divi-
sion and motility, as well as in muscular contraction, blood
clotting, neural transmission, cellular proliferation and dif-
ferentiation and apoptosis (For review, see Brown, 1991).
Therefore, maintenance of a nearly constant level of the
extracellular calcium concentration (Cal+) is a high biolog-
ical priority, which is accomplished by the complex inter-
play of various organs that include parathyroid gland, thy-
roidal C-cells, kidney, bone and intestine (for review, see
Chattopadhyay et a/., 1996b).
Over the years, several lines of evidence suggested the
presence of a Cao+-sensing mechanism in parathyroid
cells, C-cells and kidney through which Ca2/*" acts as an ex-
tracellular first messenger via its own cell surface, recep-
tor-like mechanism (for review, see Brown, 1991). Evi-
dence suggesting the existence of such a Ca^-sensing
mechanism in the parathyroid gland came from studies
with dispersed bovine parathyroid cells. When subjected
to increased levels of Ca§+, the cells responded with ac-
tivation of phospholipase C (PLC) leading to accumulation
of inositol 1,4,5-trisphosphate (IP3) and consequent re-
lease of Ca2* from intracellular stores (Nemeth and
Scarpa, 1986; Brown et a/., 1987). High levels of Ca§+ also
produced a pertussis toxin-sensitive inhibition of agonist-
stimulated cAMP accumulation in bovine parathyroid cells
(Chenefa/., 1989). In addition, these and other studies re-
vealed the capacity of the Cao+-sensing apparatus to re-
cognize other divalent cations (i.e., Ca2*, Mg2*), trivalent
cations (e.g., La3+ and Gd3+) and even polyvalent cations,
such as polylysine, protamine, and neomycin, suggesting
that it was a low affinity receptor having rather promis-
Brought to you by | Universitaetsbibliothek Basel
Authenticated
Download Date | 11/21/17 12:26 PM
760 N. Chattopadhyay et a/.
cuous polycation-sensing properties (Brown, 1991;
Chattopadhyay et a/., 1996b). While elevations in Ca§+
produced a prominent release of Ca2+ from its intracellular
stores in parathyroid cells, the high Cao+-evoked rise in Caj
in thyroidal C-cells occurred primarily through opening of
voltage-sensitive Ca2+ channels, suggesting that these
channels might represent an important part of the Cao1"-
sensing apparatus in the latter cell type (Fried and
Tashjian, 1986; Scherublef a/., 1991).
Cao* also exerts several apparently direct actions on di-
verse cell types within the kidney. Elevations in Ca2/ inhibit
the 1 -hydroxylation of 25-hydroxyvitamin D, produce a
pertussis toxin-sensitive inhibition of cAMP accumulation
in the medullary thick ascending limb (similar to the effect
of Cao* on cAMP accumulation observed in parathyroid
cells) and inhibit the tubular reabsorption of NaCI, Ca2+
and Mg2+ in the cortical thick ascending limb (CTAL) (for
review, see Brown, 1991). In bone, raising Cafr inhibits
osteoclastic bone resorption and increases Caj in
osteoclasts, a response somewhat reminiscent of that
elicited in parathyroid cells by high levels of Cao+ (Zaidi ef
a/., 1989).
Cloning and Characterization of G Protein-
Coupled CaRs
Cloning of the Bovine Parathyroid CaR
With this background information, Brown ef a/., employed
expression cloning in Xenopus laevis oocytes to isolate
a full length cDNA encoding the bovine parathyroid cal-
cium-sensing receptor (BoPCaR) (Brown ef a/., 1993)
(Figure 1 shows proposed topology of human CaR). Char-
acterization of BoPCaR revealed that it is a seven mem-
brane-spanning receptor sharing limited homology only
with the metabotropic glutamate receptors (mGluRs)
among the superfamily of G protein-coupled receptors
(GPCR). In the parathyroid gland the receptor is coupled,
most likely via Gq/Gn (Varraulteta/., 1995), to activation of
phospholipase C (PLC), presumably through one or more
members of the PLCbeta family of the G protein-activated
forms of the enzyme. The receptor may also couple to in-
hibition of adenylate cyclase (Chen ef a/., 1989), although
this later action has not yet been demonstrated unequivo-
cally with the cloned CaR.
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Fig. 1 Schematic Illustration of the Proposed Topology of the Cao+-Sensing Receptor Cloned from Human Parathyroid, Depicting
Locations of Activating and Inactivating Mutations.
Abbreviations are as follows: SP = signal peptide; HS = hydrophobic segment. Also shown are positions of missense and nonsense mu-
tations that cause either familial hypocalciuric hypercalcemia (FHH) or autosomal dominant hypocalcemia; the latterare indicated with the
three letter amino acid code. The normal amino acid is shown before and the mutant amino acid after the number of the relevant codon.
Reproduced with permission from Brown E.M., Bai, M., and Pollak, M. Familial benign hypocalciuric hypercalcemia and other syndromes
of altered responsiveness to extracellular calcium. In: Metabolic Bone Diseases, 3rd ed., S.M., Krane and L.V., Avioli, eds. (in press).
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Table 1 Selected Features of CaR Cloned from Various Species.
Species
Human
Bovine
Rat
Rabbit
Chicken
Number of
amino acids
1079
1085
1079
1070
1059
Size of protein
(kDa)1
130-160
130-160
130-160
-
-
Putative
PKA sites
2
2
2
2
2
Putative
PKC sites
5
4
8
6
5
Putative
N-Glycosylation
sites
11
9
9
11
12
References
Garrett ef a/., 1995
Brown et a/., 1993
Ruatefa/,,1995
Butters et a/., 1997
Diaz et a/. ,1997
1
 Most of immunoreactive CaR protein on Western analysis is present as two glycosylated bands with only a small amount of the
-120 kDa non-glycosylated CaR.
Cloning of the Ca^-sensing receptor (CaR) was follow-
ed almost immediately by the identification of inherited
human hyper- or hypocalcemic disorders resulting from
loss- or gain-of-function mutations in the CaR, respec-
tively (Pollak et a/., 1993; 1994). Mutations reducing the
activity of the CaR occur in either a heterozygous form that
usually causes a generally asymptomatic, hypercalcemic
disorder [familial hypercalcemic hypocalcemia (FHH)] or in
a homozygous form that leads to a severe form of hyper-
parathyroidism in newborn infants [neonatal severe hy-
perparathyroidism (NSHPT)] (for review see Chattopad-
hyay et a/., 1996). NSHPT can also result, however, from
heterozygous inactivating mutations, particularly those
that exert a dominant negative effect on the normal allele
of the CaR (Bai ei a/., 1997). FHH is characterized by ab-
normal parathyroid and renal responsiveness to Ca§+. The
former produces an elevated set-point for Ca^-regulated
PTH release (the level of Cao+ half-maximally inhibiting
PTH secretion), while the latter causes inappropriately
avid renal tubular reabsorption of both Ca2* and Mg2*, the-
reby producing not only hypercalcemia but also hyper-
magnesemia in some affected individuals (Chattopad-
hyay etal., 1996b). Conversely, gain-of-function CaR muta-
tions are associated with an autosomal dominant form of
hypocalcemia accompanied by a reduction in the set-
point of the parathyroid and an excessive degree of hyper-
calciuria for any given level of Cao+. The identification of
these disorders as well as the development of mice he-
terozygous or homozygous for targeted inactivation of the
CaR gene (Ho ef a/., 1995) that share many of the bioche-
mical features of FHH and NSHPT, respectively, has provi-
ded incontrovertible evidence for the physiological impor-
tance of the CaR in mineral ion homeostasis.
Following the cloning of the bovine parathyroid CaR, ef-
forts were made to clone additional organ and species-
specific homologs of the receptor and to determine if there
were additional CaR isoforms. These screening efforts en-
abled cloning of additional, highly homologous receptors
from organs and tissues involved in calcium homeostasis,
such as human parathyroid (Garrett ef a/., 1995a) and thy-
roidal C-cells (Garrett ef a/., 1995b), rat kidney (Riccardi ef
a/., 1995)aswellasfromratbrain(Ruatefa/., 1995) [where
the CaR may not play any role in systemic Cao1" homeosta-
sis (see below)]. These various CaRs share greater than
90% identity in their amino acid sequences, indicating that
they are species and tissue homologs of the same ance-
stral gene (see Table 1 for a summary of selected features
of CaRs cloned from various species to date). Expression
of these receptors in Xenopus laevis oocytes or in mam-
malian cells also revealed functional properties very simi-
lar to those of BoPCaR, in that they recognize changes in
Cao* and Mgo* within the physiological, millimolar range
(Bai ef a/., 1997).
Cloning and Characterization of the
Rabbit Kidney CaR
Previous studies had shown that the New Zealand white
rabbit exhibits a PTH-dependent increase in serum cal-
cium concentration to levels about 30-40% higher than
those in humans and most other mammals (Warren etal.,
1989). Since rabbits don't suffer any obvious ill effects of
their 'hypercalcemia', it was thought that this species
might provide a mammalian homolog of FHH, and that
there might, therefore, be structural and functional differ-
ences between the rabbit CaR and other mammalian
CaRs that might explain the altered Cao+-sensing in rab-
bits. Cloning and functional expression of rabbit CaR from
kidney, however, revealed that despite several differences
in its amino acid sequence from the human, rat and bovine
CaRs, it exhibited no alterations in its affinities for Cao'',
Mg2,* or Gdj)+ (Butters, 1997).
Cloning and Characterization of the Chicken
Parathyroid CaR
Another interesting and well-studied animal model in
terms of its calcium metabolism is the domestic chicken
(Gallus domesticus). Because a laying hen deposits the
equivalent of about 10% of its total bodily calcium daily in
each egg shell, chickens are remarkable among terrestrial
vertebrates in the rapidity with which they turn over bodily
calcium stores. During the period of time each day when
the egg shell is forming, the ionic Ca2+ present in plasma
turns over approximately four times every minute. Total
plasma calcium in the growing chicken is 10 mg/dl, com-
parable to that of mammals, but this level doubles during
the egg-laying cycle due to the expression of a Ca2+-bind-
ing protein, vitellogenin-A, in the serum, while serum ioniz-
ed Ca2+ remains unchanged at 1.2-1.3mM. These facts
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lead us to clone and characterize the cDNAforthe chicken
CaR from chicken parathyroid gland (Diaz et a/., 1997).
Functional expression of this CaR in Xenopus laevis
oocytes revealed agonist-evoked increases in Ca2+-ac-
tivated CI" currents in response to elevated levels of Cao*,
Mgo+ and Gdo1" that were similar to those of the various
mammalian CaRs cloned previously (Diaz et a/., 1997).
Therefore, a CaR with structural and functional properties
very much like those in mammals can apparently provide
for the unusually rapid turnover of bodily calcium in the
chicken, presumably through adaptations in the effector
limb of the mineral ion homeostatic system.
Are there Additional Ion-Sensing Receptors?
Northern blot analysis has revealed the presence of CaR
transcripts in a variety of tissues with considerable diver-
sity in the relative abundance and sizes of the different
transcripts (Brown et a/., 1993; Buttersei a/., 1997; Diazef
a/., 1997; Garrettef a/., 1995a, b; Ruatef a/., 1995). A com-
pilation of the sizes of the CaR transcripts in various tis-
sues and species is provided in Table 2. Interestingly, more
than one transcript is present in every organ of each spe-
cies studied to date, thereby implying the existence of im-
portant biochemical mechanisms involving eitherdiffering
half lives of the transcripts or alternate promoter usage, is-
sues that have yet to be addressed. The highest levels of
expression of the CaR are in tissues known to sense Cao+
and to be intimately involved in mineral ion homeostasis,
namely parathyroid gland, regions of the kidney involved
in divalent cation transport and the thyroidal, calcitonin-
secretingC cells.
In the parathyroid gland the CaR likely regulates several
aspects of parathyroid functions (for review, see Chatto-
padhyay et a/., 1996b). The inhibition of PTH secretion by
elevations in Ca§+ is severely disrupted in individuals with
NSHPT who are homozygous for inactivating CaR muta-
tions as well as in mice homozygous for targeted disrup-
tion of the CaR gene (Chattopadhyay et a/., 1996b; Ho et
a/., 1995). Thus the CaR plays a central, non-redundant
role in regulating PTH secretion. Recent studies suggest
that the CaR may also be involved in the high Cao+-media-
ted inhibition of PTH gene expression; moreover, the often
marked parathyroid cellular hyperplasia present in NSHPT
as well as in homozygous CaR 'knockout' mice indicates
that the receptor may also directly or indirectly regulate
parathyroid cellular proliferation (Chattopadhyay ef a/.,
1996b). Interestingly, the C-cells of the thyroid glands,
whose secretion of calcitonin is stimulated rather than in-
hibited by increases in Cao*, express the same CaR as in
parathyroid (Garrett ef a/., 1995b). High Cao* likewise sti-
mulates hormonal secretion from the CaR-expressing,
ACTH-secreting AtT-20cell line(Emanualefa/., 1996).The
same receptor, therefore, can apparently mediate either
stimulation or inhibition of secretion depending on the cel-
lular context in which it is expressed.
Thus no novel isoforms of the CaR other than the one
present in parathyroid and kidney have been isolated to
date. Although it is possible that the CaR has been strictly
conserved through evolution without undergoing gene
duplication, this situation would contrast markedly with
that for the mGluRs, where there are at least 8 different
mGluR genes, with the different mGluRs varying in the ex-
tent to which they couple to various intracellular effector
systems (for review, see Nakanishi, 1994). It is also possi-
ble, although as yet unproven, that the CaR could be the
first identified member of a broader 'cation-sensing' fam-
ily of cell surface receptors, as hypothesized by some in-
vestigators (Quarles et a/., 1997). For example, Cao1" and
other polyvalent cations, such as aluminium Alo+, are po-
tent mitogens for osteoblasts and certain osteoblast-de-
rived cell lines, despite the clear absence of the previously
cloned CaR as assessed by sensitive techniques to
search for its transcripts, such as the use of the reverse
transcription-polymerase chain reaction (RT-PCR) (Quar-
les etal., 1997). Moreover, there may be additional Ca§+-
sensors structurally distinct from the CaR. A putative
Cao+-sensing protein has been cloned from human pla-
centa and rat kidney that is a member of the LDL receptor
superfamily (Lundgren ef a/., 1994). Although antibodies
raised against this protein alter the sensing of Cao+ by pa-
rathyroid cells, the very large protein predicted by the clo-
ned cDNA, which has been called 'megalin', has not been
functionally characterized by expression in heteroiogous
systems to prove that it does, in fact, exhibit Caf^-sensing
properties (Saito et a/., 1994). Finally, osteoclasts are re-
sponsive to Cao* as noted above (Zaidi ef a/., 1989). The
Cao+-sensor in the latter cell type has been suggested to
be related to the ryanodine receptor, a protein that nor-
mally is involved in intracellular Carinduced Ca2+ release
and has previously been shown to function in the sensing
of Cao+ (Zaidi ef a/., 1992). Cloning and expression of the
putative osteoclast Ca^-sensor, however, will be neces-
sary to clarify further its structural and functional pro-
perties.
Table 2 Sizes of CaR Transcripts in Various Organs of Different Species (in Kb).
Species Parathyroid C-cells Kidney Intestine Brain References
Human
Bovine
Rat
Rabbit
Chicken
5.6,4.8,4.2 5.6
5.3, 9.5
-
6.6
6.2
5.3,2.0
7.5,4.1
6.6
6.2,1.1
-
7.5,4.1,3.0
3.5
4.2
5.3
7.5,4.1
Undetectable
6.2,1.1
Garrettef a/., 1995
Brown ef a/., 1993
Ruatef a/., 1995
Butters ef a/., 1997
Diazef a/., 1997
'-' = data not available
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Localization and Functions of the CaR in
the Kidney
In rat kidney, in situ hybridization and RT-PCR performed
on isolated nephron segments have localized the CaR to
the glomerulus, proximal convoluted and straight tubule,
medullary (MTAL) and cortical thick ascending limb
(CTAL), distal convoluted tubule (DCT) and cortical (CCD)
as well as inner medullary collecting duct (IMCD) (Riccardi
et a/., 1995, 1996). During renal development in the rat,
CaR transcripts and protein are expressed at very low
levels prenatally except in large tubules and branching
ureteric buds of developing nephrons (Chattopadhyay et
a/., 1996a). Postnatally, there is a marked increase in CaR
expression, especially in the CTAL and to some extent in
the CCD. The largest increases in its level of expression
correlate with development of the thick limb, which exhi-
bits the highest level of expression of the CaR in the adult
kidney as well (Riccardi et a/., 1995). In the TAL, the recep-
tor protein is localized predominantly on the basolateral
surface of the cell, particularly in the CTAL (Butters ef a/.,
1997), where it probably senses systemic levels of Cao*
and Mgo+ and responds to the changes in the circulating
levels of these divalent cations with reciprocal changes in
their tubular reabsorption. The decreased and increased
responsiveness of these CaRs to Ca§+ in FHH and autoso-
mal dominant hypocalcemia, respectively, presumably
account for the inappropriately low and high urinary excre-
tion of divalent cations in these two disorders (Chatto-
padhyay et a/., 1996b).
Recent studies have shown that the CaR likely media-
tes the reduced maximal urinary concentrating capacity in
hypercalcemic individuals, probably by reducing the ac-
tivity and/or number of vasopressin-stimulated water
channels (e.g., aquaporin-2 channels) resident in the api-
cal plasma membrane of the tubular cells of the IMCD
(Sands ei a/., 1997). A similar action of the CaR during the
early postnatal development of the kidney may contribute
to the impaired urinary concentration of newborn rats and
humans, particularly since the increase in the expression
of the CaR postnatally precedes that of the vasopressin
receptor in the collecting ducts (Chattopadhyay ef a/.,
1996a). As with the CTAL, alterations in renal water hand-
ling in patients with loss- or gain-of-function CaR muta-
tions provide additional indirect evidence for the role of the
CaR in regulating renal handling of water. Individuals with
FHH concentrate their urine normally despite being hyper-
calcemic, whereas those with autosomal dominant hypo-
calcemia may develop impaired urinary concentrating
capacity during treatment of their hypocalcemia with cal-
cium and vitamin D, even when their levels of Cao+ are with-
in the normal range (Chattopadhyay ef a/., 1996b). The lat-
ter observation, combined with the marked hypercalciuria
that can develop in autosomal dominant hypocalcemia
during such treatment, has led to the suggestion that
therapy be reserved for those patients with symptoms de-
finitely attributable to hypocalcemia (i.e., seizures) (Chatto-
padhyay ef a/., 1996b).
CaR in Non-Homeostatic Organs/Cell Types
Although the CaR was originally considered to be involved
primarily in the process of Ca§+ homeostasis among tis-
sues such as parathyroid, C-cells, kidney, bone and in-
testine (Brown, 1991; Brown ef a/., 1995), several recent
findings suggest the existence of Ca^-sensing in various
cells that do not have any obvious role(s) in the mainte-
nance of the homeostasis of calcium and other mineral
ions.
CaRs in the Brain
In adult rat brain the CaR has been localized by both im-
munocytochemistry and in situ hybridization (Ruat ef a/.,
1995; Rogers ef a/., 1997). The receptor is expressed in
most of the regions of the brain, albeit at varying levels.
The highest levels are observed in the subfornical organ
(SFO) and olfactory bulbs. High expression levels are also
found in the hippocampus, striatum, cingulate cortex, ce-
rebellum and ependymal zones of the cerebral ventricles
and in cerebral arteries. The abundant expression of the
CaR in the SFO, which is an important thirst center, implies
its role(s) in the central control of fluid and electrolyte
homeostasis. We have suggested that CaRs in the SFO
may mediate the increased thirst observed in hypercalce-
mic individuals (Chattopadhyay ef a/., 1996b). Moreover,
increased thirst during incipient or actual hypercalcemia,
coupled with CaR-mediated reduction in urinary concen-
tration in the IMCD, may ensure that excretion of a calcium
load takes place in a sufficiently large volume of dilute
urine to minimize the risk of forming calcium-containing
renal stones (Sands ef a/., 1997).
The CaR is highly expressed in synaptic regions of all
areas of the hippocampus, although it has not yet been es-
tablished with certainty whether it is located predomi-
nantly in pre- and/or postsynaptic membranes (Chatto-
padhyay ef a/., 1997a; Ruat ef a/., 1995). Because its
overall location is similar to those of the mGluRs and the
NMDA type of ionotropic glutamate receptor channels,
both of which play important roles in certain forms of long
term potentiation (LTP), it is possible that the CaR could
also contribute to cognitive functions, such as learning
and memory, although direct evidence for such roles is at
present lacking (Brown ef a/., 1995; Chattopadhyay ef a/.,
1997a). The substantial levels of expression of the CaR in
the cerebellar granule and Purkinje cells could indicate the
receptor's involvement in cerebellar functions, such as
motor coordination. The use of CaR knockout mice should
eventually make it possible to establish whether or not the
CaR plays any such postulated roles (Ho ef a/., 1995).
How might the CaR regulate the function of hippo-
campal, cerebellar and other neurons? Recently we have
shown the presence of a Ca2+-permeable nonselective
cation channel (NCC) that is modulated by the CaR in rat
hippocampal pyramidal neurons (Ye ef a/., 1996a). An
NCC with similar characteristics is regulated in a CaR-de-
pendent fashion in HEK293 cells stably transfected with
CaR but not in nontransfected cells that do not express the
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CaR (Ye ef a/., 1996b). Furthermore, spermine and other
CaR agonists stimulate the activity of a very similar NCC in
neurons cultured from wild type mice but not those from
mice with targeted disruption of the CaR gene (Ye ef a/.,
1997). The relationship of this channel to other Ca2*-per-
meable nonselective channels, such as the NMDA type of
ionotropic glutamate receptor channel that is known to
play a key role in the induction of LTP in the hippocampus,
is not yet entirely clear. CaR-mediated activation of this
channel, however, could contribute to changes in cyto-
solic Ca2+ that are important for the development of LTP
and other forms of synaptic plasticity. Our observations in
the developing rat hippocampus that large increases in
CaR expression occur at a time when LTP can first be in-
duced could indicate that the CaR is involved in such key
synaptic functions (Chattopadhyay ef a/., 1997a). Again,
however, studies on brain preparations from mice with
targeted disruption of the CaR gene will be essential to
evaluate further the CaR's role, if any, in such processes.
It should be recalled that synaptic vesicles contain
abundant calcium, potentially enabling pre- and/or post-
synaptic CaRs to sense changes in Cao+ related to neu-
rosecretion per se (perhaps in glutamatergic synapses
calcium and glutamate could function, in effect, as co-
transmitters) (for review, see Brown ef a/., 1995). In addi-
tion, substantial, neuronal activity-dependent changes in
Cao+ have been documented within the extracellular brain
microenvironment, owing to Ca2+ influx through various
channels (e.g., NMDA channels) (Heinemann ef a/., 1977).
Thus the CaR might be involved in detecting local changes
in Cao+ in the vicinity of neurons, including within synaptic
clefts, related to neuronal uptake of Ca2/, thereby poten-
tially regulating release of neurotransmitters or other syn-
aptic processes (Vassilevef a/., 1997).
An elevation in cytosolic Ca2* in the postsynaptic den-
dritic spines in hippocampus (as depicted in Figure 2) as a
result of Ca2+ influx through NMDA channels is accepted
to be a major factor in the induction of LTP (Malenkaef a/.,
1988; Jahr and Stevens, 1993). Available evidence sup-
ports the existence of one or more transsynaptic, retro-
grade messengers that modulate presynaptic glutamate
release (Bliss and Collingridge, 1993). This putative retro-
grade signaling system acts to coordinate postsynaptic
changes in Caj with presynaptic release of neuromedia-
tors, such that increases in postsynaptic Ca, further stim-
ulate glutamate release. Such a mechanism may underlie
synaptic enhancement during the induction of LTP by
high-frequency (100 Hz) electrical stimulation.
The synaptic cleft may be represented as a very thin
disk of extracellular fluid (Figure 2). It is possible that at
high stimulation frequencies the interval between pulses
would be insufficient for diffusion of Ca2+ from the peri-
phery of the cleft to replace extracellular Ca2* depleted at
the center of the cleft as a result of activation of postsyn-
aptic, Ca2+-permeable channels. We have employed
computer modeling to assess the impact of the activation
of glutamate receptor channels (GRCs) in the postsyn-
aptic membrane on the level of extracellular Ca2+ within
Presynaptic Terminal Φ CaR
Synaptic Cleft
Spine Head (Postsynaptic)
»
x 7^ Calcium Diffusion
Spine Neck
-$-
NMDA Channels
Calcium Pumps
Dendritic Shaft
Fig. 2 Model of Ca2+ Dynamics in the Synaptic Cleft between a
Hippocampal Presynaptic Terminal and a Dendritic Spine.
The CaR located on the presynaptic membrane could sense
changes in Cao+ in the cleft due to the operation of the Ca2+-per-
meable NMDA and other glutamate receptor channels as well as
Ca2* pumps in the postsynaptic spines. The PLC- and G-protein
coupled CaR might then modulate the secretion of glutamate or
other neurotransmitters according to fluctuations in Ca2)*, thereby
playing a key role in a putative retrograde messenger mechanism
[see Vassilev ef a/., (1997) for details]. The boundary between the
dendritic shaft and spine neck is marked with a dashed line. See
explanation in the text [reproduced with permission from Vassilev
et a/., (1997), Biophys. J. 72, in press].
the synaptic cleft (Vassilev ef a/., 1997) (Figure 2). The mo-
del includes calcium influx from the synaptic cleft into the
postsynaptic compartment through GRC and calcium
efflux through calcium pumps. Concentrations of extra-
cellular Ca2+ inside the cleft are estimated by using a com-
partmental model incorporating flux across the post-
synaptic membrane and radial diffusion from the edge of
the cleft. The simulations suggest that substantial deple-
tion of extracellular Ca2+ can occur in the clefts during ac-
tivation of GRCs, particularly at the high stimulation fre-
quencies (—50-100 Hz) used to induce LTP (Figure 3). In
contrast, only minimal transitory changes in extracellular
Ca2+ are observed at low frequencies (~ 3-5 Hz) (Vassilev
ef a/., 1997). These frequency-dependent alterations in
Cao+ dynamics are a direct reflection of the activity of
GRCs and could be involved in the modulation of presyna-
ptic function via a retrograde messenger mechanism if
there are extracellular Ca2+ sensors on the presynaptic
membranes. The CaR that is known to be present in nerve
terminals in hippocampus and other areas of the brain
could potentially play such a role.
CaR in Keratinocytes
Additional non-homeostatic tissues expressing the CaR
include human keratinocytes (Bikleef a/., 1996), a cell line
derived from a human colon cancer (Kallay ef a/., 1997),
lens epithelial cells (Chattopadhyay ef a/., 1997b), and the
pituitary-derived, ACTH-secreting AtT-20 cell line (Ema-
nuel ef a/., 1996), providing additional indirect evidence for
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Fig. 3 Time Course for Changes in the Extracellular Calcium Concentration in the Synaptic Cleft at Various Stimulation Frequencies: 3Hz
in A; 5 Hz in B; 10 Hz in C; 30 Hz in D; 50 Hz in E; and 100 Hz in F.
The profiles for the changes in Cao"1" at various distances from the center of the cleft are marked with different lines, as indicated in the in-
sets. The center is marked with r_0 and the periphery with r_1.0. Other lines are as follows: r_.25, r.50 and r_.75 represent 25%, 50% and
75% of the distance from the center of the cleft to the periphery, respectively. By sensing fluctuations in Ca§+ within the cleft occurring at
different stimulation frequencies, the CaR might serve as a frequency detecting unit. [Reproduced with permission from Vassilev ef a/.
(1997).]
a broader role for the CaR and the Ca^ signal in the con-
trol of cellular differentiation, proliferation, neural trans-
mission, apoptosis and potentially other processes.
Human keratinocyte differentiation in vitro is known to be
triggered by elevations in Ca-, in response to increases in
Cao* through the involvement of (a) release of Cao+ from in-
tracellular stores and (b) Ca2* influx through NCC (Bikle ef
a/., 1996). Moreover, human keratinocytes express tran-
scripts for the CaR, and the differentiating stimulus of an
increase in Cao* leads to an increase in CaR mRNA (Bikle
ef a/., 1996). Thus the CaR might mediate the effects of
Caj)+ on keratinocyte differentiation through its known ca-
pacity to activate PLC and NCC (Bikle ef a/., 1996; Yeef a/.,
1996a,b).
CaR in Lens Epithelial Cells
It has long been appreciated that high Caj)+ has several ef-
fects on lens epithelial cells in culture, viz., disruption of
plasma membrane integrity, loss of the cytoskeletal pro-
tein, vimentin, and activation of Ca-ATPase, leading to cat-
aract formation (for review, see Delamere and Paterson,
1981). In addition, clinical observations, such as the de-
velopment of osmotically-induced cataracts in hypopara-
thyroid patients and the high calcium content of these cat-
aracts, are strongly suggestive of the role(s) of Cao1" (and
potentially the CaR) in the physiology of lens epithelial
cells (Duncan and Bushell, 1975). We have recently shown
that cultured human lens epithelial cells express the CaR
(Chattopadhyay ef a/., 1997b). The receptor is linked to a
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Ca2+-activated K* channel having a conductance of ~ 82
pS, with the open state probability of the channel being in-
creased by addition of high Cao+ or the polycationic CaR
agonist, neomycin (Chattopadhyay et a/., 1997b). We pre-
viously characterized Ca2+-activated K* channels in para-
thyroid cells, whose activity was stimulated by CaR ago-
nists (Kanazirska ef a/., 1995). In addition, a similar
Ca2+-activated K* channel is present in hippocampal neu-
rons cultured from wild type mice as well as those from
mice homozygous for targeted disruption of the CaR gene
(Ye ef a/., in preparation). This channel could only be ac-
tivated by CaR agonists in the neurons from the wild type
mice, however, and not in those from mice with inactiva-
tion of the CaR gene. Therefore, the presence of a similar,
CaR-regulated K* channel in these three cell types sug-
gests that receptor might be involved in membrane repo-
larization and associated voltage-dependent changes in
cellular metabolism, neural transmission and secretion.
CaR in Cells Derived from Intestinal Cells
Cao+ inhibits the proliferation of human colonocytes in cul-
ture, while reducing Cal+ increases proliferation of the
colonocytes in association with a rise in the expression of
the c-myc proto-oncogene (Kallay ef a/., 1997). We have
shown that the human colon cancer-derived cell line,
Caco-2, expresses the CaR, which might, therefore, be
involved in the low Cao+-evoked upregulation of c-myc
expression through the activation of the PKC pathway,
since the use of H7, a PKC inhibitor, abolished low Ca§+
induced proliferation of these cells (Kallay ef a/., 1997). It
remains unclear, however, how the CaR would mediate an
increase in PKC activity with a decrease in Ca§+, since the
receptor is generally positively coupled to phosphoinosit-
ide-specific PLC. It was further shown that application of
low levels of Ca2)"1" to the apical but not to the basolateral
side of the cultured Caco-2 cells leads to upregulation of
c-myc expression (Kallay ef a/., 1997). The lower one third
of the lumen of the colonic crypts has been suggested to
contain reduced levels of Ca2,* due to binding of Ca2+ by
the mucus component of the luminal aspect of the cells
(Whitfield, 1991). Therefore, Caj^-sensing by the CaR
might represent a key cellular 'switch1 that normally inhi-
bits the proliferation and promotes the differentiation of
the stem cells at the crypt bases as they migrate up the
crypts (Kallay ef a/., 1997; Sorenson ef a/., 1988). The use
of a specific CaR antagonist and/or colonic cells from
mice with targeted disruption of the CaR gene, however,
will be necessary to establish unequivocally the CaR's role
in regulating colonic cell proliferation/differentiation.
Regulation of CaR Gene Expression
Relatively few studies are available on the regulation of
CaR expression. CaR gene expression is dramatically re-
duced in cultured bovine parathyroid cells. A 75-80%
loss of receptor mRNA takes place within 18 h of the initia-
tion of culture, followed by a comparable loss of receptor
protein that is accompanied by a marked reduction in high
Cag^-induced inhibition of PTH secretion within 36-48h
(Mithal ef a/., 1995). Conversely, as noted above, there is a
dramatic upregulation of CaR mRNA and protein in rat kid-
ney during the first week of postnatal life, mainly in the TAL
and to a lesser degree in the CCD (Chattopadhyay ef a/.,
1996a). Substantial reductions in the immunoreactivity of
the CaR protein have also been observed in parathyroid
adenomas and parathyroid tumors from uremic subjects
with severe secondary or tertiary hyperparathyroidism
(Kifor ef a/., 1996). Reduced CaR expression in hyperpara-
thyroidism might potentially account, at least in part, for
the abnormal Cao*-regulated PTH release that contributes
importantly to the genesis of hypercalcemia in these pa-
tients. At this stage it is uncertain whether the receptor
downregulation acts as the primary event leading to sub-
sequent parathyroid cellular hyperplasia or is a secondary
phenomenon resulting from predisposing somatic muta-
tions in genes controlling growth. The latter is likely an
important contributory factor, as recent studies have do-
cumented loss of tumor suppressor genes from several
chromosomal loci in various types of parathyroid tumors
(Arnold ef a/., 1995).
Treatment of rats with 1,25(OH)2D in vivo has given rise
to divergent findings. Administration of 1,25(OH)2D mod-
estly increased CaR mRNA in parathyroid gland and kid-
ney in one study (Brown ef a/., 1996), while it had no signi-
ficant effect in another (Rogers ef a/., 1995). However,
chronic alterations in serum calcium concentration had no
effects on CaR gene expression in either tissue. In AtT-20
cells, in contrast, elevated levels of Ca§* produced ~ 2-
fold increases in CaR mRNA (Emanuel ef a/., 1996).
Moreover, hippocampus of developing rats, beginning
during the second postnatal week and extending until
about 30 days of age, displays ~ 3 fold higher levels of
CaR expression relative to adult rats (Chattopadhyay ef
a/., 1997b). Thus the time course for the developmental
expression of the CaR gene differs in rat hippocampus
and kidney, occurring in the immediate postnatal period in
the latter (Chattopadhyay ef a/., 1996a) and achieving a
level that remains constant into adulthood, rather than
decreasing as in the hippocampus (Chattopadhyay ef a/.,
1997a). Finally, as noted before, changes in CaR mRNA
expression occur in association with the induction of diffe-
rentiation of keratinocytes by increases in Ca2/ (Bikleef a/.,
1996). The physiological relevance of regulation of CaR
gene expression in these various tissues is not clear; how-
ever, these observations raise the possibility that the re-
gulation of the receptor in tissues involved in calcium
homeostasis, such as parathyroid cell and kidney, may dif-
fer from that in other tissues, including the brain, AtT-20
cells and keratinocytes, that are not directly involved in sy-
stemic mineral ion homeostasis. In the former, recognition
of the systemic Cao+ signal (e.g., by parathyroid and C-
cells as well as the CTAL) appears to be crucial for main-
taining near constancy of Cao+. In the latter, in contrast, lo-
cal changes in Ca§+ (or perhaps other CaR agonists, such
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as Mg§* or spermine) may provide signals that regulate
cellular differentiation or regulate local Ca§+ homeostasis.
For instance, neuronal activity-dependent changes in the
brain microenvironment, by modulating the activity of
nearby CaRs, might reduce the activity of Ca2+-permeable
channels (e.g., NCC) that contributed to the initial change
in Cao* (Heinemann ei a/., 1977).
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Bacteria contain an array of transport proteins in their
cytoplasmic membrane. Many of these proteins play
an important role in conferring resistance to toxic com-
pounds. The multidrug efflux systems encountered
in prokaryotic cells are very similar to those observed
in eukaryotic cells. Therefore, a study of the factors
which determine the substrate specificity and energy
coupling to drug translocation in bacteria has signifi-
cance for the general field of multidrug resistance.
Three issues will be dealt with in this review. First, an
overview of the various classes of prokaryotic mul-
tidrug transporters will be presented. Second, the cur-
rent understanding of the regulation of bacterial mul-
tidrug resistance will be summarized. Third, the pres-
ent knowledge of the molecular mechanisms involved
in drug transport processes will be discussed.
Key words: Antibiotics / ATP-binding cassette trans-
porter/Transport mechanism / P-glycoprotein /
Prokaryotes / Secondary transporter.
Multidrug Resistant Bacteria
The introduction of antibiotics into clinical use has brought
about a spectacular decline in the prevalence of infectious
diseases in humans. However, the emergence of resistant
bacteria is changing this situation. Diseases such as tu-
berculosis and pneumonia, evocative of a former era when
pathogenic bacteria were often deadly killers, are now re-
emerging as major threats to public health (Cohen, 1992).
In addition, the constant pressure of antibiotics in hospital
environments has selected for drug resistant bacterial
species which may not possess strong virulence but can
infect debilitated patients (Neu, 1992).
Toxic compounds have always been part of the natural
environment in which bacteria dwell. The development of
strategies for life in this habitat has been crucial for surviv-
al of the organisms. As a result, bacteria have developed
versatile mechanisms to resist antibiotics and other cyto-
toxic drugs. Examples are the enzymatic degradation or
inactivation of drugs (Davies, 1994), and the alteration of
drug targets (Spratt, 1994). In addition, mechanisms exist
in which the entrance of a variety of cytotoxic compounds
into the cell is prevented by the barrier and active transport
function of the cell envelope which encloses the cyto-
plasm (Nikaido, 1994).
The envelope of Gram-negative bacteria consists of the
cytoplasmic (or inner) membrane, a peptidoglycan layer,
and the outer membrane that contains lipopolysaccha-
rides (Nikaido and Vaara, 1985). Gram-positive bacteria
are not enclosed by an outer membrane. Instead, their
cytoplasmic membrane is directly surrounded by a thick
peptidoglycan layer. Both the peptidoglycan layer of cer-
tain Gram-positive bacteria [e.g. mycobacteria (Jarlier
and Nikaido, 1994)] as well as the outer membrane of
Gram-negative bacteria are able to serve as a barrier
against rapid penetration of drugs (Thanassi et a/., 1995).
However, these barriers cannot prevent the drugs from
exerting their action once they have entered the cell. Ad-
ditional mechanisms are therefore needed to achieve sig-
nificant levels of drug resistance. One of the major mecha-
nisms to lower the cytoplasmic drug concentration is
based on direct efflux of drugs across the cytoplasmic
membrane.
Drug Transport Proteins
Microorganisms possess membrane proteins which cata-
lyze transmembrane drug transport (Levy, 1992; Lewis,
1994; Nikaido, 1996). Some of these drug transporters are
fairly specific for a given drug or class of drugs, but the
so-called multidrug transporters have specificity for com-
pounds with very different chemical structures and cellu-
lar targets. On the basis of bioenergetic and structural cri-
teria, these transport systems can be divided into:
(i) Secondary transporters, which mediate the extrusion
of drugs from the cell in a coupled exchange with ions
(Paulsenefa/., 1996a), and
(ii) ATP-binding cassette [ABC] transporters, which utilize
the release of phosphate bond-energy by ATP hydro-
lysis to pump drugs out of the cell (Higgins, 1992).
Secondary Multidrug Transporters
The number of secondary multidrug transporters discovered
in prokaryotic and eukaryotic cells is vast and rapidly ex-
panding. Secondary multidrug transporters have been
detected in pathogenic bacteria such as methicillin-re-
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sistant Staphylococcus aureus [QacC] (Littlejohn ef a/.,
1992), Mycobacterium smegmatis [LfrA] (Liu ef a/., 1997),
and Neisseria gonorrhoeae [MtrCD] (Hagman ef a/., 1995).
Computer-based sequence analyses have revealed that
secondary drug transporters belong to one of three dis-
tinct families of transport proteins: the Major Facilitator
Superfamily [MFS] (Marger and Saier, 1993), the Resist-
ance-Nodulation-Cell Division [RND] (Saier ef a/., 1994)
family, and the Small Multidrug Resistance (SMR) family
(Paulsen ef a/., 1996b) (Table 1).
Examples of each type of secondary drug transporter,
L lactis LmrP [MFS family] (Bolhuis ef a/., 1995), S. aureus
QacC [SMR family] (Littlejohn ef a/., 1992), and Pseudo-
monas aeruginosa MexB [RND family] (Poole ef a/., 1993),
are presented schematically in Figure 1. LmrP and QacC
have specificity for an exceptionally wide range of amphi-
philic, cationic drugs including antibiotics, quaternary am-
monium compounds, aromatic dyes, and phosphonium
ions. MexB confers resistance to amphiphilic anionic
compounds such as antibiotics, basic dyes and deter-
gents. In Gram-negative bacteria, transport of drugs from
the interior of the cell to the external medium requires the
translocation of solutes across the cytoplasmic and outer
membrane. Therefore, some drug transporters [e.g.,
MexB] in such organisms are found in association with an
accessory protein which spans the periplasmic space and
interacts with a porin in the outer membrane. These auxil-
iary proteins belong to the Membrane Fusion Protein fami-
ly (Saier ef a/., 1994) and Outer Membrane Factor family
(Dinhefa/,,1994).
Table 1 Multidrug Transporters in Bacteria.
Transporter
Family
ABC family5
MFS family0
RNDfamilyd
SMR family6
Protein
LmrA
LmrP
Bmr
QacA
EmrB
LfrA
MexB
MtrD
AcrB
QacC
QacE
EmrE
Organism
Lactococcus
lactis
Lactococcus
lactis
Bacillus
subtilis
Staphylococcus
aureus
Escherichia
COli
Mycobacterium
smegmatis
Pseudomonas
aeruginosa
Neisseria
gonorrhoeae
Escherichia
coli
Staphylococcus
aureus
Klebsiella
aerogenes
Escherichia
coli
Accession
No.a
GB U63741
GBX89779
SW P33449
EM X56628
SWP27304
GB U40487
GBL11616
SWP43505
EM U00734
SWP14319
PRS25583
SWP23895
a
 Accession number: GB, Genbank; SW, SwissProt; EM, EMBL;
PR, PIR
b
 ATP-binding cassette family (Higgins, 1992)
c
 Major Facilitator Superfamily (Marger and Saier, 1993)
d
 Resistance-Nodulation-Cell Division family (Saier ef a/., 1994)
e
 Small Multidrug Resistance family (Paulsen ef a/., 1996b)
drug drug
outside
inside
Fig. 1 Schematic Presentation of Representative Secondary Multidrug Transporters in Prokaryotes.
LmrP in Lactococcus lactis (Major Facilitator Superfamily), QacC in Staphylococcus aureus (Small Multidrug Resistance family) and MexB
in Pseudomonas aeruginosa (Resistance-Nodulation-Cell Division family) are driven by the proton motive force which is present across
the cytoplasmic membrane (CM). MexB is associated with the accessory protein MexA (Membrane Fusion Protein family) and the outer
membrane porin OprM (Outer Membrane Factor family). These additional proteins enable the MexB-mediated transport of drugs across
the outer membrane (CM) in the Gram-negative bacterium.
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Energetics of Drug Transport
Bacterial secondary transporters are located in the cyto-
plasmic membrane, across which usually a proton motive
force [interior negative and alkaline] exists. Based on (i) the
structural similarity between secondary drug transport
proteins and known proton motive force-dependent
transport systems, and (ii) the sensitivity of drug transport
to agents that dissipate the proton motive force, it is as-
sumed that secondary drug transporters function as
drug/proton antiporters. The direct involvement of the
proton motive force as driving force was demonstrated for
the E co// tetracycline transporter TetA(B) [MFS family],
which mediates an electroneutral exchange reaction of a
metal2Metracycline1~ complex and one proton (Yama-
guchi ef a/., 1991), and the lactococcal multidrug trans-
porter LmrP which mediates an electrogenic drug/nr-T
antiport reaction [n > 2] (Bolhuis ei a/., 1996a).
Structure-Function Relationships
Analysis of the topography of secondary drug transpor-
ters suggest the presence of either 12 or 14 membrane-
spanning segments in members of the MFS family, and 12
membrane-spanning segments in members of the RND
family. The transmembrane segments are most likely in
α-helical conformation, and are connected by hydrophilic
loops protruding into the cytoplasm or periplasmic space.
The structure of TetA(B) has been studied most extensi-
vely, by limited proteolysis (Eckert and Beck, 1989), site-
directed antibody binding (Yamaguchi etal., 1990), PhoA-
fusion analysis (Allard and Bertrand, 1992), and
site-directed chemical labeling (Kimuraef a/., 1997). A rel-
atively large cytoplasmic loop in the middle of the protein
separates TetA(B) in an N- and C-terminal half, each con-
taining 6 transmembrane segments. Both halves are evo-
lutionary related, presumably by a gene duplication event,
and are well conserved among TetA proteins of various
classes (Rubin ef a/., 1990). The N- and C-terminal halves
of TetA(B) represent separate domains in the drug trans-
porter (Curiale and Levy, 1982). The functional interaction
between these domains is suggested by
(i) the intragenic complementation between mutations in
the first and second halves of the fefA(B) gene (Curiale
ef a/., 1984; McNicholasef a/., 1995),
(ii) the ability of hybrid tetracycline efflux transporters
containing N- and C-terminal halves of different clas-
ses of tetracycline efflux proteins (e.g., class A and C),
to confer resistance (Rubin and Levy, 1990) and
(iii) the functional reconstitution of tetracycline resistance
upon co-expression of the N- and C-terminal halves of
TetA(B) as separate polypeptides (Rubin and Levy,
1991).
Members of the SM R family contain 4 putative transmem-
brane α-helices. This topological model has recently been
confirmed for QacC by genetic fusion using alkaline phos-
phatase and -galactosidase as reporters of subcellular
localization (Paulsen ef a/., 1995), and for E co// EmrE by
transmission fourier-transform infrared spectroscopy
(Arkin ef a/., 1996). In view of the 12 transmembrane mo-
dels proposed for members of the MFS and RND families,
members of the SMR family may function as a homotrimer
(Yerushalmiefa/.,1995).
Multiple alignment of the amino acid sequences of the
MFS family members reveals the presence of two con-
served sequence motifs that are located at similar posi-
tions within the putative secondary structure of the pro-
teins. Motif A [GXXXDRXGR(K/R)] is found in many mem-
bers of the MFS family (Marger and Saier, 1993) and is
present in the cytoplasmic loop between transmembrane
segment 2 and 3. Motif A may be of structural importance
by mediating opening and closing of the translocation
pathway. Motif B [GXXXGPXXGG], the drug extrusion con-
sensus sequence, is found at the end of transmembrane
segment 5, and is typical for LmrP and other drug export
systems of the Major Facilitator superfamily (Bolhuis etal.,
1995; Griffith etal., 1992). At present, the role of motif B in
drug recognition or binding is unclear.
It has been suggested that amino residues within trans-
membrane segments of the human multidrug resistance
P-glycoprotein MDR1 play a role in drug specificity (for
review see Gottesman ef a/., 1995). Observations on sec-
ondary drug transporters in bacteria are consistent with
this notion. The MFS members QacA and QacB in S. aureus
are homologous proteins [98% identical amino acid resi-
dues]. QacB confers resistance to monovalent organic ca-
tions but differs from QacA by conferring no resistance to
the divalent organic cations pentamidine isothionate and
propamidine isothionate. This phenotypic difference be-
tween QacA and QacB is solely due to the presence of the
acidic Asp323 within the putative transmembrane segment
10 of the QacA protein, instead of the neutral Ala323 in
QacB (Paulsen etal., 1996c). The ability of the MFS mem-
ber Bmr in Bacillus subtilis (Neyfakh etal., 1991) to interact
with reserpine and other drugs is strongly affected by sub-
stitutions of Val286 (Ahmed ef a/., 1993), and of Phe143 or
Phe306 (Klyachko ef a/., 1997), which are located within
transmembrane segments. Thus, both charged and aro-
matic residues located within the phospholipid bilayer
appear to interact with drugs and may be involved in drug
recognition or binding. Interestingly, it has been shown
that quaternary ammonium compounds and other cations
can bind to the IT face of the aromatic ring structures of
tyrosine, phenylalanine or tryptophan residues in the
hydrophobic environment of the membrane (Dougherty,
1996).
Regulation of Gene Expression
The expression of drug-specific efflux transporters is
usually induced by the drugs themselves through their
interaction with DMA-binding regulatory proteins. The
best understood example is the regulation of bacterial te-
tracycline-efflux transporter TetA(B), where the binding of
tetracycline to a specific represser protein (TetR) causes
the represser to dissociate from the promoter of the trans-
porter gene thereby allowing transcription (Hinrichs ef a/.,
1994; Kisker ef a/., 1995). Studies on the regulation of the
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expression of ß. subtilis Bmr, E coli EmrAB (Lomovskaya
and Lewis, 1992), and N. gonorrhoeae MtrCD suggest that
specific regulator proteins also play a role in the regulation
of the expression of multidrug transporters.
Drugs recognized by Bmr enhance the expression of
this multidrug transporter. In drug resistant mutants, Bmr
can be overexpressed by gene amplification. In wild type
cells, however, the regulation of gene expression is de-
pendent upon expression of the regulatory protein BmrR
which is encoded downstream of the bmr gene (Ahmed et
a/., 1994). BmrR shows sequence homology and functio-
nal similarity with several known bacterial transcription
activator proteins and contains a conserved N-terminal
DMA binding domain. Upon binding of drugs to the C-ter-
minal drug-binding domain, the protein binds to the bmr
promoter and induces Bmr expression (Markham et al.,
1996). Interestingly, the ß. subtilis genome encodes two
additional multidrug efflux transporters:
(i) Bit, which shares 51 % amino acid sequence identity
with Bmr (Ahmed et al., 1995), and
(ii) Bmr3, which shares 21 % amino acid sequence iden-
tity with EmrB (Ohki and Murata, 1997).
Bmr, Bit and Bmr3 have an overlapping drug specificity
but are differentially expressed in response to drugs. The
expression of Bit is regulated by BltR, a transcriptional ac-
tivator (Ahmed etal., 1995). Although the DNA-binding do-
mains of BmrR and BltR are related, their putative drug-
binding domains are dissimilar. Apparently, the expression
of Bmr and Bit is mediated by regulatory proteins which,
like their regulated transporters, are capable of recogniz-
ing structurally diverse compounds.
Like Bmr and Bit, the expression of EmrAB in E. coli is
enhanced in the presence of the drugs which are recogni-
zed by this multidrug efflux system. However, regulation
of the expression of EmrAB is dependent on a negative
regulator, EmrR, which is encoded upstream of emrAB
(Lomovskaya et al., 1995). Whether the transcriptional re-
pression caused by EmrR is due to direct binding to the
emrAB promoter is not known. In contrast to BmrR and
BltR, EmrR does not contain known DNA-binding motifs.
MtrCD expression in N. gonorrhoeae is negatively regu-
lated by a represser protein, MtrR, which is homologous to
TetR(Hagmanefa/., 1995). Mutations that inactivate MtrR
result in an increase in the level of MtrCD expression.
Interestingly, the MtrR protein was found to be homolo-
gous to previously unidentified open reading frames (acrR
and e/wR) that are upstream of the E coli acrAB and
envCD operons (Pan and Spratt, 1994). Although AcrAB
expression is primarily regulated by global regulatory path-
ways (Okusu et al., 1996), a major role of the represser
AcrR is to function in the fine tuning of this expression (Ma
etal., 1996). Mutations in envR may result in increased lev-
els of the EnvCD proteins, and hence, in increased resis-
tance of E coli to antimicrobial agents.
Besides the specific regulatory mechanisms that affect
the expression of single multidrug efflux systems, global
regulatory mechanisms have evolved in bacteria that af-
fect the expression of (dedicated) drug efflux systems and
other proteins involved in the intrinsic resistance of the
cell. The mar regulon of E co//(Cohen ei a/., 1993a; Rosner
and Slonczewski, 1994) and various other bacteria
(Zhanel etal., 1995; George etal., 1995) is involved in chro-
mosomally mediated multiple antibiotic and Superoxide
resistance. The inducing agents of this regulon are often
used in clinical situations: antibiotics such as tetracycline
and chloramphenicol, and aromatic weak acids including
salicylate and acetylsalicylate. The agents stimulate the
transcription of themarRAB operon (Cohen etal., 1993a,
b). Specifically, expression of mar A, encoding a transcrip-
tional activator (Martin etal., 1996), elevates the expres-
sion of about 10 unlinked genes that affect the outer mem-
brane permeation (Cohen ef al., 1993a, b), antibiotic efflux
(Seoane and Levy, 1995a), and the reducing potential of
the cell (Ariza ef al., 1994). Although salicylate appears to
induce the mar operon by binding to the negative regulator
MarR, tetracycline and chloramphenicol do not bind to the
regulator (Seoane and Levy, 1995b). The latter com-
pounds must therefore induce the mar operon by an indi-
rect mechanism (Martin and Rosner, 1995). Besides the
marRAB-dependent pathway for multiple antibiotic and
Superoxide resistance, the soxRS genes provide E co//
with a mar-independent pathway (Cohen et al., 1993b).
SoxS is a transcriptional activator homologous to MarA
[39% identical residues], which elevates the transcription
of the operons of the mar regulon (Martin ef al., 1996).
SoxR is a [2Fe-2S] sensor of Superoxides that positively
regulates soxS gene-expression in its oxidized form
(Greenberger ef a/., 1990; Gaudu and Weiss, 1996). The
dual regulation by marRAB and soxRS of a common set of
genes may enable different environmental signals to trig-
ger responses (Rosner and Slonczewski, 1994).
ABC-Type Drug Transporters
Transport proteins belonging to the ABC transporter su-
perfamily are involved in the tolerance to a wide diversity of
cytotoxic agents in both prokaryotes and eukaryotes
(Higgins, 1992). Included in this superfamily are the well-
known human multidrug resistance P-glycoprotein (Gottes-
man and Pastan, 1993) and human multidrug resistance-
associated protein MRP1 (Coleef a/., 1992) plasma mem-
brane transporters, which catalyze the extrusion of anti-
tumor drugs during the chemotherapy of human cancer
cells.
A number of dedicated ABC-type antibiotic export sys-
tems have been found in prokaryotes. In Sfrepfomyces
strains, these transporters mediate the excretion of var-
ious antibiotics to ensure self-resistance to the antibiotics
that they produce. A well-known example is, amongst
others, DrrAB which is implicated in the efflux of daunoru-
bicin/doxorubicin (Guilfoile and Hutchinson, 1991). ABC
transporters dedicated to the efflux of specific drugs have
also been detected in other bacteria such as Bacillus in
which the BcrABC (Podlesek ef al., 1995) and TmrB (Noda
ef al., 1992) proteins confer resistance to bacitracin and
tunicamycin, respectively.
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Remarkably few prokaryotic ABC-type efflux systems
have been characterized that are able to transport multiple
drugs (Table 1). To date, most multidrug transporters in
bacteria utilize the proton motive force, rather than ATP as
the driving force and act via a drug/hT antiport mecha-
nism. The first example of an ABC-type multidrug trans-
porter has been found in L lactis (van Veen et a/., 1996).
The gene encoding this transporter, termed ImrA, has
been cloned and sequenced. It encodes a 590-amino-
acid membrane protein, the hydropathy analysis of which
suggests the presence of an N-terminal hydrophobic do-
main with 6 putative transmembrane regions and a C-ter-
minal hydrophilic domain. The latter domain contains the
ATP-binding cassette (Figure 2).
Comparison of LmrA and various ABC transporters
clearly identifies the lactococcal transporter as a struc-
tural homolog of the human multidrug resistance P-glyco-
protein (Gottesman and Pastan, 1993). This 1280-residue
membrane protein is predicted to contain two homolo-
gous halves, each with 6 transmembrane regions and an
ABC domain. Amino acid alignment of LmrA and each half
of P-glycoprotein indicates that they share 32% identity
with an additional 16% conservative substitutions for an
overall similarity of 48%. Interestingly, the sequence iden-
tity includes particular regions which, in P-glycoprotein,
have been implicated as determinants of drug recognition
and binding. Indeed, the specificity of both transporters
for amphiphilic organic cations appears to be identical,
whereas the activity of both systems is reversed by a sim-
TMD TMD
OUT
NBD
Fig. 2 Secondary Structure Model of the ABC-Type Multidrug
Transporter LmrA of Lactoccus lactis.
LmrA consists of a transmembrane domain [TMD] with 6 trans-
membrane α-helices (depicted as ellipses), and a nucleotide-
binding domain [NBD] containing the ABC family signature and
Walker A/B motifs. In view of the twelve-transmembrane model
proposed for the human multidrug resistance P-glycoprotein,
LmrA may function as a homodimeric complex. OUT and IN refer
to the outside and inside of the cytoplasmic membrane, respec-
tively.
ilar set of inhibitors (van Veen ef a/., 1996). Thus, LmrA re-
presents a naturally occurring, functional 'half-molecule'
of the human multidrug resistance P-glycoprotein. On the
basis of the general domain organization of ABC trans-
porters, two ATP binding domains and two hydrophobic
domains (Higgins, 1992), the lactococcal export system is
predicted to function as a homodimeric complex (Figure
2).
Besides the drug transporters LmrP and LmrA, L lactis
also possesses ATP-dependent drug extrusion systems
with specificity for organic anions. One system in L lactis
has the ability to extrude the fluorescent pH indicator
BCECF [2',7'-bis-(2-carboxyethyl)-5(and 6)-carboxyflu-
orescein] (Molenaar ef a/., 1991,1992). BCECF efflux was
directed against a concentration gradient and strictly cor-
related with the cellular ATP concentration. In addition,
BCECF efflux was strongly decreased in the presence of
ortho-vanadate, a well known inhibitor of P-type ATPases
and ABC transporters. Most convincingly, an UV mutant
with a strongly reduced efflux rate could be isolated from a
BCECF-loaded and lactose-energized cell population by
selection of highly fluorescent cells in a flow cytometer-
cell sorter. Recently, evidence has been obtained for the
presence of a second ATP-dependent transporter with
specificity for the fluorescent pH indicator FTUG [N-(flu-
orescein thio-ureanyl)-glutamate] (Glaaskeref a/., 1996).
Although true P-glycoprotein homologs have not yet
been found in bacteria other than L. lactis, there is little
doubt that many more systems remain to be identified.
Recently, physiological evidence has been obtained for
the presence of an ATP-dependent multidrug transporter
in Enterococcus hirae (Midgley, 1994), Enterobacter cloa-
cae (Aspedon and Nickerson, 1993), and the archaeon
Haloferax volcanii (Miyauchi et a/., 1992). In E coli, the mdl
gene is predicted to encode a member of the ABC trans-
porter superfamily closely related to the human multidrug
resistance P-glycoprotein (Allikmets et a/., 1993). Func-
tional studies on this E coli protein have not yet been per-
formed.
Molecular Mechanism of Multidrug
Transporters
Several models have been postulated for the pump func-
tion of multidrug transporters to explain their broad spec-
ificity for chemically unrelated compounds. Drug translo-
cation may involve substrate transport from the cytoplasm
to the exterior via an aqueous pore with flexible 'enzyme-
like' substrate recognition sites (conventional transport
hypothesis) (Altenberg ei a/., 1994). Alternatively, multi-
drug transporters could recognize the lipophilic drugs by
their physical property to intercalate into the lipid bilayer,
and transport drugs from the lipid bilayer to the exterior
(vacuum cleaner hypothesis) (Raviv ef a/., 1990), or from
the inner leaflet to the outer leaflet of the lipid bilayer [flip-
pase hypothesis] (Higgins and Gottesman, 1992) (Figure
3).
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Aqueous
pore
Hydrophobie
vacuum cleaner Flippase
OUT
Fig. 3 Molecular Models for Drug Extrusion by Drug Transporters.
Partitioning of drugs between the water phase and phospholipid bilayer is indicated by a gray arrow. Protein-mediated drug transport is
indicated by a black arrow. A drug transport protein may function as (i) an aqueous pore which transports drugs from the intracellular (IN)
to the extracellular (OUT) water phase, (ii) a hydrophobic vacuum cleaner which transports drugs from the membrane to the extracellular
environment, or (iii) a flippase which transports drugs from the inner to the outer leaflet of the phospholipid bilayer.
On the other hand, the extraordinary broad substrate
specificity of multidrug transporters has led to the propo-
sal of alternative, indirect mechanisms via which such pro-
teins reduce the intracellular drug concentration. In one
hypothesis, multidrug transporters may affect the electro-
chemical proton gradient across the plasma membrane
(Simon ef a/., 1994). Many of the transported drugs are
weak bases having a positive charge at neutral pH. An in-
crease in the transmembrane pH gradient (interior alka-
line) and/or decrease in the transmembrane membrane
potential (interior negative), observed in human multidrug
resistant cancer cells (Roepe, 1992), would result in a de-
crease in the cellular drug concentration and, hence, in in-
creased drug resistance. Currently, no information is avail-
able with respect to changes in the magnitude or
composition of the proton motive force in multidrug resist-
ant microorganisms. However, the observation of LmrA-
mediated drug transport in the absence of a proton motive
force argues against an indirect proton motive force-de-
pendent mechanism, and favours a direct drug extrusion
mechanism (van Veen ef al., 1996).
L lactis cells expressing LmrA or LmrP were found to
actively extrude the hydrophobic acetoxymethyl ester of
BCECF (Bolhuis etal., 1996b). Similar observations on the
human multidrug resistance P-glycoprotein were taken as
evidence for the transport of hydrophobic compounds
from the plasma membrane (Homolya ef a/., 1993). The
transport mechnism of bacterial LmrA and LmrP has been
studied in greater detail by using the amphiphilic mem-
brane probe TMA-DPH [1 -(4-[trimethylamino]phenyl)-6-
phenylhexa-1,3,5-triene]. Intercalation of TMA-DPH in the
phospholipid bilayer is based on a fast partitioning of the
probe in the outer leaflet, followed by a slowertransbilayer
movement of the probe from the outer to the inner leaflet of
the membrane. Remarkably, the effect of the partitioning
of TMA-DPH in the membrane on the drug pumping activ-
ity of LmrA (Bolhuis ef a/., 1996b)and LmrP (Bolhuis ef a/.,
1996a) suggests that both transporters extrude TMA-DPH
from the inner leaflet of the membrane. Thus, LmrA and
LmrP recognize drugs by their hydrophobic properties. In
view of the structural and functional similarities between
LmrA and Pgp, the LmrA-mediated transport of amphiphi-
lic drugs from the inner leaflet of the phospholipid bilayer
of L lactis provides strong support for the hydrophobic va-
cuum cleaner model for the human multidrug resistance
P-glycoprotein (Figures).
It has been proposed that the human multidrug resist-
ance P-glycoprotein participates in the protection of hu-
man cells against hydrophobic xenobiotics by active
excretion of these compounds from the membrane into
bile, urine, or the intestinal lumen, and by preventing their
accumulation in critical organs such as the brain (Schinkel
ef a/., 1994). Likewise, the physiological role of multidrug
transporters in microorganisms could involve the efflux of
amphiphilic compounds which originate from endoge-
nous metabolism such as the oxidation of phospholipids
or conjugation of xenobiotics, or amphiphilic compounds
which are encountered in the extracellular environment. It
is noteworthy that the natural environment of enteric bac-
teria is enriched in bile salts and fatty acids, and that these
compounds are substrates for various multidrug transpor-
ters (Ma ef a/., 1995; Thanassi ef a/., 1997). Alternatively,
microbial multidrug transporters may play a role in the
transport of a common endogenous substrate, such as
lipid (Smit et al., 1993; Higgins, 1994; Ruetz and Gros,
1994; van Helvoort ef a/., 1996), which remains to be es-
tablished.
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Avoidance of Iron Toxicity through Regulation of
Bacterial Iron Transport3
Volkmar Braun
Mikrobiologie / Membranphysiologie, Universität
Tübingen, Auf der Morgenstelle 28, D-72076 Tübingen,
Germany
Under oxic conditions and at pH 7, ferric iron is insol-
uble, and complex formation of Fe3+ with ligands is
required to supply cells with iron. Bacteria and fungi
synthesize and secrete low-molecular-weight com-
pounds, termed siderophores, that bind Fe3+. Certain
human pathogens take up iron from human transfer-
rin, lactoferrin, hemoglobin, and heme. The ferric side-
rophores are actively transported into bacterial cells
by highly specific transport systems. In Gram-nega-
tive bacteria, the ferric siderophores and iron released
from the host proteins are actively transported across
the outer membrane (OM). The electrochemical po-
tential of the cytoplasmic membrane (CM) energizes
transport across the outer membrane, which requires
an energy-transducing device, consisting of the pro-
teins TonB, ExbB and ExbD, from the CM to the OM.
Active transport across the CM is energized by ATP
hydrolysis. Transport is regulated at the level of gene
transcription. In Gram-negative bacteria, this is con-
trolled by the Fur protein, in most gram-positive bacte-
ria, by the DtxR protein. Fur and DtxR act as repressers
when loaded with Fe2*. In the cytoplasm, iron is re-
leased from the siderophores by reduction to Fe2*, and
the siderophores are either inactivated or secreted.
The intracellular iron is built into heme and non-heme
iron proteins, and a small proportion is incorporated
into bacteriof erritin, but most of the iron is present in a
poorly defined state. Iron overload results in iron tox-
icity, mainly due to the formation of hydroxyl radicals
that strongly react with all kinds of biomolecules, of
which DNA damage has the most deleterious conse-
quences.
Key words: Iron / Regulation /Toxicity /Transport.
Introduction
The wide range of Fe2"VFe3+ redox potentials from -300 to
+ 700 mV, depending on the iron ligands and the protein
a
 This article is an expanded version of the lecture given at the
Meeting of the German Society of Biological Chemistry and
Molecular Biology 1997 at the University of Tubingen.
environment, may be the reason why iron is contained in
many membrane-bound and soluble redox enzymes in al-
most all organisms. For the growth of 109 bacterial cells in
1 ml medium, 1014 iron ions are required. The concentra-
tion of free ferric ions in equilibrium with the ferric hydrox-
ide polymer at pH 7 is 103 ions per ml, which demonstrates
the extreme shortage of biologically available iron despite
its great abundance in nature. To cope with iron limitation,
bacteria synthesize and secrete siderophores, and they
frequently can use siderophores synthesized and released
into the surrounding by other bacteria and even fungi. The
ferric siderophores have molecular masses of approx-
imately 750 Da and they contain hydroxamate, catecho-
late, or carboxylate iron ligands. The formation constants
of ferric siderophores is in the order of 10~23 to 10"35, which
enables them to complex the scarce iron ion in equilibrium
with ferric hydroxide and with transferrin, lactoferrin, and
ferritin in the human body. Some bacterial genera that are
adapted to humans can use heme, hemoglobin, transfer-
rin, lactoferrin, and hemopexin iron directly without inter-
connection of siderophores. For the uptake of ferric side-
rophores, heme, and iron released from iron-binding pro-
teins, bacteria have developed highly sophisticated active
transport systems. In Gram-positive bacteria, the iron com-
plexes have direct access to the cytoplasmic membrane
through which ferric iron and ferric siderophores are trans-
ported by a mechanism which in principle, but perhaps not
in every detail, is common for all ferric iron sources in
Gram-positive and in Gram-negative bacteria. The same
mechanism is used for the transport of certain amino
acids, peptides, sugars, and inorganic anions into bacte-
ria. In Gram-negative bacteria, ferric iron and ferric sidero-
phores also have to be transported across the outer mem-
brane; this involves a unique transport mechanism.
Transport of Ferric Siderophores across the
Outer Membrane of Gram-Negative Bacteria
Ferric siderophores are extracted from the culture medium
and concentrated at the bacterial cell surface by binding
to outer membrane receptor proteins. The receptors have
a high specificity for the ferric siderophores, which mainly
determines which ferric siderophore is used as iron donor
for a particular strain. A certain receptor only binds ferric
siderophores with very similar structural elements. Escher-
ichia coll K-12, the standard laboratory strain, synthesizes
two receptors for ferric hydroxamates, three receptors for
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Hydroxamate
Siderophores
Ferrichrome Coprogen Aerobactin
ΤΙ, Τ5, Φ80
Albomycin CloacinDFlS
Colicin M
l
Catechol
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Colicin B, D
OM
PP
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FecE
Fig. 1 Ferric Iron Transport Systems of Escherichia coli K-12.
Multifunctional receptor proteins in the outer membrane (OM) bind specifically the ferric Siderophores and transport them into the peri-
plasm (PP) where theferric hydroxamates bind to the FhuD protein, the ferric catecholates bind to the FepA protein, and ferric citrate binds
to the FecB protein. The periplasmic binding proteins donate the ferric Siderophores to transport proteins in the cytoplasmic membrane
(CM). Transport across the CM is energized by ATP hydrolysis catalyzed by the FhuC, FepC, and FecE proteins, which are associated with
the CM. For the sake of clarity, the Ton system, composed of the TonB, ExbB, and ExbD proteins, and which catalyzes transport across
the OM, is not included in the Figure. DBS, dihydroxybenzoyl serine. The receptors also serve for infection by the phages T1, T5, and φ80,
and for the uptake of the antibiotic albomycin and the colicins B, D, l, M, and V, and cloacin DF13, which are bacterial protein toxins.
ferric catecholates, and one receptor for ferric citrate
(Figure 1).
Once bound to the receptors, the ferric Siderophores
have to be transported into the periplasm. An idea how this
might happen was obtained when a 34-amirio-acid resi-
due fragment of the FhuA receptor for the uptake of fer-
richrome (Figure 1) was excised by genetic means. This
fragment represents the largest FhuA loop at the cell sur-
face (Koebnik and Braun, 1993) and its removal converted
FhuA into a permanently open channel (Killmann ef a/.,
1993). Uptake of ferrichrome into cells that synthesized
the FhuA deletion derivative (FhuAA322-355) is diffusion-
controlled and no longer displays saturation kinetics. This
demonstrates that within the concentration range used,
the rate of ferrichrome uptake into cells that synthesize
wild-type FhuA is determined by the transport rate across
the outer membrane and not by the transport rate across
the cytoplasmic membrane. Other substances, such as
SDS and the antibiotic bacitracin, for which the outer
membrane of wild-type cells forms a permeability barrier,
diffuse through the FhuA deletion derivative and kill the
cells. A fine-mapping of the region corresponding to the
excised fragment (gating loop) with hexapeptides repres-
enting amino acid sequences of the gating loop disclosed
three subdomains for uptake of ferrichrome, infection by
the bacteriophages T1, T5 and φ80, and import of colicin
M, all of which use FhuA as a receptor (Killmann ef a/.,
1995). The properties of other FhuA derivatives, in which
fragments in the gating loop are excised, support the as-
signment of functional subdomains within the gating loop
(Killmann ei a/., 1996). The recent determination of the
nucleotide sequence of the fhuA gene of Salmonella para-
fyp/?/, Salmonella typhimurium, and Pantoea agglomerans
revealed that these FhuA proteins have deletions in the
gating loop, as compared with the E. coli gating loop
(Killmann ef a/., unpublished results). The ferrichrome up-
take and phage binding receptor properties of the FhuA
proteins agree with the predictions derived from the E. coli
FhuA studies. Incorporation of FhuAA322-355 into artifi-
cial black lipid membranes results in an open channel
through which cations and anions diffuse at similar rates.
Wild-type FhuA does not increase the conductance of
lipid bilayer membranes. Single-channel conductance
measurements of the open FhuA predict a channel three
times as large as the diameter of the E. coli outer mem-
brane porin channels (Killmann ef a/., 1993). Addition of
phage T5 to FhuA integrated in planar lipid bilayer mem-
branes opens a channel (Bonhiversef a/., 1996), which ex-
hibited electrophysiological properties similarto FhuAA322-
355. This demonstrates that the phage creates the chan-
nel for the transfer of the phage DMA across the outer
membrane and that the experimentally created channel
reflects the properties of the naturally formed channel. If
FhuA formed a permanently open channel of this size, E.
coli would be vulnerable to deleterious compounds, such
as bile salts in the gut.
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Excision of 139 residues from the ferric enterobactin re-
ceptor FepA results in an open channel that allows non-
specific diffusion of unrelated compounds through the
outer membrane of E coli (Ruiz et a/., 1992). The two re-
ceptors, FhuA and FepA, are probably typical for all regu-
lated protein channels used for the transport of all ferric
siderophores across the outer membranes of gram-nega-
tive bacteria.
Energy Transfer from the Cytoplasmic
Membrane into the Outer Membrane
If FhuA forms a closed channel that is occasionally open-
ed for the transport of ferrichrome, then the question aris-
es how the channel is opened. This poses a very intri-
guing and interesting problem. Energy input is required for
either opening or closing a channel. However, the outer
membrane does not contain an energy source. Older data
from the time when molecular biology was being founded
indicated that an additional genetic locus, designated
tonB, is required for infection of E. coli cells via the fhuA
determinant (then designated fon>4) by phage T1 (ton de-
rived from T-one). It was later shown that the electrochem-
ical potential of the cytoplasmic membrane is the energy
source for adsorption of phage T1 to FhuA-containing
cells, and it was proposed that TonB somehow transmits
the energy from the cytoplasmic membrane to the FhuA
receptor in the outer membrane (Hancock and Braun,
1976). This concept is still valid and is supported by many
additional data, which, however, do not disclose the mech-
anism of TonB energization and of TonB-mediated energy
transfer. The topology of TonB supports a function in
energy transfer. TonB is inserted in the cytoplasmic mem-
brane through its N-terminus, and most of the protein is
located in the periplasm (Postle and Skare, 1988). TonB
interacts with the FhuA receptor (Schöffler and Braun,
1989; Günter and Braun, 1990) and with the FepA receptor
involved in the transport of ferric enterobactin (Skareef a/.,
1993). Our current concept proposes that TonB senses
the electrochemical potential of the cytoplasmic mem-
brane and assumes an energized conformation. TonB
binds to FhuA, which leads to the opening of the FhuA
channel, and then TonB folds back into the nonenergized
conformation. This cycle is then repeated with FhuA or
with other ferric siderophore receptors. The activity of
only those outer membrane proteins depends on TonB
which transport ferric siderophores, transferrin, lactofer-
rin, hemoglobin iron, and vitamin B12 (Kadner, 1990).
Two additional proteins, ExbB and ExbD, are required
for TonB activity (Ton system). ExbB spans the cytoplas-
mic membrane three times, and most of the protein is
located in the cytoplasm (Kampfenkel and Braun, 1993).
ExbD is arranged like TonB with the N-terminus in the
cytoplasmic membrane and the remainder of the poly-
peptide in the periplasm (Kampfenkel and Braun, 1992).
TonB, ExbB, and ExbD interact with each other (Fischer
efa/., 1989; Larsenefa/., 1994; Braun et a/., 1996), which
suggests that they form a functional complex for TonB
energization and energy transfer from the cytoplasmic
membrane to the outer membrane.
Transport across the Outer Membrane of
Heme and of Iron Released from Transferrin and
Lactoferrin
The first heme transport system was characterized in
Yersinia enterocolitica (Stojiljkovic and Hantke, 1992,
1994). The system consists of an outer membrane recep-
tor protein that requires the Ton system for heme transport
across the outer membrane. Further transport across the
periplasm and the cytoplasmic membrane is catalyzed
by proteins that are similar to those of ferric siderophore
transport systems (see below). Similar heme transport sys-
tems have been partially characterized in two other human
pathogens, Shigella dysenteriae and Vibrio cholerae.
Other bacterial pathogens, such as Neisseria meningi-
tidis (Stojiljkovic ef a/., 1995), Vibrio cholerae (Torres and
Payne, 1997), and Haemophilus ducreyi (Stevens ef a/.,
1996) extract heme in an unknown way from hemoglobin
bound to outer membrane receptors. A very interesting
case of heme mobilization is found in Serratia marces-
cens, which secretes a protein that is able to release heme
from hemoglobin (Letoffe ef a/., 1994). Neisseria meningi-
tidis contains a receptor in the outer membrane that binds
hemoglobin and the hemoglobin-haptoglobin complex
(Lewis ef a/., 1997). The receptor consists of two proteins,
one of which is a lipoprotein with a covalently bound lipid
of the type found in the murein lipoprotein (Hantke and
Braun, 1973; Braun and Wu, 1994). The same type of two-
component receptors of N. meningitidis, N. gonorrhoeae,
and Haemophilus influenzae (Gray-Owen and Shrivers,
1996) bind iron-loaded transferrin (Anderson efa/., 1994)
and iron-loaded lactoferrin (Pettersson efa/., 1994). It is
not known how iron is released from transferrin and lacto-
ferrin and how it is transported across the outer mem-
brane. Neisseria gonorrhoeae when mutated in the fonß
gene, is unable to grow on human transferrin, lactoferrin,
and hemoglobin as sole iron source and is unable to take
up radioactive iron from transferrin and lactoferrin (Biswas
efa/., 1997). At present, it is not known which step of the
iron uptake - release of iron from the proteins or the pre-
sumed opening of the receptor channel for translocation
of iron across the outer membrane - depends on the Ton
system and energization. Of interest is the high specificity
of the receptors, which in the case of human pathogens,
recognize transferrins and lactoferrins only from humans
and primates (Gray-Owen and Shrivers, 1996).
Transport of Ferric Iron and Ferric Siderophores
across the Cytoplasmic Membrane
All the ferric iron transport systems involve a periplasmic
binding protein, one or two hydrophobic integral transport
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proteins in the cytoplasmic membrane, and one or two
proteins associated with the inside of the cytoplasmic
membrane that contain the two Walker nucleotide binding
motifs and function as ATP hydrolases (Figure 1). The peri-
plasmic-binding-protein-dependent transport systems
are the most frequently occurring substrate transport
systems in bacteria. They belong to a superfamily of ATP-
dependent transporters (traffic ATPases), which in bacte-
ria also export certain proteins, polysaccharides, and to-
xic compounds. Eukaryotic members of the superfamily
are the multidrug resistance protein, the cystic fibrosis
transmembrane conductance regulator, and the a-factor
secretory yeast protein. With the reconstituted maltose
and histidine transport components in liposomes, it has
been shown that the substrate-loaded binding proteins
trigger ATP hydrolysis which is required for substrate
translocation across the lipid bilayer (summarized and di-
scussed by Boos and Lucht, 1996). For the ferrichrome
transport system of E coli, binding of ferrichrome to the
binding protein FhuD (Köster and Braun, 1990; Rohrbach
et a/., 1995a, b), interaction of FhuD with the integral trans-
port protein FhuB (Rohrbach ef a/., 1995a), and FhuB-me-
diated binding of the FhuC ATPase to the inner side of the
cytoplasmic membrane (Schultz-Hauser ef a/., 1992) has
been demonstrated.
Peptides identical in sequence to a proposed periplas-
mic loop, and unexpectedly, corresponding to a trans-
membrane segment and a connected cytoplasmic region
of the FhuB protein, bind to the isolated FhuD protein and
inhibit ferrichrome transport intocells. Thesedata suggest
that FhuD not only interacts with regions of the FhuB pro-
tein which are exposed to the periplasm, but inserts deep-
ly into and even crosses the cytoplasmic membrane.
Moreover, the cytoplasmic loop of FhuB that interacts with
FhuD is proposed to function as a binding site of the FhuC
ATPase (Köster and Böhm, 1992). The available evidence
suggests that the FhuD and FhuC binding sites on FhuB
are close to each other but do not overlap. Triggering of
FhuC-catalyzed ATP hydrolysis by ferrichrome-loaded
FhuD would occur at the same cytoplasmic loop and
would not require a signal transmitted through the cyto-
plasmic membrane via FhuB to FhuC, as has been pro-
posed for induction of ATP hydrolysis by the cytoplasmic
MalKthrough maltose-loaded periplasmic MalE (Davidson
efa/.,1992).
It is likely that transport of ferric iron, ferric sideropho-
res, and heme across the cytoplasmic membrane occurs
Table 1 Ferric Iron Transport Systems of the Sfu Type.
basically by the same mechanism. Ferric iron transport
across the cytoplasmic membrane was first demon-
strated in S. marcescens (Zimmermann ef a/., 1989;
Angerer ef a/., 1990). Sequence similarities of the genes of
other human pathogens with the S. marcescens sfuCDB
genes suggest that they determine proteins for ferric iron
transport across the cytoplasmic membrane (Table 1). It is
not known whether ferric iron as such or in complexed
form is transported across the cytoplasmic membrane. It
is likely, but not rigorously proven, that after release of iron
from transferrin and lactoferrin and entry into the peri-
plasm, iron is transported across the cytoplasmic mem-
brane by the systems listed in Table 1.
Regulation of the Iron Content in Bacteria
Bacteria regulate their iron content for economic reasons
and to avoid iron toxicity. The intracellular iron concentra-
tion is measured by the Fur protein in Gram-negative bac-
teria and by the DtxR protein in most (GC-rich) Gram-po-
sitive bacteria. Fur of E. coli is a histidine-rich protein com-
posed of 148 amino acids (Schäfferef a/., 1985). DtxR of
Corynebacterium diphtheriae contains 226 residues and
shares only 25 % amino acid sequence similarity with the
E. coli Fur protein (Boyd ef a/., 1990). Fe2+ binds to Fur and
DtxR and converts these proteins into repressers that in-
hibit transcription of genes that determine ferric sidero-
phore synthesis and transport proteins. Footprinting with-
in the promoter region of the biosynthesis genes for aero-
bactin, a bacterial siderophore, has revealed interaction of
the Fur protein with a 19-bp-long degenerate palindromic
sequence (de Lorenzo ef a/., 1987), which is of the same
minimal size that is covered by the DtxR protein in the pro-
moter region of the fox gene that encodes diphtheria toxin
(Tao and Murphy, 1994). X-ray analysis of DtxR crystals
has revealed that the second and third helix forms the
helix-turn-helix motif that binds to the iron-regulated pro-
moter DMA. A similar region in the N-terminus of Fur is pre-
dicted to bind to DMA, based on NMR studies and se-
quence similarities to the known LexA protein (Holm ef a/.,
1994). Negative complementation of wild-type Fur by mu-
tated inactive Fur (Braun ef a/., 1990), and visualization of
Fur bound to promoter DMA by electron microscopy and
atomic force microscopy (Le Cam ef a/., 1994) have shown
that Fur functions as a multimer. Studies with genetically
constructed Fur-Xcl hybrid proteins indicate dimerization
Periplasm Cytoplasmic Cytoplasmic Strain
membrane ATPase
Reference
SfuA SfuB SfuC Serratia marcescens
FbpA FbpB FbpC Neisseria gonorrhoeae*
HitA HitB HitC Haemophilus influenzae
YfuA YfuB YfuC Yersinaenterocolitica
AfuA AfuB AfuC Actinobacillus pleuropneumoniae
Angerer ef a/., 1990
Adhikariefa/., 1996; Berishefa/., 1990
Adhikariefa/,,1995
Saken and Heesemann, 1995; EMBLAcc. No. Z47200
Chin ef a/., 1996
a
 also Neisseria meningitidis
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of Fur, and interaction of the Fur N-terminus with promoter
DMA (Stojiljkovic and Hantke, 1995).
Induction of Transport Genes by Ferric
Siderophores: Induction from Without
Besides derepression of iron transport genes when trans-
port is needed under conditions of iron deprivation, syn-
thesis of transport proteins through induction of the genes
by the transported ferric Siderophores is another econo-
mical way to control the iron supply. Regulation of the fer-
ric citrate transport system of E coli K-12 has been stud-
ied in most detail (Braun, 1997). Transcription of the five
transport genes fecABCDE is induced by ferric citrate in
the culture medium. For induction, ferric citrate does not
have to enter the cytoplasm (Zimmermann et a/., 1984).
Ferric citrate bound to the outer membrane transport pro-
tein FecA induces transcription (Härleef a/., 1995). FecA
occupied by ferric citrate transmits a signal into the peri-
plasm where the regulatory protein FecR is located. Ferric
citrate does not induce fee transcription in the absence of
FecR. C-terminally truncated FecR derivatives no longer
respond to ferric citrate and induce fee transcription con-
stitutively (Ochs et a/., 1995). FecR is anchored to the
cytoplasmic membrane such that residues 1-85 are lo-
cated in the periplasm, residues 86-100 span the cyto-
plasmic membrane, and residues 101-317 extend into
the periplasm (Ochs et a/., 1995). This arrangement ena-
bles FecR to transmit the induction signal across the cyto-
plasmic membrane into the cytoplasm. Transcription is in-
itiated by the fee-specific sigma factor Feel, which directs
the E. coli RNA polymerase core enzyme to the fee trans-
port gene promoter upstream of the fec>4 gene. The feel
fecR regulatory genes are encoded upstream of the fee
transport genes and are not autoregulated by Feel and
FecR, but repressed by the Fur protein when Fur is loaded
with Fe2t An E coli mutant with a deletion of the entire fee
operon transcribes in response to added ferric citrate a
plasmid-encoded fecA-lacZ gene fusion or a fecB-lacZ
operon fusion when transformed with the genes fee/, fecR,
fecA, tonB, exbB, and exbD. Signal transduction across
the outer membrane requires the same gene products as
transport of ferric citrate across the outer membrane.
However, transport can be uncoupled from induction by
mutations in fecA For example, removal of residues 47-
101 (numbering includes the signal sequence from resi-
dues 1 -33), which have been localized in the periplasm,
abolishes signal transduction but fully retains the trans-
port activity (Kim ef a/., 1997). Overproduction of the N-
terminal fragment from residues 1 to 127 of FecA (com-
plete FecA contains 741 residues) interferes with ferric
citrate induction, but not with ferric citrate transport.
These data suggest that the N-terminus of FecA interacts
with the C-terminus of FecR for induction of fee transport
gene transcription.
Induction by ferric citrate and its transport requires the
electrochemical potential of the cytoplasmic membrane.
Carbonyl cyanide m-chlorophenylhydrazone (CCCP) in-
hibits induction and transport, while a fec>4 mutant that
induces but does not transport independent of TonB indu-
ces also in the presence of CCCP (Kim ef a/., 1997).
In vitro, transcription of a fecA DMA fragment depends
on the presence of Feel and RNA polymerase core en-
zyme. Transcription is strongly enhanced in crude extracts
of cells that synthesize FecA, Feel, FecR, TonB, ExbB, and
ExbD and that are grown in a medium containing ferric
citrate (Angerereia/., 1995; Enzefa/., 1995). Nocovalent
modification such as phosphorylation of the regulatory
proteins has been found. These data are consistent with
the following model: Binding of ferric citrate to FecA in
the outer membrane of E coli induces a conformational
change in FecA. Induction-competent FecA changes the
conformation of FecR by interaction through its N-termi-
nus with the C-terminus of FecR. FecR in the induction-
competent conformation activates Feel, which binds to
the RNA polymerase core enzyme. The Feel - RNA-poly-
merase complex binds to the promoter upstream of fecA
and initiates transcription of the fee transport genes.
The ferric Siderophores pseudobactin BN7 and BN8
induce transcription of the ferric pseudobactin transport
system in Pseudomonas putida by a mechanism that
strongly resembles ferric citrate induction. Transcription
of pupB, which encodes an outer membrane transport
protein, is induced by the ferric pseudobactins. Two
genes, pupl and pupR, with sequence similarities to feel
and fecft, respectively, regulate pupB transcription. The
N-terminus of PupB is important for transcription induc-
tion since its replacement by the N-terminus of the similar
PupA receptor abolishes induction, but retains transport
activity for pseudobactin BN7. Replacement of the N-ter-
minus of PupA by the N-terminus of PupB results in a hy-
brid protein that induces pupB transcription in response to
pseudobactin 358, which is recognized by PupA (Koster ef
a/., 1994).
Induction of transport gene transcription by the cog-
nate ferric Siderophores seems to be the rule in Pseudo-
monas (Venturi ef a/., 1995), and has been found in some
other bacterial genera, but the control mechanism does
not involve transcription initiation by ligand interaction at
the cell surface and signal transfer to the cytoplasm.
Iron-Mediated Oxic Stress
Aerobic metabolism creates hydrogen peroxide and su-
peroxide radicals (Figure 2). In a mixture of Fe2* and H2O2,
highly reactive hydroxyl radicals are formed. Superoxide
reduces Fe3+ to Fe2+ and molecular oxygen. The sum of
both reactions yields oxygen, hydroxyl radicals, and hy-
droxyl anions. The Superoxide radicals are destroyed by
Superoxide dismutase; the manganese-containing form
of Superoxide dismutase of E coli is encoded by the sod A
gene, and the iron-containing form by thesodß gene. Fur
is required for the synthesis of the iron Superoxide dismu-
tase during aerobic growth (Niederhoffer ef a/., 1990). It is
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Fe2+ + H202 => Fe3+ + OH + OH ' Fenton
Fe3+ + 02"=>Fe2++02
02" + H2O2 => O2 + OH + OH' Haber-Weiss
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Fig. 2 Formation of Reactive Oxygen Radicals in the Fenton and
Haber-Weiss Reactions and Their Enzymatic Destruction.
not clear whether Fur activates sodß transcription directly
or via regulation of a control protein, for example, by re-
pressing the transcription of a represser. In cells grown
anaerobically, Fur represses transcription of sodA (Tardat
and Touati, 1993) which is presumably not needed under
these conditions. In an E. coll fur mutant, iron uptake is no
longer adjusted to the iron requirement; this results in iron
overload. This mutant shows an increased oxygen-de-
pendent mutation rate and is not viable under oxic condi-
tions when it carries an additional mutation in the recA
gene, which is required for DMA repair (Touati etal., 1995).
Reduction of ferric iron transport by a mutation in the tonB
gene, overproduction of the iron storage protein FTNF,
addition of ferrozine, which chelates intracellular iron, and
supplementation with the hydroxyl radical scavengers di-
methyl sulfoxide and thiourea prevent killing of the cells.
In £ coll, the Superoxide radical induces transcription
of sodA via the [2Fe-2S] protein SoxR, which binds to
the soxS promoter and in the oxidized form activates soxS
transcription (Hidalgo et a/., 1997). SoxS serves as a tran-
scriptional activator of a number of stress-induced pro-
moters. The iron-sulfur center of SoxR serves as a redox
indicator that is not destroyed upon reduction, but func-
tions reversibly.
Cell damage by intracellular iron also has to take into
account intracellular iron metabolism, in particular iron
storage in compounds that do not actively participate in
intermediary metabolism. Mössbauer spectroscopy indi-
cates that most of the iron in E. coll is not incorporated into
redox enzymes, but is present in a poorly defined state,
such as one compound that seems to be an acidic poly-
saccharide that contains 40% of the 'mobile iron pool'
(Böhnke and Matzanke, 1995). A number of bacterial fer-
ritins have been identified and sequenced, and even an
X-ray structure is available. However, the amounts of the
ferritins are too low to serve as major iron storage com-
pounds and their role in iron metabolism still has to be
elucidated (discussed in Braun er a/., 1998).
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The search for the membrane proteins mediating the
ATP-dependent transport of conjugates with gluta-
thione, glucuronate, or sulfate has led to the identifica-
tion of the multidrug resistance proteins MRP1 and
MRP2. Both 190-kDa membrane glycoproteins were
cloned in the recent years and shown to be unidirec-
tional ATP-driven export pumps with an amino acid
identity of 49% in human. MRP1 is detected in the
plasma membrane of many cell types, including ery-
throcytes, whereas MRP2, also termed canalicular
MRP (cMRP) or canalicular multispecific organic an-
ion transporter (cMOAT), has been localized to the api-
cal domain of polarized epithelia, particularly to the
hepatocyte canalicular membrane. Physiologically
important substrates of both transporters include glu-
tathione S-conjugates such as leukotriene C4, biliru-
bin glucuronides, 17ß-glucuronosyl estradiol, dianio-
nic bile salts such as 6a-glucuronosyl hyodeoxy-
cholate, and glutathione disulfide. Both transporters
have been associated with multiple drug resistance of
malignant tumors because of their capacity to pump
drug conjugates and drug complexes across the
plasma membrane into the extracellular space. The
substrate specificity of MRP1 and MRP2 is very differ-
ent from MDR1 P-glycoprotein. MRP1 and MRP2may
be termed conjugate transporting ATPases function-
ing in detoxification and, because of their role in gluta-
thione disulfide export, in the defense against oxida-
tive stress.
Key words: ABC transporters / ATP-dependent
transport / Glucuronides / Glutathione S-conjugates /
Multidrug resistance proteins /Transport ATPases.
Introduction
It has long been known that glutathione S-conjugates and
glucuronides are transported across cellular membranes
(Combes, 1965; Billing, 1978; Wahlländer and Sies, 1979).
This process has been characterized as a primary-active,
ATP-dependent transport by studies using inside-out
plasma membrane vesicles from many cell types inclu-
ding erythrocytes (Kondo et a/., 1980, 1982) and hepa-
tocytes (Kobayashi et a/., 1988; Ishikawa ef a/., 1990;
Kitamuraef a/., 1990; Akerboomef a/., 1991; Fernändez-
Checa ef a/., 1992). Identification of the membrane pro-
teins mediating the ATP-dependent unidirectional trans-
port of glutathione S-conjugates and glucuronides was
closely linked to the characterization of the 190 kDa mem-
brane glycoprotein mediating the ATP-dependent export
of the endogenous glutathione S-conjugate leukotriene
C4 (LTC4) (Leier eta/., 1994a). These studies resulted in the
elucidation of the function of the multidrug resistance pro-
tein (MRP1) as a primary-active ATP-dependent mem-
brane transporter for leukotriene C4 and many other am-
phiphilicanionic conjugates (Jedlitschky ef a/., 1994; Leier
ei a/., 1994b; Müllerei a/., 1994; Jedlitschky eta/., 1996;
Loeefa/.,1996a,b).
MRP1 is a membrane glycoprotein of an apparent mo-
lecular mass of 190 kDa that was identified on the basis of
its overexpression in multidrug-resistant tumor cell lines
(Coleef a/., 1992; Zaman ef a/., 1993; Krishnamachary ef
a/., 1994). The original sequence analysis of MRP1 indica-
ted that it is a member of the ATP-binding cassette (ABC)
superfamily of transporters (Cole ef a/., 1992). An isoform
of MRP1 with a similar substrate specificity and a distinct,
although related, sequence has been cloned recently and
localized predominantly to the hepatocyte canalicular
membrane (Büchler ef a/., 1996; Paulusma ef a/., 1996;
Keppler and Kartenbeck, 1996; Taniguchi ef a/., 1996;
Keppler and König, 1997). This isoform has been termed
MRP2, or canalicular MRP (cMRP), or canalicular multi-
specific organic anion transporter (cMOAT). MRP2 media-
tes the ATP-dependent transport of glutathione S-conju-
gates and glucuronides from the liver into bile (Keppler
and König, 1997; Jedlitschky eta/., 1997) and across the
apical membrane of kidney proximal tubules (Schaub ef
a/., 1997). Both MRP1 and MRP2 may be termed conju-
gate transporting ATPases with a broad substrate speci-
ficity.
Sequence Comparison and Localization of
MRP1 and MRP2
Human MRP1 and MRP2 are composed of 1531 and 1545
amino acids, respectively. They contain two characteristic
ATP-binding domains, and belong to the MRP family of
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transporters within the superfamily of ABC transporters
(Coleef a/., 1992; Kepplerand König, 1997). Comparison
between human MRP1 and MRP2 indicates an overall
amino acid sequence identity of 49%; the highest degree
of amino acid identity is in the carboxyl-terminal domain
and, of course, in both nucleotide-binding domains
(Büchler ei a/., 1996). The molecular mass of unglycosyla-
ted MRP1 and MRP2 is 172 kDa (Coleef a/., 1992) and 174
kDa (Taniguchi ef a/., 1996), respectively. Both are/V-gly-
cosylated in their mature form and exhibit an apparent mo-
lecular mass of about 190 kDa (Table 1). The number of
transmembrane segments predicted for MRP1 has varied
between 14 (Zaman and Borst, 1996) and 18 (Loe et a/.,
1996c). The predicted topology model for MRP2 suggests
13 transmembrane segments (Keppler and König, 1997),
and this topology model proposes an extracellular posi-
tion of the amino-terminus (Büchler ei a/., 1996). Four
transmembrane segments are predicted between the first
and second nucleotide-binding domain (Büchler et a/.,
1996; Kepplerand König, 1997).
Based on the amino acid sequence identity of the cur-
rently known members of the MRP family of transporters,
human MRP2 and its homologs from rabbit and rat are clo-
sely related to human MRP1 and its homologs from mouse
and rat (Keppler and König, 1997). The ABC transporters
MRP1 and MRP2 from the soil nematode Caenorhabditis
elegans are 43% identical and the conjugate-transporting
cadmium resistance factor from yeast, termed YCF1 or
YDR135c (Szczypka et a/., 1994) is 41% identical to
MRP2. The long-known members of the P-glycoprotein
family, some of which have been associated with multiple
drug resistance, are only distantly related to MRP1 and
MRP2. The amino acid sequence identity between MRP1
and MDR1 P-glycoprotein is only 15% (Cole etal., 1992).
The amino acid identity between MRP2 and the MDR1 and
MDR2 P-glycoproteins is 25% and 24%, respectively.
Localization of the conjugate-transporting ATPases en-
coded by the MRP1 and the MRP2 (cMRP/cMOAT) genes
by immunofluorescence microscopy and confocal laser
scanning microscopy indicated the predominant localiza-
tion of both export pumps in the plasma membrane, parti-
cularly of tumor cells (Hipfner et a/., 1994; Flens ef a/.,
1996; Büchler ef a/., 1996; Kepplerand Kartenbeck, 1996).
EXTRACELLULAR C* INTRACELLULAR
CONJUGATES
BILIRUBIN
BILE SALTS
CYTOTOXINS -*-
CARCINOGENS -
GLUTATHIONE
GLUCURONATE
SULFATE
BASOLATERAL .
CONJUGATES
Fig. 1 Conjugation and ATP-Dependent Export of Endogenous
and Xenobiotic Substances by the Multidrug Resistance Proteins
MRP1 and MRP2.
These conjugate transporting ATPases are localized at the baso-
lateral membrane (MRP1) or at the apical membrane domain
(MRP2) of polarized cells.
In polarized epithelial cells, such as hepatocytes, MRP1
appears to be localized to the lateral membrane domain
(Mayer ef a/., 1995; Kepplerand Kartenbeck, 1996; Roe-
lofsen etal., 1997), whereas MRP2 is strictly localized to
the apical domains of hepatocytes (Büchler ei a/., 1996)
and proximal tubule epithelial cells of the kidney (Schaub
ef a/., 1997) (Figure 1).
Substrate Specificity of the Conjugate
Transporting ATPases MRP1 and MRP2
The substrate specificity of recombinant human MRP1
determined in membrane vesicles from transfected cells is
indistinguishable from that determined in membrane ve-
sicles from drug-selected MRP1-overexpressing cells,
suchastheHL60/ADRIine(Jedlitschkyefa/., 1994,1996;
Leier ef a/., 1994b). The glutathione S-conjugate LTC4 is
the substrate with the highest affinity known at present,
whereas ATP-dependent transport of oxidized glutathi-
one (GSSG) is a relatively low affinity process with a Km
value of 93 (Leier ef a/., 1996). Reduced glutathione
(GSH) itself is not a substrate for MRP1, however, it may
undergo complex formation or serve as a co-substrate
with cationic substances. This is indicated by the ATP-de-
pendent transport of vincristine in the presence of GSH
Table 1 Comparison of the Human Conjugate Transporting ATPases MRP1 and MRP2.
MRP1 MRP2 (cMRP/cMOAT)
Chromosomal localization of gene
Total amino acids
Cellular localization
Glycoprotein mass
Structure/topology
Function
High-affinity substrates
Inhibitors
16p13.1a
1531a
plasma membrane (ubiquitous, basolateral)d-e
~190kDad>e
ABC transporter, 4+9 predicted transmembrane segments0
ATP-dependent transport of anionic conjugatesh>iij>k
LTC4> estradiol17ß-glucuronideitkj
amphiphilic anions, e.g. LTD4 receptor antagonists*1·'·1
10q24b
1545blC
apical plasma membrane domain1·9
samef>i
same0
same
sameftl
ec,f.g.i
kc,f,i
aColeefa/.,1992; b Taniguchi ef a/. ,1996; c Keppler and König, 1997; dLoeefa/.,1996c; e Zaman and Borst, 1996; f Büchler ef a/. 1996;
9
 Keppler and Kartenbeck, 1996; hJedlitschkyefa/.,1994; 'Jedlitschkyefa/.,^?; jLeierefa/.,1994b; kJedlitschkyefa/.,1996; 'Loe
efa/.,1996a.
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(Loe ef a/., 1996b). The glutathione moiety is not a struc-
tural determinant of the substrate properties of MRP1 as
indicated by the efficient transport of the /V-acety Icy steine
S-conjugate A/-acetyl-LTE4 (Leier ei a/., 1994b), and of
the glucuronate conjugates 17ß-glucuronosyl estradiol,
monoglucuronosyl bilirubin and bisglucuronosyl bilirubin
(Jedlitschky ef a/., 1996,1997). These results indicate that
the term glutathione S-conjugate (GS-X) pump (Ishikawa,
1992) is not appropriate for the description of the function
of MRP1. On the other hand, many organic anions, inclu-
ding monoanionic bile salts, are not transported by MRP1.
Therefore, the term multispecific organic anion transpor-
ter (MOAT) suggests a substrate specificity much broader
than the actual specificity of MRP1. A ranking of the sub-
strates for MRP1 according to the Vmax/Km ratios was as
follows:
LTC4 > LTD4 > S-(2,4-dinitrophenyl)glutathione >
17ß-glucuronosyl estradiol > monoglucuronosyl bilirubin >
3a-sulfatolithocholyl taurine > GSSG.
The substrate specificity of MRP2 has been studied most
extensively in inside-out hepatocyte canalicular mem-
brane vesicles from normal rat liver in comparison with
membrane vesicles from mutant rats lacking MRP2
(Ishikawa ef a/., 1990; Büchler ef a/., 1996). ATP-depend-
ent transport of substrates by human MRP2 has been ana-
lyzed in membrane vesicles from HepG2 hepatoma cells
cultured under conditions with a predominant expression
of MRP2 (Jedlitschky ef a/., 1997). The ranking of sub-
strates for rat (and human) MRP2 according to the Vmax/Km
ratio was as follows:
LTC4 > LTD4 > S-(2,4-dinitrophenyl)glutathione >
monoglucuronosyl bilirubin > 17ß-glucuronosyl estradiol
> 3a-sulfatolithocholyl taurine > GSSG.
A similar spectrum of substrates for MRP2 in the rat liver
canalicular membrane was suggested by in vivo measure-
ments of the hepatobiliary elimination of substances in
normal and transport-deficient mutant rats (Jansen ef a/.,
1985; Huber ef a/., 1987; Oude Elferinkef a/., 1995).
Substrate specificity differences between MRP1 and
MRP2 are indicated by a higher affinity and transport rate
of MRP1 for LTC4 and by the preferential transport of
monoglucuronosyl bilirubin and bisglucuronosyl bilirubin
by MRP2 (Jedlitschky ef a/., 1997). In addition, the quino-
line-based LTD4 analog MK571 more potently inhibits
MRP1 (Leier ef a/., 1994b) than rat MRP2 (Büchler ef a/.,
1996). These comparisons indicate that the substrate
specificity of both conjugate transporting ATPases is quite
similar, in spite of the differences in the amino acid se-
quence between MRP1 and MRP2.
Function of MRP1 and MRP2 in Detoxification
and Defense Against Oxidative Stress
Formation and excretion of conjugates of endogenous
and xenobiotic substances with glutathione, glucuronate,
or sulfate is of vital importance in detoxification and cellu-
lar homeostasis. The broad substrate specificity of the
conjugate export pumps MRP1 and MRP2 enables the
terminal excretion of a multitude of conjugates and am-
phiphilic anions which are formed by a large number of
relatively specific monooxygenases and transferases in
phase I and phase II metabolism of endogenous and xe-
nobiotic substances (Figure 1). This is indicated by the
MRP1- and MRP2-mediated export of bilirubin glucuro-
nides and bile salt conjugates (Jedlitschky ef a/., 1996,
1997). With respect to carcinogens it is of interest that
the glutathione S-conjugate of aflatoxin B^ was recently
shown to be a high-affinity substrate of MRP1 (Loe ef a/.,
1997). In addition, several glutathione and glucuronate
conjugates of cytotoxic anticancer agents are substrates
for human MRP1 (Jedlitschky ef a/., 1996). The finding that
GSSG, but not GSH, is transported by MRP1, as well as by
ratMRP2(Leierefa/., 1996), points to an important role of
MRP1 and MRP2 in the export of GSSG from cells under
conditions of oxidative stress, when the reduction of
GSSG becomes rate-limiting and GSSG export must be
increased (Ishikawa and Sies, 1989).
Hereditary Deficiencies of the Apical Conjugate
Transporting ATPase MRP2
The human Dubin-Johnson syndrome represents an in-
herited defect in the secretion of amphiphilic anionic con-
jugates from hepatocytes into bile (reviewed by Roy
Chowdhury ef a/., 1994). Identification of the human cana-
licular membrane protein mediating the ATP-dependent
transport of glutathione and glucuronate conjugates as
MRP2 suggested that the absence of this transporter is
the molecular basis of this hereditary disease (Büchler ef
a/., 1996; Kartenbeck ef a/., 1996). Selective detection of
human MRP2 by an antibody directed against the car-
boxyl-terminal sequence of this transporter has recently
demonstrated that the MRP2 protein is only expressed
in normal human liver but not in the liver of a patient
with Dubin-Johnson syndrome (Keppler and Kartenbeck,
1996). MRP1 has been detected in erythrocyte membra-
nes from patients with Dubin-Johnson syndrome (Karten-
beck ef a/., 1996), in agreement with the normal ATP-
dependent transport of glutathione S-conjugates into
inside-out membrane vesicles from the patients red blood
cells (Board ef a/., 1992). The cDNA sequencing of human
MRP2 and of the homologous rat cDNA (Büchler ef a/.,
1996; Paulusma ef a/., 1996; Taniguchi ef a/., 1996), to-
gether with our demonstration of the absence of the MRP2
protein from the hepatocyte canalicular membrane in
Dubin-Johnson syndrome provide the basis for the eluci-
dation of mutations in this disorder.
Two hyperbilirubinemic mutant rat strains have been
described which are deficient in the transport of conjuga-
tes and amphiphilic anions across the canalicular mem-
brane (Jansen ef a/., 1985; Takikawa ef a/., 1991; Oude
Elferink ef a/., 1995). ATP-dependent transport of gluta-
thione S-conjugates by canalicular membrane vesicles
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is below detectability in the Groningen yellow / transport-
deficient (GY/TFT) (Ishikawa et a/., 1990) and the Eisai
hyperbilirubinemic (EHBR) mutant rats (Fernandez-Checa
ei a/., 1992), which are derived from the Wistar and the
Sprague-Dawley strain of rats, respectively. Immuno-
fluorescence microscopy and confocal laser scanning
microscopy have revealed the absence of the MRP2 pro-
tein from the canalicular membrane domain of both mu-
tant strains (Büchler ei a/., 1996; Kartenbeck ef a/., 1996).
The mutation in the EHBR mutant rat (Ito ef a/., 1997) has
similar consequences as in the GY/TR" mutant (Paulusma
ei a/., 1996), as shown by Northern blotting, immunoblot-
ting, and double-label immunofluorescence microscopy
(Büchler ef a/., 1996; Paulusma ef a/., 1996). These mu-
tants have promoted and facilitated the characterization
of the rat canalicular conjugate export pump. Cloning and
sequencing of the cDNA encoding rat MRP2 and the sub-
sequent immunoblot analysis has proven that the ab-
sence of the 190 kDa membrane glycoprotein causes the
transport deficiency in the mutant rats. Therefore, canali-
cular membrane vesicles from normal hepatocytes in
comparison with those from EH BR or GY/TR~ mutant liver
provide a valuable tool to analyze in further detail the func-
tion, substrate specificity, and regulation of rat MRP2.
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Glutathione is a storage form of cysteine and protects
against reactive oxygen species and potentially toxic
xenobiotics in the central nervous system. Marked re-
ductions in intracellular or intramitochondrial gluta-
thione are associated with cell death. Enzymes in-
volved in glutathione metabolism are very active in the
choroid plexus, and astrocytes maintain a high con-
centration of glutathione. Astrocytes probably play an
important role in regulating cerebral sulfur/glutathi-
one metabolism and in protecting the brain against
noxious chemicals. Oxidative stress contributes to
age-related neurodegenerative diseases. Patients with
inborn errors of glutathione metabolism often exhibit
progressive neurological problems. Therefore, increas-
ing brain glutathione levels may have therapeutic be-
nefits.
Keywords: Anti-oxidants/^-Glutamyl cycle/Glutathione/
Glutathione disulfide/ Reactive oxygen species.
Introduction
Glutathione (GSH) was first discovered by J. de Rey-Pail-
hade over 100 years ago and its structure (i.e. L-^-gluta-
myl-L-cysteinylglycine) was deduced in the 1930s. [See
Meister (1989) for a discussion of historical perspectives.]
GSH is present in most mammalian cells at concentrations
ranging from 0.5 to 12mM (~ 2-3mM in whole brain)
(Cooper, 1997).
GSH may exert its anti-oxidant activity synergistically
with both ascorbate (Jain et a/., 1994; Meister, 1995) and
vitamin E. Vitamin E is essential for normal neurological
function and is both afree radical scavenger and structural
stabilizer (see discussion in Heslop et a/., 1996). The link
between GSH and vitamin E is apparent from the fact that
dietary selenium (an essential component of glutathione
peroxidase) is known to prevent many symptoms of vita-
min E deficiency (Heslop ef a/., 1996). Dehydroascorbate
resulting from oxidation of ascorbate is reduced by GSH
(and NADPH) in brain (Rose, 1993). Patients with disorders
of GSH metabolism apparently exhibit an increased reli-
ance on ascorbate as an antioxidant, and many display
progressive neurological disease. These observations un-
derscore the importance of GSH for normal brain function.
[See Cooper (1997) for a recent review].
Generally, GSH serves as:
a) A non-toxic storage form of cysteine,
b) an enzyme cofactor,
c) a component in metabolic (and transport) pathways,
and
d) a protectant against reactive oxygen species (ROS)
and potentially harmful xenobiotics.
(For discussions on the physiological roles of GSH see, for
example, Meister and Anderson, 1983; Meister, 1989). A
scheme that shows interrelationships among these func-
tions is presented in Figure 1. The general properties of
GSH are briefly discussed below, followed by a more de-
tailed description of its metabolism in brain and possible
therapeutic interventions designed to increase GSH.
Glutathione Is a Non-Toxic Storage
Form of Cysteine
An important physiological role of GSH is as a carrier and
storage form of cysteine. Elevated cysteine/cystine is ex-
citotoxic, possibly by interfering with the /V-methyl-D-as-
partate (NMDA) receptor. Cysteine also has more genera-
lized toxic effects through possession of a reactive
sulfhydryl group that forms hemithioketals with a-keto
acids and hemithioacetals with aldehydes. An example of
reactivity with aldehydes is the formation of a hemithio-
acetal with pyridoxal 5'-phosphate. This adduct cyclizes
to a thiazolidinone thereby inhibiting some key pyridoxal
5'-phosphate-containing enzymes, such as glutamate
decarboxylase. In contrast, the sulfhydryl of GSH is less
reactive, permitting concentrations in mammalian tissues
to be —10-100 times higher than those of cysteine.
(Reviewed by Cooper, 1997).
Cofactor Functions
GSH is an essential cofactor for a number of enzymes in-
cluding formaldehyde dehydrogenase, glyoxylase, maley-
lacetoacetate isomerase, dehydrochlorinase, and pros-
taglandin endoperoxidase isomerase. In these reactions,
GSH is not consumed but presumably plays a critical role
in the catalytic mechanism (Meister, 1989).
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Fig. 1 Metabolism of Glutathione (GSH).
(1) 7-Glutamyltranspeptidase; (2) Ύ-glutamylcylotransferase; (3) 5-oxoprolinase; (4) -y-glutamylcysteine synthetase; (5) glutathione syn-
thetase; (6) cysteinylglycine dipeptidase; (7) L-cysteine S-conjugate A/-acetyltransferase; (8) glutathione S-transferase; (9) glutathione
peroxidase; (10) free radical quenching (probably non-enzymatic); (11) glutathione transhydrogenase; (12) glutathione disulfide (GSSG)
reductase; (13) enzymatic reactions in which GSH is required as a cofactor but is not consumed; (14) transport of -γ-glutamylcystine and
reduction to ^-glutamylcysteine. AA, amino acids; CYSH, cysteine; CYS2, cystine; X = compounds that form conjugates with glutathione.
Modified from Meister (1989).
Metabolism of GSH and Possible Transport
Functions
In 1970, Orlowski and Meister noted that enzymes in-
volved in GSH metabolism may be linked in such a way as
to form a process for the recycling of the constituent amino
acids of the tripeptide. This process was named the y-
glutamyl cycle (Figure 1). GSH is synthesized by the con-
secutive actions of the ATP-dependent enzymes -y-gluta-
mylcysteine synthetase (reaction 4) and glutathione
synthetase (reaction 5). Levels of GSH are regulated in part
by feedback inhibition of Ύ-glutamylcysteine synthetase
by GSH. In the presence of a suitable amino acid [AA] ac-
ceptor, GSH is catabolized by the action of -y-glutamyl·
transpeptidase (reaction 1) to yield a -y-glutamyl amino
acid [γ-GLU-AA] and cysteinylglycine [CYSH-GLY]. Theγ-
GLU-AA is converted to free amino acid and 5-oxoproline
by the action of Ύ-glutamylcyclotransferase (reaction 2).
5-oxoproline is converted back to glutamate by the ATP-
dependent 5-oxoprolinase reaction (reaction 3). The gluta-
mate released in this process can then be reused in the
synthesis of GSH, thus completing the cycle with the
glutamate component of GSH. The cysteinylglycine re-
leased in the ^-glutamyltranspeptidase reaction is hydro-
lyzed by the action of a dipeptidase (reaction 6) to glycine
and cysteine, completing the cycle with the glycine and
cysteine components of GSH. Cystine is an especially
active amino acid substrate of -γ-glutamyltranspepti-
dase yielding ^-glutamylcystine fr-GLU-CYS2] (reaction
1, square brackets) which in turn is reduced to Ύ-gluta-
mylcysteine [Ύ-GLU-CYSH] and cysteine (reaction 14).
Note that when cystine is used as the amino donor, the
cycle is short-circuited by bypassing reactions 3 and 4
(Thompson and Meister, 1975).
Orlowski and Meister (1970) suggested that the positio-
ning of Ύ-glutamyltranspeptidase on the cell surface and
of the other enzymes of GSH metabolism within the cell
permits the Ύ-glutamyl cycle to play a role in the transloca-
tion of amino acids across the cell membrane. Certainly,
strong evidence suggests that the cycle operates in vivo
(Griffith and Meister, 1979). Moreover, the constituent en-
zymes of the Ύ-glutamyl cycle are most active in tissues,
such as the kidney, where transport of amino acids is
especially prominent (Meister and Anderson, 1983).
However, many amino acid transporters have now been
characterized and found to be unrelated to the Ύ-glutamyl
cycle (e.g. Tateef a/., 1992). The cycle is now recognized to
play a minor role in transport of amino acids across cell
membranes. Perhaps the Ύ-glutamyl cycle is too energeti-
cally expensive (requiring the hydrolysis of 3 ATPs at steps
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3,4 and 5) and spacially too diffuse for efficient transloca-
tion of most amino acids. A possible exception is cystine,
because as noted above this amino acid is an excellent
substrate of -γ-glutamyltranspeptidase.
Current opinion holds that the -y-glutamyl cycle has a
major role in metabolism of leukotrienes, estrogens and
prostaglandins (depicted as X in Figure 1) through S-con-
jugate formation. Here, we discuss the role of the y-
glutamyl cycle in leukotriene metabolism. Leukotriene A4
(LTA4) is formed from arachidonic acid that is released from
membrane phospholipids in response to a variety of im-
munological and inflammatory stimuli. DA* is either hy-
drolyzed to the leukocyte stimulator leukotriene B4 (LTB4)
or is converted consecutively to glutathione S-conjugate
(LTC4), -γ-glutamylcysteine S-conjugate (LTD4) and cy-
steine S-conjugate (LTE4) by the actions of a specialized
form of glutathione S-transferase, cysteinylglycine di-
peptidase and L-cysteine S-conjugate A/-acetyltrans-
ferase, respectively (Figure 1, reactions 8-»1->6). LTC4.
LTD4 and LTE4 are now known to be components of the
'slow acting substance of anaphylaxis' and are involved in
pulmonary smooth muscle contraction, mucous secre-
tion, vasoconstriction and vascular permeability (Nichol-
son, 1993). The physiological effects of the leukotriene
S-conjugates are terminated by conversion of the cy-
steine S-conjugate to the mercapturate [/V-acetyl cysteine
S-conjugate (/V-Ac-CYS-X); Figure 1, reaction 7] which is
excreted. Alternatively, the cysteine S-conjugate may
enter directly into the -γ-glutamyl cycle as a substrate of
Ύ-glutamyltranspeptidase. This reaction generates the
•γ-glutamylcysteine S-conjugate which in turn is a sub-
strate of the cyclotransferase (reactions 1 and 2) effec-
tively translocating the cysteinyl S-conjugate.
In addition, the Ύ-glutamyl cycle and associated reac-
tions are involved in the detoxification of potentially poiso-
nous xenobiotics (again depicted as X in Figure 1) (reac-
tions 8->1 ->6-»7). This pathway is discussed in more
detail later in the review.
In brain, the enzymes of the Ύ-glutamyl cycle (Figure 1,
reactions 1 through 6) are especially abundant in the
choroid plexus (T te etal., 1973). The specific activities are
comparable to those in the kidney, suggesting that the cy-
cle is involved in some sort of transport process in the
brain. GSH is present in the cerebrospinal fluid (CSF) at
μΜ concentrations, and the choroid plexus plays a role in
the formation and recycling of GSH in the CSF (Anderson
etal., 1989). γ-Glutamyltranspeptidase is present in brain
capillaries and is regarded as a marker for capillaries.
However, 7-glutamyltranspeptidase is also present in
astrocytes and neurons (Makar et a/., 1994). Special as-
pects of GSH turnover and metabolism in brain are descri-
bed later in the review.
Protective Functions
The mammalian, adult brain has a very high energy de-
mand, normally relying almost entirely on the oxidative
metabolism of glucose to meet its energy demands. Most
(> 90%) of the glucose taken up by the brain is fully oxi-
dized to CO2. This very high capacity to oxidize glucose
suggests that the brain may generate ROS at an apprecia-
ble rate. The brain contains relatively low levels of some
anti-oxidant defenses (e.g., catalase) and a high lipid con-
tent. The combination of high levels of ROS production,
highly susceptible targets, and relatively low levels of de-
fense mechanisms suggests that the brain may be espe-
cially vulnerable to oxidative stress. GSH is a major pro-
tectant in the brain against oxidative stress by interacting
directly with ROS or by participating in enzyme-catalyzed
redox cycling reactions.
An important enzyme in glutathione redox reactions is
glutathione peroxidase (eq. 1) which catalyzes the reduc-
tion of potentially toxic H2O2 (or lipid peroxides; ROOH) to
H2O (or ROH) with the concomitant conversion of GSH to
glutathione disulf ide (GSSG). Catalase also converts H2O2
to H2O, but this enzyme is not present in mitochondria of
most tissues (with the notable exception of heart) and can-
not detoxify lipid peroxides. Therefore, glutathione peroxi-
dase is especially significant in protecting these organ-
elles against H2O2 generated from incomplete reduction of
O2 (Benzi and Moretti, 1995). [The importance of glutathi-
one peroxidase is underscored by recent work of Zeevalk
et al. (1997) who showed that mice overexpressing this
enzyme are resistant to oxidative damage resulting from
treatment with malonate (an inhibitor of succinate dehy-
drogenase). Addition of malonate to GSH-depleted me-
sencephalic cultures elicited a toxic response (Zeevalk ef
a/., 1997).] Mitochondria also contain glutathione disulfide
reductase (eq. 2) completing a glutathione redox cycle. A
relatively large pool of GSH is maintained in mitochondria
through the action of a high-affinity GSH uptake system
(M rtensson ef a/., 1990). Depletion of this pool in pre-
weanling rats leads to damaged brain mitochondria and
death (Jain etal., 1991; Meister, 1995).
2GSH + H2O2(orROOH)
l (D
GSSG + 2 H20 (or ROH + H2O)
GSSG + NADPH + H*
•4'
2GSH + NADP+
(2)
GSH has been known for many years to play a crucial role
in mitochondria by helping maintain normal function and
structure (Hunter ef a/., 1964). If mitochondria are not sui-
tably protected against metabolic insults (including those
induced by ROS) the organelles may become irreversibly
damaged through a process culminating with induction of
a mitochondrial permeability transition (mPT). As summa-
rized by Gunter ef al. (1994), the mPT is characterized by a
sudden increase in the permeability of the mitochondrial
inner membrane to small ions and molecules (with Mr va-
lues < 1500). This increase is associated with the complete
collapse of the mitochondrial membrane potential (ΔΨ)
and colloid-osmotic swelling of the mitochondrial matrix.
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Agents that can precipitate the mPT include compounds
that oxidize pyridine nucleotides, deplete matrix GSH
(Gunter ef a/., 1994; Reed and Savage, 1995) or increase
the GSSG/GSH ratio (Beatrice et a/., 1984) thereby crea-
ting stress. GSH detoxifies 4-hydroxyhexenal (a lipid
peroxidation byproduct) - the most potent inducer of the
mPT yet identified (Kristal etal., 1996). Until recently, al-
most all work on the mPT was carried out on liver and heart
mitochondria. However, work from our laboratory has
shown that a PT can be induced in isolated rat brain mito-
chondria and in mitochondria in situ in primary cultures of
astrocytes (Kristal and Dubinsky, 1997). Some evidence
suggests that mitochondrial dysfunction is a primary
event in the cascade leading to glutamate excitotoxicity
(White and Reynolds, 1996; Schinder ef a/., 1996). Taken
together these findings suggest that GSH and the gluta-
thione redox cycle play a crucial role in maintaining mito-
chondrial integrity in brain and other organs.
The glutathione redox cycle is present in the cytosol of
brain cells (Cooper, 1997). In addition, the brain contains
a phospholipid hydroperoxide glutathione peroxidase.
Moreover, certain cytosolic glutathione S-transferases
also catalyze GSH-dependent reduction of lipid peroxi-
des. Lipids are protected against free radical damage by
α-tocopherol (vitamin E), which quenches free radical pro-
pagation by formation of α-tocopheroxyl radical (Figure 1,
reaction 10), and by other lipophilic scavengers such as
the ubiquinols. The α-tocopheroxyl radical does not accu-
mulate, in part because it can be re-reduced nonenzyma-
tically to α-tocopherol by GSH (Meister, 1989). This reac-
tion and those catalyzed by glutathione peroxidase,
glutathione S-transferases possessing peroxidase activ-
ity, phospholipid hydroperoxide glutathione peroxidase,
and transhydrogenases (eq. 3) all result in the formation of
GSSG.
R'SSR" + 2GSH R'SH + R"SH + GSSG (3)
Under normal conditions, oxidative stress puts little
'strain1 on the glutathione redox cycle, and the concentra-
tion of GSSG in most tissues is usually low. Indeed, in rat
forebrain the concentration of GSSG (in GSH equivalents)
is normally < 1.0% that of GSH (Cooper, 1997; Cooper ef
a/., 1980). The low GSSG/GSH ratio is presumably due to
strong GSSG reductase activity in brain and rapid synthe-
sis of NADPH from NADP+. About 3-5% of cerebral glu-
cose is converted to CO2 via the oxidative branch of the
pentose phosphate pathway - providing a ready source of
NADPH for reduction of GSSG (Baquer ef a/., 1988). The
pentose phosphate pathway is up-regulated in CMS cells
exposed to H2O2(Ben-Yosefef a/., 1996). In addition to the
pentose phosphate pathway, other possible sources of
NADPH for reduction of GSSG include the reactions cata-
lyzed by the two malic enzymes and by isocitrate dehy-
drogenase.
In addition to its role in protecting tissues against ROS,
GSH is important in the detoxification of potentially harm-
ful xenobiotics. GSH forms S-conjugates with electrophi-
lic compounds in reactions that are catalyzed by, or acce-
lerated by, a large family of glutathione S-transferases.
These enzymes are mostly cytosolic with the exceptions
of a single microsomal enzyme and possibly a single mito-
chondrial enzyme. [Leukotriene C4 synthase is a speciali-
zed membrane-bound glutathione S-transferase (Nichol-
son, 1993).] The glutathione S-conjugate formed from the
action of these enzymes is converted to the correspond-
ing L-cysteinylglycine-S-conjugate and then to the L-cy-
steine-S-conjugate by the consecutive actions of -γ-gluta-
myltranspeptidase and dipeptidase. The L-cysteine-S-
conjugate is then acetylated to the corresponding mer-
capturate (A/-acetyl-L-cysteine-S-conjugate) which is ex-
creted, completing the detoxification process. [The mer-
capturate pathway is depicted in Figure 1 to the side of
the -γ-glutamyl cycle as reactions 8-»1->6->7).] However,
the mercapturate pathway can also sometimes lead to
bioactivation (generation of a toxin). Halogenated cy-
steine S-conjugates that generate highly reactive sulfhy-
dryl-containing fragments through the action of cysteine
S-conjugate -lyases (eq. 4) are nephrotoxic. Dichloro-
acetylene is both nephrotoxic and neurotoxic. The com-
pound is an excellent substrate of microsomal glutathione
S-transferase yielding S-(1,2-dichlorovinyl)glutathione
(DCVG) which is transformed to S-(1,2-dichlorovinyl)-L-
cysteine (DCVC). The latter conjugate is converted to
pyruvate, ammonia and a reactive (toxic) sulfhydryl-con-
taining fragment by the action of cysteine S-conjugate
-lyases. The neurotoxicity of dichloroacetylene may be
due to formation of the glutathione S-conjugate and sub-
sequent metabolism to a toxic fragment exclusively within
the brain. However, it is also conceivable that dichloro-
acetylene is converted to glutathione- and cysteine S-
conjugates elsewhere in the body and transported to the
brain. The blood-brain barrier (BBB) possesses uptake
systems for both DCVC (probably the L-type transporter)
and DCVG. For a discussion see Cooper (1994).
RSCH2CH(NH2)C02H + H2O
CH3C(O)CO2H + NH3 + HSR
(4)
The mercapturate pathway is present in the brain (see be-
low), where it is presumably important for the metabolism
of endogenous substances (such as leukotrienes) and in
detoxifying reactions. However, the role of the pathway in
detoxifying (and toxifying) reactions in the brain has not
been extensively studied.
Origin of GSH in the Brain
The metabolism of GSH is intimately linked with overall
sulfur homeostasis in the brain. The concentration of GSH
in the brain (~2-3mM) is much greater than that in the
blood (—15 μΜ) or cerebrospinal fluid (~ 5 μΜ). Therefore,
the brain must havean avid systemforaccumulating GSH,
or more likely, of synthesizing it in situ. Some evidence
suggests that the brain is able to take up GSH (Kaplowitz
ef a/., 1996), but other evidence suggests that uptake from
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the blood is not the major source of brain GSH (Jain ef a/.,
1991). Cysteine is taken up into the brain on the L-type
carrier (Oldendorf and Szabo, 1976; Wade and Brady,
1981). Cystine is apparently not transported by this mech-
anism, but cystine moieties may enter the brain as cystinyl
bisglycine and 7-glutamylcyst(e)ine both of which are
ready sources of free cysteine (Jain ef a/., 1991). Cysteine
taken up by the brain is used for protein synthesis and for
the synthesis of GSH. Cysteine can also be released from
brain. Isolated brain capillaries contain an ASC-type trans-
porter on the abluminal surface that is presumably in-
volved in the egress of cysteine (Tayarani et a/., 1987).
Methionine is readily taken up into brain on the L-type
transporter (Oldendorf and Szabo, 1976). This methionine
is used for protein synthesis and as a source of methyl
groups. The extent to which this methionine is a source of
cysteine sulfur and indirectly of GSH sulfur in the brain is
not clear.
Metabolic Compartmentation of GSH
Metabolism within the Brain
In the brain, glutamine is synthesized in a small, rapidly turn-
ing over pool of glutamate (primarily in astrocytes) that is
kinetically distinct from a larger, more slowly turning over
pool of glutamate (primarily in neurons). Tracer studies,
histochemical studies, and studies of cells in culture all
suggest that GSH formation is similarly compartmented.
In brain, GSH is synthesized from glutamate primarily, but
not exclusively, in the small pool (astrocytes) and astro-
cytes maintain a large pool of this tripeptide. Nerve end-
ings also probably contain appreciable levels of GSH.
Several authors have measured GSH levels in cultured
astrocytes and neurons. Without exception all these stud-
ies have found high levels of GSH in cultured astrocytes
(2-20 ΠΓΙΜ). The reported levels in neurons tend to be more
variable but generally appreciably less than in astrocytes.
[Reviewed by Cooper (1997).] Enzymes of GSH synthesis
and turnover are present in neurons in culture (Makar et a/.,
1994). As described below, compartmentation of GSH
metabolism in the brain has important physiological con-
sequences. GSH metabolism in brain is shown schemati-
cally in Figure 2.
A Role for Astrocytic GSH in Neuroprotection
Astrocytes and the Detoxification of Glutamate and
Cysteine
Excess glutamate in the extracellular space is neurotoxic
(Olney ef a/., 1971). Astrocytes contain relatively strong
uptake systems for glutamate, glycine and cysteine.
Dringen and Hamprecht (1996) have suggested that under
physiological conditions the synthesis of GSH from gluta-
mate in the presence of glycine and cysteine in these cells
may be a way of disposing potentially toxic glutamate. The
same system would also dispose of potentially neurotoxic
cysteine.
Astrocytes and Metallothioneins
Metallothioneins are low Mr proteins that contain high lev-
els of cysteine, serine and lysine residues but no aromatic
amino acid residues. These proteins have been suggested
to play a role as free radical scavengers and in protection
against UV and X-ray damage (Dunn et a/., 1988), pre-
sumably as a result of high cysteine content. Metal-
lothioneins are especially rich in mouse, rat, monkey and
human astrocytes and are inducible by cytokines (Ebadi
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Fig. 2 Compartmentation of Sulfur Metabolism in the Brain.
Note the proposed central importance of GSH within the astrocytes. The transfer of sulfurfrom methionine to cysteine occurs via the trans-
sulfuration pathway and is denoted as MET -> CYS. Neurons contain GSH and the enzymes necessary for its synthesis (e.g. Makar et a/.,
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Figure.
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ef a/., 1995). Four isoforms (MT-I, MT-II, MT-III, MT-IV) are
known to be present in mammalian tissues. MT-I and MT-II
are ubiquitously expressed, and these isoforms are known
to protect against metal toxicity. MT-IV is expressed in tis-
sues containing stratified squamous epithelia (Ebadi ef a/.,
1995,1996).
MT-III is expressed almost exclusively in the brain and is
thought to regulate brain zinc homeostasis, which itself
appears to be regulated in part through redox reactions.
One scenario is that an oxidative challenge to the brain will
result in increased GSSG formation. GSSG causes the re-
lease of free zinc from MT-III, which in turn stimulates zinc-
dependent processes and zinc-dependent enzymes. Up
to a point this release of zinc may be protective, but
beyond a threshold value the release of zinc may be dele-
terious (e.g. by inhibiting -SH-dependent enzymes) (Ebadi
ef a/., 1995,1996; Maret, 1995). Inasmuch as astrocytes
contain large pools of GSH and metallothioneins, these
cells may be especially important in controlling the redox-
driven zinc homeostasis in the brain.
Astrocytes and the Mercapturate Pathway
Earlier immunohistochemical studies suggested that glu-
tathione S-transferases in the brain were present exclusi-
vely in astrocytes. However, some of these enzymes are
now known to occur in the choroid plexus, oligoden-
drocytes and in selected neuronal cell populations.
Nevertheless, it is apparent that glutathione S-transfera-
ses are particularly abundant in astrocytes (especially in
the end feet) and ependymal cells (Lowndes et a/., 1994;
Makaref a/., 1994; Cooper, 1997). This location of gluta-
thione S-transferases suggests the possibility that astro-
cytes and ependymal cells in the brain form a first line of
defense against potentially toxic xenobiotics that can dif-
fuse across the BBB and CSF-brain barrier, respectively
(Gammer ef a/., 1989). Possibly, glutathione S-transfera-
ses also participate in transport of substances into and out
of the brain. Such bidirectional transport could affect hor-
monal control over processes such as myelination and
neuronal growth and could facilitate removal of endoge-
nous as well as exogenous toxins from the central nervous
system (CMS) (Gammer ef a/., 1989). However, as noted
above, the extent to which the glutathione S-transferases
and the mercapturate pathway are involved in detoxifica-
tion reactions in the brain is unknown and the pathway
may actually lead, on occasion, to bioactivation of xeno-
biotics.
Possible additional roles of glutathione S-transferases
in the brain include protection of the myelin sheath against
toxic substances, removal of epoxyeicosatrienoic acid
derivatives from cells, and participation in the local metab-
olism of prostaglandins and leukotrienes (Gammer ef a/.,
1989). LTC4 and LTB4 are present in brain and these com-
pounds may have a role in the secretion of luteinizing hor-
mone from the anterior pituitary (Sammuelsson ef a/.,
1987).
Quantitatively, in the whole body, the most important
site for reaction of electrophiles with GSH is the liver. The
glutathione S-conjugates formed by this process in the liv-
er are released to the bile. In the intestinal lumen they are
converted in part to the cysteine S-conjugate. The cy-
steine S-conjugates enter first the portal vein and then
eventually the general blood circulation. In the kidney the
cysteine S-conjugates are A/-acetylated to the mercaptu-
rate and excreted (Dekantef a/., 1994). In future work it will
be interesting to determine how the enzymes of the mer-
capturate pathway in the brain conform with this general
scheme. As noted already, enzymes involved in the forma-
tion of glutathione S-conjugates and enzymes of the
• -glutamyl cycle are present in the choroid plexus. If
cysteine S-conjugate A/-acetylases are similarly located
then the data would suggest excretion of mercapturates
to the CSF is analogous to excretion of mercapturates
from kidney into urine. Evidently, the role and dynamics of
the mercapturate pathway in brain are fertile areas for fur-
ther research.
Astrocytes and ROS
In addition to maintaining high levels of GSH, astrocytes in
culture have relatively high levels of -tocopherol and en-
zymes of GSH metabolism (Makar ef a/., 1994). This find-
ing suggests that astrocytes may have a special role in the
brain in protecting neurons against ROS (cf. Han ef a/.,
1996). The ability of astrocytes to detoxify ROS may be
particularly important for diffusible species such NO*.
Astrocytes in culture are much more resistant to ROS than
are neurons (Bolafios ef a/., 1995; Han ef a/., 1996; Ben-
Yosef ef a/., 1996) and recent evidence suggests that both
catalase and glutathione peroxidase are important in
these cells for detoxifying external H2O2 (Dringen and
Hamprecht, 1997). GSH biosynthesis may be up-regula-
ted in astrocytes exposed to ROS (Ben-Yosef ef a/., 1996;
Han ef a/., 1996). ß-Amyloid has been shown to induce
apoptosis and oxidative stress in neurons in vitro. For ex-
ample, depletion of GSH by Aß25-35 leads to oxidative
stress in rat cortical neurons (Müller ef a/., 1997). Whether
stimulation of the antioxidative defense systems of astro-
cytes in Alzheimer's disease is of therapeutic value re-
mains to be determined.
Despite the generally protective role of astrocytes, un-
der some pathophysiological conditions (e.g. reflow after
stroke) these cells may exacerbate injury to neurons. The
activity of inducible NO synthase may increase in stressed
astrocytes. This induction would in turn be predicted to
cause increased NO* production and increased ONOO"
formation, resulting in damage to nearby neurons (Barker
ef a/., 1996) and interference with mitochondrial energy
metabolism (Bolanos ef a/., 1997). Such mitochondrial
dysfunction may occur in certain neurodegenerative dis-
eases (Bolanosef a/., 1997).
Brought to you by | Universitaetsbibliothek Basel
Authenticated
Download Date | 11/21/17 12:26 PM
Glutathione in Brain 799
Sulfur Trafficking between Astrocytes
and Neurons
An understanding of the processes involved in sulfur ho-
meostasis and sulfur trafficking in the CNS must take into
account the following three observations:
1) Astrocytic end feet surround capillaries - controlling in
part the flow of many substances, including sulfur-con-
taining amino acids, across the BBB;
2) GSH is a major store of cysteine in the brain; and
3) astrocytes contain a large pool of GSH.
These observations underscore the central importance of
GSH in sulfur homeostasis in the CNS (Figure 2). As noted
above, some GSH may enter the astrocytes by transport
intact across the BBB. It is likely, however, that the
astrocytic GSH pool is maintained largely by ingress of
cysteine which is converted to GSH directly. Inasmuch as
cysteine movement across the BBB is bidirectional, the
GSH pool in the astrocytes may be regarded as a cy-
steine/sulfur buffer that can be enlarged or depleted as
dictated by the requirements of the whole brain. This buf-
fering is disrupted by metabolic insults. For example,
ischemia to the rat forebrain results in depleted GSH levels
(Cooper et a/., 1980). This depletion is presumably due to
lack of ATP which will seriously restrict GSH synthesis but
notcatabolism. In brain, the ischemia-induced loss of GSH
is matched almost stoichiometrically by an increase in
cysteine (Slivka and Cohen, 1993). The accumulation of
cysteine may be substantial and contribute to ischemia-
induced neurotoxicity (Slivka and Cohen, 1993).
Astrocytes also presumably act normally to buffer neu-
ronal metabolism of sulfur-containing amino acids. Neu-
ronal requirements for sulfur-containing amino acids are
probably met in part by uptake of cysteine and methionine
released from astrocytes (Figure 2). Cysteine in the extra-
cellular space is readily oxidized non-enzymatically to cy-
stine, which can betaken up by astrocytes, but not by neu-
rons (Sagara ef a/., 1996). Inasmuch as elevated levels of
both cysteine and cystine are neurotoxic, the concentrati-
ons of these two compounds in the extracellular space
must be tightly regulated.
Cysteine and GSH are readily interconvertible via reac-
tions of the 7-glutamyl cycle, but cysteine is not formed
anew by this process. Net synthesis of cysteine can, how-
ever, occur via the transsulfuration pathway (Figure 2,
MET->CYS). Methionine is a source of methyl groups (via
its conversion to S-adenosylmethionine), and as noted
above, methionine is readily taken up across the BBB by
the L-transporter (Oldendorf and Szabo, 1976). Methyla-
tion reactions are extensive in the brain, generating S-
adenosylhomocysteine which in turn is converted to
homocysteine. The complete transsulfuration pathway
provides the machinery for the removal of potentially toxic
homocysteine, generation of de novo cysteine, and recyc-
ling of methionine carbon and sulfur. Inborn errors of me-
thionine adenosyltransferase, and thus abnormalities in
the transsulfuration pathway, can lead to demyelinating
disease (Ubagai ef a/., 1995). As with cysteine, the astro-
cytes presumably control the flow of methionine from
blood to neurons. Evidently, the importance of the trans-
sulfuration pathway in the brain is yet another fertile area
for further research.
Extracellular GSH in the CNS is provided by the choroid
plexus (Anderson ef a/., 1989), astrocytes (Yudkoff ef a/.,
1992; Sagara ef a/., 1996; Dringen ef a/., 1997), and possi-
bly nerve endings (Zängerle ef a/., 1992). Sagara ef a/.
(1996) could find no evidence for uptake of GSH by neu-
rons, suggesting that astrocytes regulate the levels of this
tripeptide in the extracellular space.
The GSH in the extracellular space may be involved in
neuronal signaling. Astrocytes have high-affinity binding
sites for GSH that may regulate physiological responses
such as G-protein coupling, activation of second messen-
gers, regulation of protein kinases, and Ca2+ release (Guo
and Shaw, 1992). Some evidence has also been presented
that GSH may be a modulator of glutamatergic transmis-
sion by acting as a selective agonist for the A/-methyl-D-
aspartate (NMDA) recognition domain of the NMDA re-
ceptor ionophore (Ogita ef a/., 1995). These observations
suggest that the concentration of GSH may regulate phys-
iological signals.
Finally, the central nervous system contains large a-
mounts of taurine. This amino acid may be involved, for
example, in osmoregulation and neurotransmitter modu-
lation (Huxtable, 1989). Taurine is synthesized from cy-
steine via sulfur oxidation/decarboxylation. Inasmuch as
GSH is a storage form of cysteine the tripeptide may have
a regulatory role in the synthesis and disposition of taurine
in the brain.
Cerebral GSH in Aging and Disease
Several studies have shown that the levels of GSH and of
'total' glutathione (i.e., GSH plus GSSG) in the rodent brain
decline with age and that the brains of older rodents are
more susceptible to peroxidative stress (reviewed by
Benzi and Moretti, 1995). Several reports also suggest
that the ratio of GSSG to GSH increases with age, but be-
cause GSH is easily oxidized during tissue extraction the
results of these studies must be viewed cautiously
(Cooper, 1997).
A large body of evidence suggests the involvement of
ROS in several neurodegenerative diseases [e.g., Parkin-
son's disease (PD)]. GSH levels are decreased in substan-
tia nigra of PD patients (Sian ef a/., 1994) and of individuals
with incidental Lewy bodies considered presymptomatic
for PD (Dexter ef a/., 1994). Although some evidence sug-
gests that Alzheimer's disease (AD) is associated with
ROS, no evidence has been found that GSH levels are al-
tered in the brains of these patients compared with the
levels in the brains of age-matched controls (Makaref a/.,
1995). However, as noted above, Aß25-35 causes a de-
crease in GSH in neuronal cells in vitro. Perhaps the con-
trast between AD and PD is due to differences in the chem-
ical nature of the ROS or to the site(s) of their generation
Brought to you by | Universitaetsbibliothek Basel
Authenticated
Download Date | 11/21/17 12:26 PM
800 A. J.L Cooper and B.S. Kristal
in brain. Decreased levels of GSH are associated with
decreased survival rate in patients with HIV (Herzenberg
ei a/., 1997). The concentrations of S-adenosylmethionine
and GSH are decreased in the CSF of HIV patients exhibit-
ing neurological symptoms, suggesting impaired cerebral
GSH metabolism/transsulfuration (Castagnaef a/., 1995).
Animal Models of GSH Deficiency
Many methods have been devised to interfere with the
turnover of GSH. For example, GSH synthesis may be in-
hibited by buthionine sulfoxide, a specific inhibitor of y-
glutamylcysteine synthetase (reviewed by Meister, 1995;
Cooper, 1997). Other methods designed to decrease GSH
include administration of diamide (oxidizes GSH), cyclo-
hexene-1-one or cycloheptene-1-one (deplete free GSH
by forming glutathione S-conjugates) (for original referen-
ces see Benzi and Moretti, 1995; Cooper, 1997). Inter-
estingly, challenges with diethyldithiocarbamate (a cop-
per chelator and inhibitor of Superoxide dismutase),
paraquat (induces Superoxide formation), or aminotria-
zole (inhibits catalase) lead to a small, but significant in-
crease in GSH in the forebrains of rats (Benzi and Moretti,
1995). Perhaps, brain tissue in vivo, as was noted earlier
for astrocytes in culture, up-regulates GSH synthesis in
the face of an oxidative challenge.
In addition to causing an oxidative stress, depletion of
brain GSH can lead to enhanced toxicity toward xenobio-
tics. For example, the agrochemical intermediate L-2
chloropropionic acid is acutely neurotoxic to rats, causing
cerebellar edema and locomotor dysfunction (Wyattefa/.,
1996). The compound destroys cerebellar granule cells.
Toxicity toward these cells is exacerbated by depletion of
GSH with buthionine sulfoximine. On the other hand, glu-
tathione isopropyl ester (a precursor of GSH; see the fol-
lowing section) is protective (Wyatt ef a/., 1996).
Possible Therapeutic Benefits Associated with
Increasing Glutathione Levels
The role of GSH in neuroprotection suggests that raising
tissue GSH levels may be therapeutically beneficial.
Administration of relatively large amounts of GSH to expe-
rimental animals, however, does not result in appreciable
increases in tissue GSH because of poor penetration into
cells (Meister, 1995; Jain ef a/., 1991). In animal models of
GSH deficiency, GSH levels can be restored by admini-
stration of /V-acetylcysteine (A/-Ac) or 2-oxothiazolidine-
4-carboxylate (OTC), two compounds that are converted
to cysteine in vivo. GSH esters are also GSH precursors in
vivo (reviewed by Cooper, 1997). In addition, as noted
above, ascorbate has a sparing effect on GSH (Meister,
1995; Märtensson and Meister, 1992; Jain ei a/., 1994). As
a result of these findings ascorbate, OTC, A/-Ac and GSH
esters have all been considered as possible therapeutic
agents in diseases associate with oxidative stress. For ex-
ample, ascorbate and A/-Ac have been used to treat pa-
tients with hereditary glutathione synthetase deficiency
(Märtensson ei a/., 1989; Jain et a/., 1994). Several studies
have shown that GSH monoester, /V-Ac and OTC sup-
press HIV virus expression in infected human cells
(Harekeh eta/., 1990; Kabelic ef a/., 1991). A/-Ac is espe-
cially effective, presumably because it is an excellent pre-
cursor of GSH and is also an antioxidant (Raju ef a/., 1994).
Castagna et a/. (1995) showed that the decrease in S-
adenosylmethionine and GSH in the CSF of HIV patients
could be redressed by parenteral administration of S-
adenosylmethionine. The above mentioned studies sug-
gest that regimens designed to correct the imbalance in
sulfur-containing amino acids and increase tissue GSH
status may be useful in treating HIV patients and patients
with inborn errors of GSH metabolism. Whether such regi-
mens will prove robust in treating other diseases associa-
ted with oxidative stress or exposure to toxic xenobiotics
remains to be determined.
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Glyoxysomes are specialized peroxisomes present in
various plant organs such as germinating cotyledons
or senescing leaves. They are the site of ß-oxidation
and of the glyoxylate cycle. These consecutive path-
ways are essential to the maintenance of gluconeo-
genesis initiated by the degradation of reserve or struc-
tural lipids.
In contrast to mitochondrial ß-oxidation, which is
prevalent in animal cells, glyoxysomal ß-oxidation and
the glyoxylate cycle have no direct access to the mito-
chondrial respiratory chain because of the impermea-
bility of the glyoxysomal membrane to the reduced
cofactors. The necessity of NAD* regeneration can
conceivably be fulfilled by membrane redox chains
and/or by transmembrane shuttles.
Experimental evidence based on the active metabo-
lic roles of higher plant glyoxysomes and yeast peroxi-
somes suggests the coexistence of two mechanisms,
namely a reductase/peroxidase membrane redox chain
and a malate/aspartate shuttle susceptible to transfer
electrons to the mitochondrial ATP generating system.
Such a model interconnects ß-oxidation, the gly-
oxylate cycle, the respiratory chain and gluconeoge-
nesis in such a way that glyoxysomal malate dehydro-
genase is an essential and exclusive component of
ß-oxidation (NAD* regeneration). Consequently, the
classical view of the glyoxylate cycle is superseded by
a tentative reactional scheme deprived of cyclic char-
acter.
Key words: Beta-oxidation / Gluconeogenesis /
Glyoxylate cycle / Glyoxysomes / Lipids / Peroxisomes.
Introduction
Germination is a critical step in the lifetime of a plant, when
growth is reinduced after a period of metabolic inactivity.
Reserve macromolecules, stored as proteins, lipids or car-
bohydrates during the maturation of seeds, are cataboli-
zed in order to provide carbon and energy to the seedling.
Since lipids do not migrate from cell to cell, oily stores are
first converted into carbohydrates, which are then translo-
cated to the growing root and shoot.
The conversion of lipids involves several consecutive
pathways occurring in various cellular compartments:
(1) Hydrolysis of triglycerides in oleosomes (Huang, 1992;
Garcia-Agustinefa/., 1992),
(2) ß-oxidation (Cooper and Beevers, 1969b) and
(3) glyoxylate cycle (conversion of C2 units into C4 units)
in glyoxysomes (Breidenbach and Beevers, 1967),
(4) partial citric acid cycle (conversion of succinate into
malate) in mitochondria (Cooper and Beevers, 1969a),
and finally
(5) gluconeogenesis in the cytosol (Nishimura and
Beevers, 1979).
A comparable reactional scheme involving structural
lipids has also been observed in various senescing plant
tissues. Senescence, which is initiated by natural or expe-
rimentally triggered photosynthate starvation, is an active
and genetically programmed process leading to the orga-
nized disassembly of biological functions at various lev-
els, from individual cells or specific organs to entire plants
(for a review, see Nooden, 1988). Reserve carbohydrates
are rapidly depleted during senescence, so that lipids be-
come the major energy source for the process, as substra-
tes of the mitochondrial respiration (Dieuaide ef a/., 1992,
1993; Hooks ef a/., 1995). Galactolipids, which are predo-
minant components of thylakoid membranes, are degra-
ded during senescence (Gut and Matile, 1988a, b). Most of
the acyl residues are released as CO2, but a portion is con-
verted into metabolites such as sucrose and glucose
(Wannereia/., 1991). This conversion implies reinitiation of
gluconeogenesis. Reactivation of peroxisomal ß-oxida-
tion has indeed been observed in senescent petals (De
Bellis ef a/., 1991), and glyoxylate cycle activities have
been measured in senescent tissues such as leaves
(Godavariefa/., 1973; Gut and Matile, 1988b; Pistelliefa/.,
1991; Graham ef a/., 1992; Pastori and Del Rio, 1994), co-
tyledons (De Bellis ef a/., 1990; Vincentini and Matile,
1993; Me Laughlin and Smith, 1995; Pistelliefa/., 1995), or
petals (De Bellis ef a/., 1991). Gluconeogenesis enzyme
activities have also been detected in senescent cotyle-
dons (Kim and Smith, 1994).
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During post-germinative growth, the conversion of li-
pids into carbohydrates via ß-oxidation and the glyoxylate
cycle is essential to the development of the seedling,
whereas two situations can be described for the similar
conversion characterizing senescing tissues. For mono-
carpic plants, where whole plant senescence is associ-
ated with the transition from vegetative to reproductive
growth, gluconeogenesis based on structural lipids pro-
vides carbon and energy to the maturing seeds. In con-
trast, gluconeogenesis associated with the seasonal se-
nescence of leaves of a perennial plant results in the
temporary storage of carbohydrates (in the trunk and
roots), which subsequently sustain the chemoheterotro-
phic metabolism of the organism at the onset of the next
growing season, i.e. before photosynthesis is reinitiated.
Mitochondria! and Peroxisomal/Glyoxysomal
Metabolism during Lipid Mobilization
Peroxisomes are ubiquitous small spherical one-mem-
brane organelles that contain H2O2 producing enzymes,
such as urate oxidase, acyl-CoA oxidase, glycolate oxi-
dase or L-amino acid oxidase, as well as H2O2 scavenging
enzymes such as catalase or ascorbate peroxidase. They
contain neither DMA, nor ribosomes or internal membrane
systems. Their granular matrix is amorphous but some-
times contains a paracrystalline dense core, or a protein
crystal (for a review, see Beevers, 1979). Peroxisomes are
bounded by a fragile membrane that is easily broken dur-
ing isolation procedures (for reviews, see Lazarow and
Fugiki, 1985; Van den Bosch ef a/., 1992; Suiter ef a/.,
1993). Glyoxysomes are plant specific peroxisomes first
observed in germinating castor bean (Breidenbach and
Beevers, 1967). They are the sites of two major metabolic
pathways that are active in growing seedlings as well as in
senescing tissues, namely ß-oxidation and the glyoxylate
cycle. The glyoxysome diameter may reach 2-4 ,
whereas the peroxisome typical diameter ranges from 0.1
to 1.7 . The final size of peroxisomes/glyoxysomes
appears to depend on the amount of imported matrix
proteins (Mullen and Trelease, 1996), which in turn is
correlated with the nature and intensity of the prevalent
metabolic pathways.
Several reports on the biogenesis of yeast and mammal
peroxisomes describe them as self-perpetuating organel-
les essentially characterized by processes of prolifera-
tion/enlargement or enlargement/proliferation. The corre-
sponding mechanisms for higher plant peroxisomes have
not yet been elucidated to a comparable extent (for a re-
view, see Mullen and Trelease, 1996).
The ß-oxidation of fatty acids is composed of a recur-
ring sequence of four reactions: first oxidation (dehydro-
genation), hydration, second oxidation, and finally thioly-
sis. Each round of catalysis produces one FADH2, one
NADH2 and one acetyl-CoA. In animal cells, ß-oxidation is
active in mitochondria (where it depends on the carnitine
acyltransferase system for the import of fatty acids), as
well as in peroxisomes. The main function of mito-
chondrial ß-oxidation is to provide the cell with ATP, since
it completely degrades fatty acids and feeds electrons into
the respiratory chain. By contrast, animal peroxisomal ß-
oxidation serves to shorten fatty acids to medium chain
compounds (~ C > 12), which can be channelled into va-
rious metabolic processes.
In plant cells, ß-oxidation mainly occurs in peroxiso-
mes, where degradation of fatty acids reaches completion
(Cooper and Beevers, 1969b; Mutton and Stumpf, 1969).
At the onset of seed germination as well as in senescing
tissues, redirection of the ensuing carbon flow toward glu-
coneogenesis is observed.
The initial dehydrogenation step of ß-oxidation is per-
formed by an acyl-CoA dehydrogenase in mitochondria
and by an acyl-CoA oxidase in peroxisomes. Acyl-CoA
dehydrogenase transfers redox equivalents to the respir-
atory chain and initiates production of ATP, whereas acyl-
CoA oxidase directly uses molecular oxygen as electron
acceptor without recovery of chemical energy (Masterson
ef a/., 1992; Dieuaideef a/., 1993) (Figure 1). Various types
of plant acyl-CoA oxidases that show specific affinities for
long, medium or short acyl-CoA chain lengths have been
identified and purified. Coordinate expression of these en-
zymes provides a control of the levels of substrates and
products of peroxisomal ß-oxidation (Hookseia/., 1995).
In animal systems, multifunctional proteins are known
to participate in the ß-oxidation pathway in mitochondria
(Carpenter ef a/., 1992; Uchida ef a/., 1992), as well as in
peroxisomes (for a review, see Hiltunen ef a/., 1996), where
proteins exhibiting multifunctional enzyme activities are
involved in the degradation of the low amounts of unsatu-
rated fatty acids. It has also been noted that some activi-
ties of the ß-oxidation pathway in plant systems are simi-
larly carried out by multifunctional proteins, or show
multiple locations on several distinct proteins (Kindl,
1992). For example, enoyl-CoA hydratase, hydroxyacyl-
acyNCoA
acyl-CoA oxidase
A^frans-enoyl-CoA
t£-trans-enoyl-CoA \f H2O
hydratase
L(+)-ß-hydröxyacyl-CoA
T J-  NAD+
LM-p-hydroxyacyl-CoA
dehydrate
ß-ketothiolase
ß-ketoacyl-CoA
L-HSCoA
acyl-CoA + acetyl-CoA
Fig. 1 The Peroxisomal ß-oxidation Pathway (Saturated Fatty
Acids), as Proposed by Cooper and Beevers (1969b).
In peroxisomes, the first oxidation is performed by an acyl-CoA
oxidase, whereas the mitochondrial pathway is characterized by
an acyl-CoA dehydrogenase (both enzymes are flavoproteins). It
should also be noted that several activities of peroxisomal (as well
as mitochondrial) ß-oxidation are carried out by multifunctional
proteins. The hydrogen peroxide produced by the oxidase can be
degraded by catalase and/or peroxidase activities.
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CoA dehydrogenase and hydroxyacyl-CoA epimerase ac-
tivities are achieved by a trifunctional protein in the mold
Neurospora crassa (Thieringer and Kunau, 1991) and in
cucumber (Gühnemann-Schäfer and Kindl, 1995).
Plant ß-oxidation is specifically characterized by the
nature of its substrates, since saturated fatty acids, cha-
racteristic of animal triglycerides, are present in plants in
very low amounts only. Degradation of unsaturated or po-
lyunsaturated fatty acids therefore necessitates two addi-
tional enzymes, namely an isomerase and an epimerase
that catalyze the conversions of the produced A3-c/s-
enoyl-CoA and D(-)-ß-hydroxyacyl-CoA to A2-frans-
enoyl-CoA and L(+)-ß-hydroxyacyl-CoA respectively, the
appropriate substrates of hydratase and hydroxyacyl-
CoA dehydrogenase (Kindl, 1992,1993).
Plant mitochondria are a minor site of ß-oxidation,
whose exact role is still unsolved (investigations on ß-oxi-
dation activities in plant tissues have shown that mito-
chondrial and peroxisomal enoyl-CoA hydratases have
distinct kinetic and immunological properties; Miernyk ef
a/., 1991). The low capactiy of this mitochondrial pathway
for long chain fatty acid degradation raises the question of
its in vivo function. Compared to the corresponding pero-
xisomal activity, plant mitochondrial medium-chain fatty
acid ß-oxidation is however not negligible. This suggests
some role for plant mitochondria in the oxidation of me-
dium-chain fatty acids (Dieuaide ef a/., 1993). These orga-
nelles possess carnitine acyltransferase activity (Master-
son ef a/., 1992) just as animal mitochondria do. This
further suggests that fatty acids may be not entirely deg-
raded in plant mitochondria since carnitine transferase
would compete with ß-oxidation enzymes for acyl-CoAs.
This would induce export of shortened acyl-CoA chains. In
other words, ß-oxidation in plant mitochondria might not
reach completion, the ensuing situation being the oppo-
site of that assumed to prevail in animal cells.
At the onset of germination or senescence, acetyl-CoA
produced by ß-oxidation in plant peroxisomes (in this
case more appropriately designated as glyoxysomes) is
transferred in various proportions to the glyoxylate cycle,
which can be considered as a short cut of the citric acid
cycle. The glyoxylate cycle possesses two specific en-
zymes, isocitrate lyase (EC 4.1.3.1) and malate synthase
(EC 4.1.3.2), and 'borrows' three enzyme activities (by
gene duplication) from the citric acid cycle, namely citrate
synthase (EC 4.1.3.7), aconitase (EC 4.2.1.3) and malate
dehydrogenase (EC 1.1.1.37) (Figure 2). This pathway by-
passes the two decarboxylative steps of the citric acid
cycle, and redirects the 2-carbon units produced by ß-oxi-
dation toward gluconeogenesis. In the classical view,
each turn of the cycle integrates two molecules of acetyl-
CoA and produces one molecule of succinate, a citric acid
cycle intermediate that is exported to the mitochondrion
and subsequently initiates gluconeogenesis after oxida-
tion. The glyoxylate cycle was initially described in Psei;-
domonas spp. (Saz and Hillary, 1956; Kornberg and
Madsen, 1957), where it allows growth on acetate as the
sole source of carbon. In plants, the pathway was first de-
nmlate
syntliase
ß-oxidation
I
2 acetyl-CoA
malate
malate etyr°ge^se
 > oxaloacetate -
HSCoA NAD* NADH2
citrate
synthase
citrate
H20 H20
glyoxylate _^
^— isocitrate
succinate
Fig. 2 Glyoxylate Cycle: Classical View.
tected in the endosperm of germinating castor bean
(Kornberg and Beevers, 1957).
The glyoxylate cycle has been localized in glyoxysomes
(Breidenbach and Beevers, 1967), although aconitase ac-
tivity has never been clearly measured in isolated organel-
les. The first interpretations assumed that aconitase is so
soluble that the enzyme is lost during organelle isolation
because of membrane disruption (Cooper and Beevers,
1969a). There is now evidence that glyoxysomes do not
contain aconitase. The enzyme possesses an Fe-S clu-
ster, and measurements by isotropic electronic parama-
gnetic resonance did not reveal any aconitase in the
glyoxysomes (Courtois-Verniquet and Douce, 1993). One
cytosolic aconitase isoform might participate in the
glyoxylate cycle, since developmental changes in the
abundance of this isoform are correlated with increases
and decreases observed for other glyoxylate cycle en-
zymes during seedling growth (Hayashi ef a/., 1995) and
cotyledon senescence (De Bellis ef a/., 1995). The ab-
sence of aconitase in glyoxysomes might be a necessity
due to its strong sensitivity to
 2 2 (Verniquet ef a/., 1991).
Since catalase shows a poor affinity for its substrate (Aebi,
1974), aconitase could not operate in peroxisomes/
glyoxysomes, where continuous production of H2O2 oc-
curs. The glyoxylate cycle thus requires a detour via the
cytosol.
Glyoxylate cycle activities are also present in various
animal tissues, such as the toad urinary bladder
(Goodman ef a/., 1980; Davis ef a/., 1986), embryos, lar-
vae, intestine and muscle of Caenorhabditis elegans
(Kahn and McFadden, 1980; Liu ef a/., 1995), marine bi-
valve mollusks (Benevidesef a/., 1989), rat epiphyseal car-
tilage and liver (Davis ef a/., 1989a, b), chicken liver (Davis
ef a/., 1990a), black bear brown adipose tissue (Davis ef
a/., 1990b), as well as human liver (Davis and Goodman,
1992). The presence of glyoxylate cycle activities in animal
cells suggests that such organisms are able to convert
fatty acids into carbohydrates. Particularly in the case of
the bear brown fat tissue (a heat producing tissue), where
peroxisomal ß-oxidation activities increase and glyoxy-
late cycle activities appear during hibernation. Further-
more, incubation of the tissue in the presence of palmitate
induces an increase of the glycogen content, which indi-
cates that the complete gluconeogenesis pathway based
on lipids is activated (Davis ef a/., 1990b; by contrast, no
such increase occurs in nonhibernating animals). What
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might be the advantage of such a process versus a direct
degradation of fatty acids by mitochondrial ß-oxidation?
Chemical energy initially contained in fatty acids would in
the latter case be recovered as ATP in the mitochondrial
matrix, via the electron transport chain and oxidative
phosphorylation. In terms of ATP production, fatty acid
degradation by peroxisomal ß-oxidation is comparatively
wasteful of chemical energy. It has been suggested that
the heat directly produced by this loss of energy might par-
ticipate in the thermoregulation of the organism (Kramaref
a/., 1978) by a mechanism different from the dissipative
proton pathway based on the mitochondrial uncoupling
protein (thermogenin; for a review of the mitochondrial
mechanism, see Wojtczak and Schonfeld, 1993).
Production of Reduced Cofactors
In peroxisomes, ß-oxidation as well as the glyoxylate cycle
(as postulated by the classical view; see Figure 2) produce
reduced cofactors: two FADH2 and three NADH2 appear
for each exported succinate molecule. These cofactors,
which do not have direct access to the mitochondrial elec-
tron transport system, must nevertheless be reoxidized in
order for both pathways to remain functional. Rat liver
peroxisomes seem to be in vitro freely permeable to low
molecular mass compounds (< 800 Da), such as NADH2 or
NAD* (Van Veldhoven ef a/., 1983), as well as ATP, carnitine
and HSCoA (Van Veldhoven ef a/., 1987). This apparent
permeability might however be due to the rupture of the
membrane during organelle isolation, since yeast peroxi-
somes are in vivo closed compartments impermeable to
NADH2, acetyl-CoA or carnitine (Van Roermund ef a/.,
1995). These results suggest that regeneration of the oxi-
dized cofactors must occur within the glyoxysomal matrix.
The first oxidation step of peroxisomal ß-oxidation is cata-
lyzed by an acyl-CoA oxidase, and the redox equivalents
are directly transferred to molecular oxygen (Figure 1). In
contrast, NADH2 produced by hydroxyacyl-CoAdehydro-
genase and by malate dehydrogenase in the glyoxylate
cycle accumulates in the matrix of isolated glyoxysomes
(Cooper and Beevers, 1969b).
Two models have been proposed for the reoxidation of
NADH2:
(1) Oxidation by a membrane dehydrogenase, or
(2) transfer of redox equivalents to another cellular com-
partment via an appropriate shuttle.
These two systems will be explained and discussed in
view of the overall equilibrium of the correlated metabolic
pathways.
Regeneration of Oxidized Cofactors via a
Membrane Redox Chain
The electron acceptors cyt c and ferricyanide have been
instrumental in the characterization of the glyoxysomal re-
dox system, in an approach similar to that already used in
the investigation of the ER (endoplasmic reticulum) elec-
tron transport. NADH2 and NADPH2 dehydrogenase ac-
tivities have thus been measured in glyoxysome membra-
nes isolated on sucrose gradients (Hicks and Donaldson,
1982; Donaldson and Fang, 1987; Luster and Donaldson,
1 987). The membranes were also shown to contain cyt bs
and cyt P420, a degradation product of cyt P450 (Fang ef a/.,
1 987). These dehydrogenases would be capable of trans-
ferring reducing equivalents generated by the glyoxyso-
mal matrix metabolism to an acceptor across the glyoxy-
somal membrane. The proposed model (Figure 3) is
analogous to the electron transport chain found in mam-
malian liver microsomes, which consists of two compo-
nents:
(1) A NADH2 dehydrogenase flavoprotein able to reduce
ferricyanide or to directly transfer electrons to cyt b5,
and
(2) a cyt b5 which can reduce cyt c (Hicks and Donaldson,
1982; Luster and Donaldson, 1987; Struglics ef a/.,
1993).
Several tests were performed in order to validate the pro-
posed system. Palmitoyl-CoA and malate oxidations can
be coupled to ferricyanide or cyt c reduction, as demon-
strated with the acceptors NAD+, ferricyanide or cyt c
(Donaldson and Fang, 1987). When membrane preparati-
ons (washed with 0.1 M Na2CO3 in order to completely re-
move the matrix) were combined with matrix fractions,
matrix dehydrogenases were able to transfer reducing
equivalents to membrane reductases (NADH2 dehydroge-
nases; Fang ef a/., 1 987). The in vitro activities of these en-
zymes are sufficient to handle a considerable portion of
the NADH2 flux in glyoxysomes as evaluated by the activ-
ity of acyl-CoA oxidase, which catalyzes the ß-oxidation
rate-limiting step (Hicks and Donaldson, 1982). However,
since the physiological acceptors of the redox compo-
nents are not known, the actual capabilities of such a
membrane electron transport system may be different
from the rates measured with experimental acceptors.
Electron transport through the glyoxysomal membrane
would require an appropriate orientation of the NADH2 de-
hydrogenase in the membrane, and this has been evalua-
ted using intact or deliberately broken glyoxysomes.
Enzyme latency phenomena have been extensively used
to assess the integrity of both outer and inner mito-
chondrial membranes, because these barriers prevent the
immediacy of various enzymatic reactions. However, ma-
hydroxyacyl-CoA
^— NAD+*^
^NADH2-^
ketoacyl-CoA
s*- ferrocyanide -s^
— ferricyanide +<
.-oxcytb5^.
^redcytb5^
^*> red cyt c
— ox cyt c
Fig. 3 Reoxidation of the Nicotinamide Coenzyme after its Re-
duction by the Second Redox Step of ß-oxidation (Scheme 1 ).
The reducing equivalents are transferred to an external acceptor
by membrane redox compounds. This scheme is based on the
NADH2:ferricyanide and cyt c reductase activities measured in
vitro in the glyoxysomal membrane.
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trix enzymes can be organized into functional clusters
(metabolons); this supposedly allows the direct inter-
change of metabolites, but might also create additional la-
tency phenomena. Such 'reactional compartmentation'
has for example been observed in leaf peroxisomes
(Heupel etal., 1991; Heupel and Heldt, 1994) and in coty-
ledon glyoxysomes(Guexef a/., 1995). In leaf peroxisomes,
the suborganelle compartmentation remains functional
after osmotic shock, so that isolated organelles lacking an
intact boundary membrane can channel their photorespi-
ratory metabolites within the remaining structures, and
enzyme latency is still observed. In addition, it is well es-
tablished that glyoxysomes are fragile organelles and that
their membranes are damaged during isolation procedu-
res. This could explain why electron donor and acceptor
sites have been assumed to be located on both sides
of the membrane, even when latency experiments sug-
gested that the organelles were intact (Luster and
Donaldson, 1987).
The evolution of NADH2 dehydrogenase activities in the
course of germination has already been determined. The
results suggest that the ER and the glyoxysomal membra-
nes are enriched with redox proteins during their develop-
ment. It is observed that the increase and decrease of the
redox activities are coordinated with the glyoxylate cycle
activities, with a peak on the 5th day after germination
(Alani etal., 1990). This peak actually corresponds to a ge-
neral maximum in the metabolism of the endosperm,
which is strongly active at the onset of germination and
then atrophies after depletion of its metabolic reserves.
More intriguing is the NADPH2 dehydrogenase activity
measured in the glyoxysomal membrane. Isocitrate dehy-
drogenase specific for NADP+ is believed to exist in the
matrix of animal peroxisomes (Masters and Crane, 1995).
In plant glyoxysomes, the presence of such an enzyme
concurrently with isocitrate lyase would be detrimental,
since the organelle compartmentation of the glyoxylate
and citric acid cycles is supposed to appropriately prevent
the partition of isocitrate between nonhydrolytic cleavage
and oxidative decarboxylation. The activity of a glyoxyso-
mal isocitrate dehydrogenase would induce a net loss of
organic carbon during germination, whereas the glyoxy-
late cycle precisely redirects the carbon flow to gluconeo-
genesis with a minimum loss. The very minor isocitrate de-
hydrogenase (NADP*) activity measured in isolated
glyoxysomes (Cooper and Beevers, 1969a) cannot ac-
tually be considered as significant, and the function of the
high proportion (16%) of total cellular NADP(H2) in these
organelles (Donaldson, 1982) therefore remains unclear.
All these experiments were performed on glyoxysomes
isolated on density gradients. In order to control that the
reductase activities measured in these membranes were
not due to contamination by microsomal membranes, the
rate of contamination was evaluated using marker en-
zymes. The purification of organelles does not result in the
strict separation of organelles, but the observed level of
contamination remains comparatively low. It appears in
such a situation that the NAD(P)H2 dehydrogenase activi-
ties measured in the glyoxysomal membranes were grea-
ter than what could be expected from contaminations by
the ER (Fang etal., 1987). However, when soybean glyoxy-
somes isolated on a sucrose gradient are gently resus-
pended and reloaded on a second gradient, residual cyt c
oxidase activity (a mitochondrial marker) is detected as a
sharp band corresponding to the density of mitochondria
(C.L. Escher, unpublished results). This observation indi-
cates that mitochondria contaminate the glyoxysomal
fractions, even if their marker enzyme activity may first be
overlooked. Similar contaminations were shown to be re-
sponsible for the mislocations of putative glyoxysomal
membrane proteins (for a review, see Mullen and Trelease,
1996). Systematic cross-contamination of membrane ma-
terial would of course mitigate the hypothesis of a glyoxy-
somal membrane redox chain involving cyt b5, and might
explain why the ER and glyoxysomal membrane redox
systems appear to be similar, as observed after isolation
on density gradients. Both membranes possess the same
redox proteins [cyt b5, cyt P420, NADH2 dehydrogenases;
Hicks and Donaldson, 1982) and NADPH2 dehydrogen-
ases (Fang et a/., 1987)], although the ER is relatively defi-
cient in flavin as compared to glyoxysomal membranes
(Hicks and Donaldson, 1982). NADH2:ferricyanide reduc-
tases isolated from both membranes are homologous
(Luster ef a/., 1988), and even immunologically indistinct
(Struglicsefa/., 1993). However, the glyoxysomal NADH2:
ferricyanide reductase is specific for the ß-hydrogen of
NADH2 (Struglics ef a/., 1993), whereas the ER enzyme is
-specific (You ef a/., 1978). ER and glyoxysomal mem-
brane proteins show similar resistance to carbonate ex-
traction compared to KCI washing, similar elution profiles
when submitted to reverse phase chromatography on a
C-18 HPLC column, and comparable mobilities in SDS
polyacrylamide gel electrophoresis (Donaldson and Gon-
zalez, 1989). Proteins recognized as common to glyoxy-
somal and ER membranes were found in similar a-
mounts in both membranes. This observation is particu-
larly intriguing in view of the postulated biogenesis of
glyoxysomes, since the glyoxysomal membrane proteins
are not synthesized on the ER but on cytosolic free poly-
somes (for reviews, see Trelease, 1984; Lazarow and
Fugiki, 1985; Suiter ef a/., 1993).
With respect to the supposed occurrence of reductase
activities in the glyoxysomal membrane, it is sensible to
consider that the performed experiments do not properly
represent the functioning of the in vivo system, since fer-
ricyanide is not a physiological compound, and cyt c is lo-
cated in vivo within the mitochondrial membrane. A tenta-
tive hypothesis had previously suggested the transfer of
reducing equivalents by primary electron acceptor® from
glyoxysomes to secondary acceptor® in the cytosol, and
finally to the mitochondrial respiratory chain. The ascor-
bate/dehydroascorbate pair would be a good candidate
as an electron mediator, because of its apparent ubiquity
in plant cells were it functions as redox buffer, and its fa-
vorable reduction potential with respect to the NADH2/
NAD+ pair. NADH2:dehydroascorbate reductase activity
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has indeed been measured in glyoxysomal membranes,
and this enzyme exhibits characteristics similarto those of
the putative NADH2:ferricyanide reductase, such as in-
sensitivity to trypsin digestion or to inactivation by Triton
X-100 (Bowditch and Donaldson, 1990). This suggests
that dehydroascorbate may be reduced by the same en-
zyme that reduces ferricyanide in vitro. Reoxidation of as-
corbate could conceivably be performed by an ascorbate
peroxidase, but this would obviously preclude any elec-
tron transport to a respiratory chain. Very few membrane
proteins have been proven to be peroxisomal/glyoxyso-
mal, but immunogold labeling (using an antibody raised
against a 31 kDa glyoxysomal membrane protein; Yama-
guchi ef a/., 1995a) definitely demonstrated the glyoxyso-
mal nature of ascorbate peroxidase (Yamaguchi ef a/.,
1995b). Its active site is now predicted to be on the matrix
side of the membrane, and it is assumed that all oilseed
glyoxysomes possess such an enzyme (Bunkelmann and
Trelease, 1996). The substrates of ascorbate peroxidase
are ascorbate and H2O2; if the presence of ascorbate in the
glyoxysomal matrix has yet not been reported, H2O2 is ef-
ficiently produced by oxidases and Superoxide dismuta-
ses.
The latter enzymes have been immunocytochemically
localized in the peroxisomal membrane (Del Rio ef a/.,
1983), where they constitute a protective mechanism
against Superoxide radicals (for a review, see Del Rio ef a/.,
1992). Superoxide radicals may be generated in these or-
ganelles by side reactions of the matrix xanthine oxidase
and of membrane NADH2 dehydrogenases (Sandalio ef
a/., 1988; Del Rio and Donaldson, 1995).
Dismutation of hydrogen peroxide by glyoxysomal ca-
talase might not be very efficient, because of a Km value in
the 1 -5 M range indicative of a low affinity between ca-
talases of various origins and their substrate (Aebi, 1974;
Huang ef a/., 1983). This property mitigates the in vivo sig-
nificance of the long established high molecular activity of
such enzymes (Barman, 1969; Schonbaum and Chance,
1976). Consequently, low concentrations of hydrogen
peroxide may be more effectively 'scavenged' by ascor-
bate peroxidase (Bunkelmann and Trelease, 1996), whose
Km value is in the 30-80mM range (Chen and Asada,
1989). Moreover, since catalase is inhibited by semidehy-
droascorbate (Davison ef a/., 1986), high concentrations
of ascorbate would further favor the ascorbate peroxidase
pathway for H2O2 degradation.
The coordinated effects of NADH2:dehydroascorbate
reductase and ascorbate peroxidase would thus simulta-
neously allow regeneration of NAD* and scavenging of re-
sidual H2O2 (Figure 4). This pathway does not involve any
transfer of electrons across the glyoxysomal membrane
toward an ATP producing system. Formally, the proposed
mechanism is stoichiometrically correct if all the H2O2 pro-
duced by acyl-CoA oxidase is reduced by ascorbate per-
oxidase. However, when glyoxysomal ß-oxidation is
strongly active (resulting in the production of significant
amounts of hydrogen peroxide), catalase efficiently com-
petes with ascorbate peroxidase. The dehydroascorbate
acyl-CoA acyl-CoA oxidase catalaseId,
enoyl-CoA
-H20
hydroxyacyl-CoA
ketoacyl-CoA
-HSCoA
2H20
NADH2:
deltydroascorbate reductase
acyl-CoA + acetyl-CoA
Fig. 4 Reoxidation of the Nicotinamide Coenzyme after its Re-
duction by the Second Redox Step of ß-oxidation (Scheme 2).
The reducing equivalents are transferred to matrix dehydroascor-
bate by an NADH2:dehydroascorbate reductase. The produced
ascorbate is then reoxidized by a membrane ascorbate peroxi-
dase.
reductase/peroxidase system may not therefore consti-
tute the primary mechanism for NAD* regeneration and
H2O2 elimination in glyoxysomes, but it certainly provides
an essential pathway for the protection of the glyoxysomal
membrane against reactive oxygen species, and sustains
the pool of NAD* required for postgerminative seedling
growth (Bunkelmann and Trelease, 1996).
Regeneration of Oxidized Cofactors via a
Transmembrane Shuttle
Another way to overcome a membrane barrier is to use a
shuttle. Such systems have been described for the trans-
fer of electrons from cytosol to mitochondria, which is
mediated by a glycerol-3-phosphate/dihydroxyacetone-
phosphate shuttle, and by a malate/aspartate shuttle. A
similar system may be considered with regard to the ne-
cessity of NAD* regeneration sustaining glyoxysomal/
peroxisomal ß-oxidation. The observation that specific
activities of the glyoxysomal forms of malate dehydrogen-
ase and aspartate aminotransferase are 10 to 100-fold
higher than those of other glyoxysomal enzymes (Cooper
and Beevers, 1969a; Schnarrenberger ef a/., 1971) sug-
gested indeed that malate and aspartate might be in-
volved in the transfer of electrons between glyoxysomes
or leaf peroxisomes and other cellular compartments
(Schnarrenberger ef a/., 1971; Tolbert, 1971). This hypo-
thesis postulates that reducing equivalents are exported
as malate, which is oxidized elsewhere in the cell, e.g. in
mitochondria, where high malate dehydrogenase and as-
partate aminotransferase activities are observed. In order
to maintain the required carbon balance and thus to en-
sure a shuttle mechanism, oxaloacetate returns to the
glyoxysome as aspartate, which is reconverted into oxalo-
acetate by aspartate aminotransferase (Figure 5; Mettler
and Beevers, 1980). In this scheme, glyoxysomal malate is
not converted into oxaloacetate as previously assumed in
the case of an 'independent' glyoxylate cycle (Figure 2),
since glyoxysomal malate dehydrogenase would now
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Fig. 5 Reoxidation of the Nicotinamide Coenzyme after Its Reduction by the Second Redox Step of ß-oxidation (Scheme 3), as Pro-
posed by Mettler and Beevers (1980).
The reducing equivalents are transferred to the mitochondrial matrix by a malate/aspartate shuttle. Nonstandard abbreviations: gAATand
mAAT, glyoxysomal and mitochondrial aspartate aminotransferases; gMDH and mMDH, glyoxysomal and mitochondrial malate dehy-
drogenases; OA, oxaloacetate, 2-OG, 2-oxoglutarate.
function in the reductive direction to consume NADH2 and
generate malate. Malate oxidation by malate dehydrogen-
ase is a thermodynamically unfavorable reaction. Whether
malate or oxaloacetate is formed by malate dehydrogen-
ase actually depends on physiological parameters such
as the NADH2/NAD+ balance. Since this ratio is maintained
at a high level by glyoxysomal ß-oxidation, oxaloacetate
reduction to malate is favored over the reverse reaction.
The opposite situation prevails in mitochondria because
NADH2 is readily reoxidized by an efficient electron trans-
port chain.
Various tests were performed in order to assess the ex-
istence of this shuttle. Addition of aspartate and 2-oxo-
glutarate to purified glyoxysomes induces a rapid oxida-
tion of accumulated NADH2, and this oxidation is pre-
vented by aminooxyacetate, which is an inhibitor of
aminotransferase reactions (Mettler and Beevers, 1980).
The postulated shuttle requires regulated transports of
malate, glutamate, aspartate and 2-oxoglutarate through
the glyoxysomal and mitochondrial membranes. For
transport studies, glyoxysomes purified on sucrose gradi-
ents at their buoyant density (1.25g/cm3; Huang, 1975)
must first be resuspended, but since these organelles are
very sensitive to osmotic shocks, no evidence could be
obtained for specific transmembrane transport mecha-
nisms for the shuttle intermediates (Mettler and Beevers,
1980). If the presence of transporters in the glyoxysomal
membrane has not been proven, it has to be borne in
mind that succinate transport from glyoxysomes to mito-
chondria is well accepted even if the corresponding trans-
porter has not been found. Moreover, the photorespiratory
pathway also involves intermediate transport through the
membranes of different organelles, namely chloroplasts,
peroxisomes and mitochondria (for a review, see Gietl,
1992). In this reactional mechanism, NADH2 required for
peroxisomal hydroxypyruvate reduction is equimolar to
NADH2 generated by mitochondrial glycine oxidation.
Since malate dehydrogenase activity has been measured
in leaf peroxisomes (Yamazaki and Tolbert, 1969), redox
equivalents are assumed to be transferred from the mito-
chondrial matrix to the peroxisomal compartment by a
malate/aspartate shuttle (Ebbighausen ef a/., 1987; Reu-
mann ef a/., 1994). The transport of the shuttle intermedi-
ates across the peroxisomal membrane could be medi-
ated by diffusion through specialized pores. The per-
oxisomal membrane contains a channel forming protein
('porin-like channel'), as demonstrated by purification
from isolated organelles and reconstitution (Reumann ef
a/., 1995). The conductance of this channel is 10 to 20-fold
lower than that of mitochondria or plastids, which are per-
meable to hydrophilic molecules up to 4 - 5 kDa (Fischer ef
a/., 1994). The diameter of peroxisomal channels has been
estimated at about 1 nm, and thus appears to be just large
enough to let photorespiratory metabolites pass through
(Reumann ef a/. ,1995).
Isolation of glyoxysomes/peroxisomes is necessary in
order to experimentally validate the hypothesis of a similar
shuttle possibly required for NAD+ regeneration (ß-oxida-
tion). In this process, partial tearing of the organelle mem-
brane cannot be avoided, and the evolution of the ob-
served reactions is further affected by the in vitro con-
ditions, such as pH and intermediate concentrations. For
example, malate oxidation by malate dehydrogenase will
inevitably be detected (instead of the opposite reaction re-
quired by the shuttle) when electron acceptors are added
in such a concentration that the overall equilibrium of the
reaction is suitably altered (Donaldson and Fang, 1987).
Therefore, the establishment of the in vivo pathway be-
yond any reasonable doubt definitely requires investiga-
tions on intact cells. Such experiments were carried out
using transformed Saccharomyces cerevisiae strains. The
inactivation of peroxisomal malate dehydrogenase by dis-
ruption of the corresponding gene results in an impaired
ß-oxidation capacity, which prevents cell growth on oleate
and induces a strong accumulation of hydroxyacyl-CoA
intermediates (Van Roermund ef a/., 1995). In contrast,
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Fig. 6 Glyoxylate Cycle Activities as the Essential Intermediate between Fatty Acid Catabolism and Gluconeogenesis.
The circled enzymes are: (1) citrate synthase, (2) aconitase (cytosolic isoform), (3) isocitrate lyase, (4) malate synthase, and (5) malate de-
hydrogenase (its reduction of oxaloacetate results in the regeneration of glyoxysomal NAD*). Nonstandard abbreviations: OA, oxaloace-
tate, 2-OG, 2-oxoglutarate.
growth of transformed yeast on C2 or C3 compounds,
such as acetate, ethanol or glycerol (known to be 'up-
stream substrates' of the glyoxylate cycle) is unaffected
(Van Roermund ef a/., 1995). These results suggest that
glyoxysomal/peroxisomal malate dehydrogenase is es-
sentially involved in the reoxidation of NADH2 generated
by fatty acid -oxidation and does not therefore constitute
a critical component of a 'classical' glyoxylate cycle.
Interplay between Glyoxysomal, Cytosolic and
Mitochondria! Reactional Pathways
The occurrence of the putative malate/aspartate shuttle is
supported by the thermodynamic parameters affecting
oxaloacetate<->malate interconversions as well as by me-
tabolic needs, and this imposes a reassessment of the
current views on the glyoxylate cycle. The initiation of the
cycle is considered to be the citrate synthase catalyzed
production of citrate from acetyl-CoA and oxaloacetate.
Acetyl-CoA can readily be formed by -oxidation of fatty
acids, and it has been assumed that oxaloacetate is pro-
duced from malate by the highly active glyoxysomal ma-
late dehydrogenase. However, since it cannot now be ru-
led out that malate dehydrogenase would function in vivo
in the reductive direction (thus catalyzing conversion of
oxaloacetate into malate), the interconnections between
-oxidation, the glyoxylate cycle, the respiratory chain
and gluconeogenesis may be different and/or more intri-
cate than previously thought. The in vivo occurrence of a
glyoxylate cycle stricto sensu might in particular be ques-
tioned. Figure 6 (Escher, 1996) proposes that glyoxyso-
mal malate dehydrogenase is an essential and exclusive
component of -oxidation (NAD* regeneration). Its sub-
strate oxaloacetate derives from the malate/aspartate
shuttle, which also meets the need of citrate synthesis.
The transport of succinate to the mitochondrion would
equilibrate the shuttle. In this overall scheme, it is also con-
sidered that the C4 metabolite initiating gluconeogenesis
would formally be malate resulting from the malate syn-
thase catalyzed condensation of acetyl-CoA and glyoxy-
late.
Concluding Remarks
The sustenance of active gluconeogenesis initiated by li-
pid degradation during the germination and senescence
processes presupposes that the glyoxysomal matrix is the
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site of efficient ß-oxidation and acetyl-CoA condensation
reactions. Since the organelle membrane is not permeable
to produced reduced cofactors, their//? situ reoxidation is
required. The readily available acceptor for the electrons
generated by the flavine containing acyl-CoA oxidase is
molecular oxygen,with subsequent elimination of the pro-
duced hydrogen peroxide by catalase and/or peroxidase
activities. It is reasonable to assume that the reoxidation of
NADH2 produced by hydroxyacyl-CoA dehydrogenase is
not independent of this reactional scheme, since the
membrane dehydroascorbate reductase/peroxidase sys-
tem is a likely candidate as a regeneration mechanism
of NAD+, concurrently with the malate/aspartate shuttle
connected to the mitochondrial respiratory chain. Both
the reductase/peroxidase system and the shuttle might
coexist in a dynamic equilibrium depending on the simul-
taneous and varying necessities of NADH2 reoxidation,
protection against damages by hydrogen peroxide and
demand for ATP.
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